| 1 |
Rilvegostomig, Tremelimumab
|
|
271 KB
|
| 2 |
Zilebesiran
|
|
327 KB
|
| 3 |
CYB704 (Ocrelizumab) 300mg/ 10 mL concentrate for solution for infusion
|
|
279 KB
|
| 4 |
QL2107 Injection
|
|
274 KB
|
| 5 |
Sacituzumab tirumotecan
|
|
270 KB
|
| 6 |
LY3298176 (Tirzepatide), LY3437943 (Retatrutid e)
|
|
283 KB
|
| 7 |
LY3537031
|
|
272 KB
|
| 8 |
Dexamethasone sodium phosphate
|
|
312 KB
|
| 9 |
LY3537031
|
|
277 KB
|
| 10 |
LY3502970
|
|
275 KB
|
| 11 |
Sacituzumab tirumotecan
|
|
273 KB
|
| 12 |
LY3537031
|
|
279 KB
|
| 13 |
Aflibercept
|
|
275 KB
|
| 14 |
"(i) Delafloxacin Tablets 450 mg (ii) Delafloxacin for Injection 300 mg/vial"
|
|
1498 KB
|
| 15 |
Avatrombopag Tablets 20 mg
|
|
1496 KB
|
| 16 |
Respiratory Syncytial Virus Vaccine -PF-06928316
|
|
481 KB
|
| 17 |
Tapinarof Topical Cream 1%
|
|
1365 KB
|
| 18 |
Inactivated Influenza Vaccine (Split Virion) I.P. (Trivalent) in Single dose (0.5 ml)
|
|
474 KB
|
| 19 |
Purified Vero Cell Rabies Vaccine (PVRV) (Human) (R-VAC-002)
|
|
464 KB
|
| 20 |
Zanubrutinib Capsules 80 mg
|
|
2856 KB
|
| 21 |
Ensifentrine Inhalation Suspension 3mg (3 mg/2.5ml)
|
|
1571 KB
|
| 22 |
Drospirenone and Estetrol tablets (3 mg + 14.2 mg)
|
|
1217 KB
|
| 23 |
Letermovir Tablets 240mg and 480mg
|
|
1373 KB
|
| 24 |
T1695 (Tacrolimus)
|
|
275 KB
|
| 25 |
Balinatunfib 100 mg Tablets
|
|
321 KB
|
| 26 |
BIIB141 or RTA-408 (Omaveloxolone)
|
|
305 KB
|
| 27 |
icotrokinra (JNJ-77242113)
|
|
287 KB
|
| 28 |
RO7837195 100mg/1ml Powder for solution for injection
|
|
273 KB
|
| 29 |
68Ga-EVG321
|
|
268 KB
|
| 30 |
Trospium Chloride+Xanomeline
|
|
270 KB
|
| 31 |
Trastuzumab Deruxtecan
|
|
270 KB
|
| 32 |
Quadrivalent Human Papillomavirus (Type 6, 11, 16, 18) Vaccine (Recombinant)
|
|
337 KB
|
| 33 |
Equine Klebsiella Immunoglobulin Injection 500 mg/5ml (100mg/ml)
|
|
1129 KB
|
| 34 |
Elagolix Tablets 200 mg
|
|
949 KB
|
| 35 |
Eluxadoline Tablets 100 mg
|
|
968 KB
|
| 36 |
SPY001-001; SPY002-091
|
|
291 KB
|
| 37 |
BAY 3401016
|
|
284 KB
|
| 38 |
Trospium Chloride+Xanomeline
|
|
2009 KB
|
| 39 |
JPB898 (Nivolumab) 10mg/ml (240mg/24ml) Concentrate for solution for infusion
|
|
2022 KB
|
| 40 |
VAY736 (Ianalumab)
|
|
2011 KB
|
| 41 |
Mezagitamab (TAK-079)
|
|
322 KB
|
| 42 |
JNJ-61186372 (amivantamab)
|
|
294 KB
|
| 43 |
Recombinant Human Serum Albumin (rHSA) 20%
|
|
265 KB
|
| 44 |
BMS-986369 CC-99282
|
|
2006 KB
|
| 45 |
Brexpiprazole Tablets 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg
|
|
4447 KB
|
| 46 |
Etofenamate Gel 10%w/w
|
|
1138 KB
|
| 47 |
Nelarabine Injection (250 mg/50 ml)
|
|
1019 KB
|
| 48 |
Revefenacin inhalation solution. 175 mcg /3ml
|
|
911 KB
|
| 49 |
Plecanatide Tablets 3 mg
|
|
966 KB
|
| 50 |
"Delafloxacin Tablets 450 mg Delafloxacin for Injection 300 mg/vial "
|
|
1243 KB
|
| 51 |
Suvorexant 20 mg Tablets
|
|
1061 KB
|
| 52 |
Vedolizumab Solution for Injection, 108 mg/0.68 mL in pre-filled syringe
|
|
373 KB
|
| 53 |
Tislelizumab Injection 100mg(10ml)/Vial
|
|
524 KB
|
| 54 |
Suvorexant Tablets 10 mg, 15mg and 20mg
|
|
1226 KB
|
| 55 |
Inactivated Kyasanur Forest Disease (KFD) Vaccine
|
|
321 KB
|
| 56 |
Meningococcal Group A, C, W-135, Y, X Conjugate Vaccine (Adsorbed & Unadsorbed)
|
|
1879 KB
|
| 57 |
Inactivated Influenza Vaccine (Split Virion) I.P. (Tetravalent) [VaxiFluTM-4] + LiteVax Adjuvant (LVA)
|
|
339 KB
|
| 58 |
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae type b conjugate vaccine (Adsorbed) I.P.
|
|
337 KB
|
| 59 |
Typhoid Bivalent Conjugate Vaccine
|
|
337 KB
|
| 60 |
Measles-Rubella (MR) Vaccine, Live, Attenuated (Freeze-dried) I.P.
|
|
360 KB
|
| 61 |
BE1040V INJECTION 400 MG / 16ML
|
|
530 KB
|
| 62 |
MP14 (Omalizumab) solution for injection 150 mg/mL in pre-filled syringe
|
|
525 KB
|
| 63 |
Sodium Zirconium Cyclosilicate powder for oral Suspension 5g/ 10g
|
|
973 KB
|
| 64 |
Mepolizumab
|
|
755 KB
|
| 65 |
Certolizumab Pegol
|
|
241 KB
|
| 66 |
"Cenobamate Tablets 12.5 mg, 25 mg, 50 mg, 100 mg, 150 mg, 200 mg "
|
|
1372 KB
|
| 67 |
Denosumab Injection 120 mg/1.7 mL (70 mg/mL)
|
|
524 KB
|
| 68 |
BMS-986489 FDC (BMS-986012+Nivolumab)
|
|
271 KB
|
| 69 |
Atacicept
|
|
275 KB
|
| 70 |
PYX-201 Solution for Injection/Infusion, 100mg/6.67 mL (15mg/mL)
|
|
266 KB
|
| 71 |
Flomoxef (Flumarin) Fosfomycin (Fomicyt)
|
|
306 KB
|
| 72 |
Phenazopyridine hydrochloride
|
|
277 KB
|
| 73 |
Saruparib (AZD5305)
|
|
274 KB
|
| 74 |
AZD6793 5 mg or 15 mg or 45 mg or Placebo Tablets
|
|
277 KB
|
| 75 |
Fluticasone furoate and vilanterol inhalation powder 100mcg/25mcg
|
|
293 KB
|
| 76 |
Trastuzumab Deruxtecan
|
|
271 KB
|
| 77 |
Verekitug (UPB-101)
|
|
278 KB
|
| 78 |
AAA817 - [225Ac]Ac-PSMA-617
|
|
269 KB
|
| 79 |
PF-07248144
|
|
280 KB
|
| 80 |
Erythropoietin 4000 IU Pre-filled syringe for intravenous injection
|
|
240 KB
|
| 81 |
Sotatercept
|
|
240 KB
|
| 82 |
Nivolumab
|
|
723 KB
|
| 83 |
Utreglutide
|
|
278 KB
|
| 84 |
LY3502970
|
|
272 KB
|
| 85 |
TQJ230
|
|
302 KB
|
| 86 |
Vicadrostat (BI 690517)
|
|
276 KB
|
| 87 |
Adagrasib
|
|
281 KB
|
| 88 |
BMS-986510 (KarXT) (Xanomeline+Trospium Chloride)
|
|
310 KB
|
| 89 |
vicadrostat (BI 690517)
|
|
276 KB
|
| 90 |
Bemnifosbuvir+Ruzasvir
|
|
281 KB
|
| 91 |
Azurity Cabozantinib Tablets
|
|
274 KB
|
| 92 |
Dexpramipexole dihydrochloride monohydrate
|
|
276 KB
|
| 93 |
"Datopotamab Deruxtecan (DS- 1062a) Lyophilised powder for concentrate for solution for infusion 100 mg/vial"
|
|
1715 KB
|
| 94 |
Belantamab mafodotin
|
|
1707 KB
|
| 95 |
Lumateperone
|
|
1715
|
| 96 |
LY3502970
|
|
272 KB
|
| 97 |
Sacituzumab vedotin (ZRC-3328) 50 mg/ vial
|
|
561 KB
|
| 98 |
Afrezza® Insulin human Inhalation powder (r DNA origin) 4 units/8 units/12 units per cartridge plus Inhaler
|
|
240 KB
|
| 99 |
Tapinarof cream 1% w/w
|
|
1363 KB
|
| 100 |
Vibegron Tablets 75 mg
|
|
1363 KB
|
| 101 |
Biphasic Insulin Aspart Injection (30/70) IP 100IU/mL (30% as soluble Insulin Aspart & 70% as Insulin Aspart Protamine Suspension)
|
|
382 KB
|
| 102 |
Remimazolam Besylate 20mg lyophilized powder for injection
|
|
1888 KB
|
| 103 |
Revefenacin Inhalation solution 175 mcg/3ml
|
|
1010 KB
|
| 104 |
Cenobamate Tablets 12.5 mg, 25 mg, 50 mg, 100 mg, 150 mg and 200 mg
|
|
1499 KB
|
| 105 |
Pertuzumab 420 mg/14 mL (30mg/mL) Concentrate solution for intravenous infusion (r-DNA origin)
|
|
241 KB
|
| 106 |
Trastuzumab Deruxtecan48530
|
|
271 KB
|
| 107 |
LY3502970Eli
|
|
275 KB
|
| 108 |
PF-07899801 (Rimegepant)
|
|
273 KB
|
| 109 |
BI 1291583
|
|
272 KB
|
| 110 |
AZD0780 30mg Tablet or PlaceboAZ
|
|
286 KB
|
| 111 |
Leuprolide acetate for injectable suspension, 30 mg
|
|
273 KB
|
| 112 |
Semaglutide tablets 3 mg, 7 mg and 14 mg
|
|
524 KB
|
| 113 |
Insulin Glargine 100 IU/ml (r-DNA origin) Injection
|
|
524 KB
|
| 114 |
Cenobamate Tablets 12.5mg, 25mg, 50mg, 100mg, 150mg and 200mg
|
|
2752 KB
|
| 115 |
Trivalent Nanoparticle Influenza (tNIV) Vaccine & Covid Trivalent Influenza Combination (CIC) Vaccine.
|
|
617 KB
|
| 116 |
Bivalent Typhoid and Paratyphoid A Conjugate Vaccine
|
|
353 KB
|
| 117 |
Abrocitinib or PF-04965842
|
|
271 KB
|
| 118 |
Pegozafermin 49422
|
|
286 KB
|
| 119 |
Yellow Fever Vaccine, Live, Attenuated (Freeze-dried)
|
|
2527 KB
|
| 120 |
SARS-CoV-2 (Covid-19) Vaccine (Variant JN.1)
|
|
776 KB
|
| 121 |
Revefenacin Inhalation solution 175 mcg/3ml (M/s BDR)
|
|
118 KB
|
| 122 |
Envafolimab injection 200mg/1ml.
|
|
796 KB
|
| 123 |
BHV-7000 PPD
|
|
662 KB
|
| 124 |
BHV-7000
|
|
309 KB
|
| 125 |
Tapinarof cream 1%
|
|
4628 KB
|
| 126 |
Cenobamate Tablets 12.5mg,25mg,50mg100mg,150mg,200mg
|
|
2855 KB
|
| 127 |
Zastaprazan Citrate Tablets 20mg
|
|
2889 KB
|
| 128 |
Gefapixant Tablets 45mg
|
|
3407 KB
|
| 129 |
Baxdrostat Tablets 1 mg or 2 mg or placebo
|
|
271 KB
|
| 130 |
1. Mirikizumab 300 mg/15 mL (20 mg/mL) solution for infusion in a single-dose vial 2. Mirikizumab 100 mg/mL solution in a single-dose prefilled pen for subcutaneous use
|
|
524 KB
|
| 131 |
Resmetirom 60mg,80mg,100mg tablet
|
|
2693 KB
|
| 132 |
Resmetirom Tablets 60 mg/ 80 mg/ 100 mg
|
|
2963 KB
|
| 133 |
GME751 (pembrolizumab) concentrate for solution for infusion 25 mg/mL (100mg/vial)
|
|
272 KB
|
| 134 |
Etavopivat 200mg
|
|
268 KB
|
| 135 |
AZD0780 30mg Tablet or Placebo
|
|
275 KB
|
| 136 |
Romiplostim (ENZ210)
|
|
421 KB
|
| 137 |
Dexpramipexole dihydrochloride monohydrate
|
|
278 KB
|
| 138 |
SBO-154 for injection (40mg/vial)
|
|
525 KB
|
| 139 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (21- Valent)
|
|
2522 KB
|
| 140 |
Trastuzumab Deruxtecan (T-DXd; DS-8201a) Lyophilized Powder for concentrate for solution for infusion 100 mg/vial
|
|
1522 KB
|
| 141 |
Plasma Derived Human coagulation factor VIII Product
|
|
278 KB
|
| 142 |
Abaloparatide Injection 3120 mcg/1.56mL
|
|
1606 KB
|
| 143 |
Tozorakimab (MEDI3506) Solution for injection 150mg/mL or Placebo
|
|
280 KB
|
| 144 |
Felzartamab
|
|
319 KB
|
| 145 |
Pegfilgrastim Injection 6mg (Single Use Prefilled Syringe)
|
|
383 KB
|
| 146 |
Rituximab 10mg/mL (500mg/50mL) (rDNA origin) , supplied as a single use vial
|
|
|
| 147 |
Daratumumab Concentrate for Solution for Infusion 100 mg/5 mL Vial and 400 mg/20 mL Vial (r-DNA origin)
|
|
588 KB
|
| 148 |
Pegylated r-Human Granulocyte Colony Stimulating Factor (Pegfilgrastim) Solution for Injection 6 mg/0.6 mL (10 mg/mL) PFS with On Body Injector
|
|
752 KB
|
| 149 |
Belumosudil Tablets 200mg
|
|
1191 KB
|
| 150 |
LEE011
|
|
275 KB
|
| 151 |
Denosumab 60 mg prefilled syringe solution for injection (60 mg/mL) (r-DNA origin)
|
|
400 KB
|
| 152 |
Palivizumab solution for injection 100 mg/ml (r-DNA origin)
|
|
398 KB
|
| 153 |
Pyrotinib Maleate Tablets 80mg
|
|
2353 KB
|
| 154 |
PF-06741086 (Marstacimab) 150mg/mL Solution for Injection
|
|
268 KB
|
| 155 |
Brexpiprazole tablets 1mg,2mg,3mg and 4 mg
|
|
2968 KB
|
| 156 |
Clascoterone Cream 1% w/w
|
|
2396 KB
|
| 157 |
Resmetirom tablets 60mg,80mg,100mg
|
|
2642 KB
|
| 158 |
Dostarlimab
|
|
317 KB
|
| 159 |
Nizubaglustat
|
|
309 KB
|
| 160 |
Ensitrelvir, S-217622
|
|
266 KB
|
| 161 |
PF-08046047 – SGN B6A –Sigvotatug Vedotin
|
|
272 KB
|
| 162 |
RABI 767
|
|
284 KB
|
| 163 |
BAY 94-8862 / Finerenone
|
|
278 KB
|
| 164 |
Disitamab Vedotin
|
|
284 KB
|
| 165 |
LY3537982
|
|
285 KB
|
| 166 |
LOU064 (Remibrutinib)
|
|
272 KB
|
| 167 |
ABL001 (Asciminib)
|
|
271 KB
|
| 168 |
Resmetirom tablets 60mg,80mg,100mg
|
|
3507 KB
|
| 169 |
Lumateperone Capsules 42mg
|
|
1091 KB
|
| 170 |
Elagolix Tablets 200 mg
|
|
1028 KB
|
| 171 |
Sutezolid, TBI-223, Pretomanid, Linezolid, Bedaquiline, Isoniazid, Rifampicin, Pyrazinamide, Ethambutol
|
|
270 KB
|
| 172 |
SAR441566 100 mg Tablets
|
|
313 KB
|
| 173 |
RO7790121/F05, 225 mg/1.5 ml (antibody) (RVT-3101, ANTI TL1A)142
|
|
280 KB
|
| 174 |
RO7790121/F05, 225 mg/1.5 ml (antibody) (RVT-3101, ANTI TL1A)s
|
|
280 KB
|
| 175 |
Rilvegostomig (AZD2936) Concentrate for solution for infusion 50 mg/mL (750 mg/vial) and Trastuzumab deruxtecan (T-DXd; DS-8201a) Powder for concentrate for solution for infusion 100 mg/vial
|
|
274 KB
|
| 176 |
Pegfilgrastim Injection 6mg PFS
|
|
672 KB
|
| 177 |
Abatacept 125 mg/mL solution for injection in autoinjector or prefilled syringe
|
|
1055 KB
|
| 178 |
Romiplostim Injection (r-DNA origin) 250 mcg/vial
|
|
863 KB
|
| 179 |
Tetanus Vaccine (Adsorbed) I. P.
|
|
880 KB
|
| 180 |
Resmetirom Tablets 60mg,80mg and 100mg (Research centre)
|
|
3142 KB
|
| 181 |
LY3502970
|
|
279 KB
|
| 182 |
Resmetirom Tablets 60mg,80mg and 100mg
|
|
1005 KB
|
| 183 |
Bevacizumab Solution for Injection 25 mg/mL (Vial 5.75 mg/0.23 mL) (rDNA origin)
|
|
370 KB
|
| 184 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults & Adolescents I.P
|
|
247 KB
|
| 185 |
Ranibizumab solution for injection 10 mg/ml (r-DNA origin)
|
|
407 KB
|
| 186 |
Brentuximab vedotin powder for concentrate for solution for infusion 50 mg (r-DNA origin)
|
|
478 KB
|
| 187 |
Guselkumab Solution for Injection 100 mg/ml (r-DNA origin)
|
|
1273 KB
|
| 188 |
Rabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM]d
|
|
249 KB
|
| 189 |
Measles, Mumps and Rubella vaccine (Live) I.P. (Freeze Drieds
|
|
416 KB
|
| 190 |
Typhoid Conjugate Vaccine (Bivalent)
|
|
2056 KB
|
| 191 |
Typhoid Conjugate Vaccine (Bivalent)
|
|
2174 KB
|
| 192 |
Aflibercept Solution for Injection 40mg/ml in Vial (r-DNA origin)
|
|
591 KB
|
| 193 |
Recombinant Insulin Aspart Injection I.P (r-DNA origin) 100U/ml or 3.5 mg/ml of Insulin Aspart in 3 ml Cartridge and 10 ml Vial
|
|
964 KB
|
| 194 |
Insulin degludec and Insulin aspart Injection
|
|
545 KB
|
| 195 |
Quadrivalent Human Papillomavirus (HPV) Vaccine
|
|
766 KB
|
| 196 |
Rabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM]
|
|
871 KB
|
| 197 |
Typhoid and Paratyphoid A Conjugate Vaccine (Bivalent)
|
|
393 KB
|
| 198 |
Tegoprazan Tablets 50 mg
|
|
1118 KB
|
| 199 |
Esaxerenone Tablets 1.25 mg or 2.5 mg or 5 mg
|
|
1229 KB
|
| 200 |
Cefepime 2gm and Enmetazobactam 500mg Dry Powder for Injection
|
|
1077 KB
|
| 201 |
CENERIMOD FILM-COATED TABLETS 4 mg
|
|
270 KB
|
| 202 |
Naxitamab and Sargramostim
|
|
306 KB
|
| 203 |
LXE408
|
|
267 KB
|
| 204 |
Vorolanib
|
|
285 KB
|
| 205 |
Cenerimod Film-Coated Tablets 4 mg1
|
|
269 KB
|
| 206 |
Evenamide
|
|
268 KB
|
| 207 |
Revefenacin Inhalation Solution 175 mcg/3ml cipla
|
|
2748 KB
|
| 208 |
CDR132L 45.2 (45,2) mg/vial1
|
|
270 KB
|
| 209 |
Tezepelumab or Placebo Solution for injection 110 mg/ mL
|
|
279 KB
|
| 210 |
KSHN001034 Injection 113 mg/mL (Eq. to 100mg Fulvestrant)
|
|
305 KB
|
| 211 |
CDR132L 45.2 (45,2) mg/vial
|
|
269 KB
|
| 212 |
Revefenacin Inhalation Solution 175 mcg/3ml
|
|
2940 KB
|
| 213 |
Typhoid Vi Conjugate Vaccine I.P
|
|
3126 KB
|
| 214 |
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) (Liquid Hexavalent Vaccine)
|
|
1408 KB
|
| 215 |
Biphasic Isophane Insulin Injection 30/70 (100 IU/mL) IP (in cartridge)
|
|
627 KB
|
| 216 |
Vedolizumab powder for concentrate for solution for infusion 300mg/vial (r-DNA origin)
|
|
1203 KB
|
| 217 |
Nirsevimab solution for injection in prefilled syringe 50mg/ 100 mg (r-DNA origin)
|
|
622 KB
|
| 218 |
Baxdrostat Tablets 1mg/ Placebo
|
|
258 KB
|
| 219 |
Axitinib (OTX TKI)
|
|
241 KB
|
| 220 |
BAY94-8862M/s George Clinical India Pvt Ltd
|
|
240 KB
|
| 221 |
Venetoclax Tablets 10/50/100 mg
|
|
1050 KB
|
| 222 |
Selatogrel 16 mg/0.5mL aqueous solution
|
|
245 KB
|
| 223 |
Inactivated Poliomyelitis Vaccine (Adsorbed)
|
|
733 KB
|
| 224 |
Trastuzumab Solution for Injection 600 mg/5 mL vial (120 mg/mL)[Trastuzumab with Hyaluronidase for s.c. use] (r-DNA origin)
|
|
431 KB
|
| 225 |
Aflibercept Injection 40 mg/ml, (2mg/0.05ml PFS/Vial)
|
|
787 KB
|
| 226 |
CagriSema 1.0 (1,0) mg/ml +0.5 (0,5) mg/ml (0.25 mg/0.25 mg) /placebo
|
|
282 KB
|
| 227 |
SAR445229 / amlitelimab
|
|
286 KB
|
| 228 |
BAY 94-8862 /Finerenone
|
|
245 KB
|
| 229 |
JNJ-77242113
|
|
255 KB
|
| 230 |
AC-203 Diacerein 1% Ointment
|
|
241 KB
|
| 231 |
Finasteride+Minoxidil
|
|
248 KB
|
| 232 |
Cladribine
|
|
266 KB
|
| 233 |
Atacicept
|
|
254 KB
|
| 234 |
NM8074 (Monoclonal Antibody)40 mg/ml Solution for infusion in vial
|
|
894 KB
|
| 235 |
Lumateperoneap
|
|
251 KB
|
| 236 |
Baxdrostat/Dapagliflozin
|
|
255 KB
|
| 237 |
Pertuzumab Concentrate for Solution for Infusion 420 mg/14 mLvial (30 mg/mL) (r-DNA origin)
|
|
433 KB
|
| 238 |
Teclistamab 30mg/3mL Vial (10mg/mL) and 153mg/1.7mL vial (90mg/mL) solution for injection
|
|
389 KB
|
| 239 |
Polatuzumab Vedotin for Injection, 30mg/vial and 140 mg/vial (r- DNA origin)
|
|
436 KB
|
| 240 |
Pembrolizumab concentrate for solution for Infusion in Vial 25mg/mL (100mg/4 mL) (rDNA origin)
|
|
416 KB
|
| 241 |
Pneumococcal polysaccharide conjugate vaccine (Adsorbed) (14 Valent)
|
|
373 KB
|
| 242 |
PF-07220060
|
|
255 KB
|
| 243 |
Evixapodlin
|
|
253 KB
|
| 244 |
Rilvegostomig (AZD2936)
|
|
251 KB
|
| 245 |
Rilvegostomig (AZD2936)n
|
|
248 KB
|
| 246 |
SAR441566
|
|
219 KB
|
| 247 |
Clindamycin+Tretinoin
|
|
257 KB
|
| 248 |
Pegfilgrastim Injection 6mg (PFS)
|
|
694 KB
|
| 249 |
Elagolix 200 mg tablet
|
|
2385 KB
|
| 250 |
Nivolumab+Relatlimab
|
|
250 KB
|
| 251 |
Tocilizumab 80mg(rDNA) solution for intravenousinfusion 80mg/4ml vial
|
|
650 KB
|
| 252 |
Recombinant Human Follicle Stimulating Hormone (Follitropin alfa)Solution for Injection 900 IU/1.44 mL in prefilled pen (r-DNA origin)
|
|
720 KB
|
| 253 |
Enfortumab vedotin 30 mg
|
|
676 KB
|
| 254 |
Aflibercept Injection 40 mg/ml, (0.278 ml/ vial)
|
|
641 KB
|
| 255 |
Romiplostim (r-DNA) powder for solution for Injection250μg/0.5ml
|
|
271 KB
|
| 256 |
Romiplostim (r-DNA) powder for solution for Injection 250μg/0.5ml
|
|
571 KB
|
| 257 |
Vilanterol Trifenatate eq. to Vilanterol 12.5mcg + Umeclidinium bromide eq. to Umeclidinium 31.25mcg metered dose Inhalation
|
|
939 KB
|
| 258 |
Bl 456906 solution for injection 0.5 ml
|
|
255 KB
|
| 259 |
Eftilagimod alfa
|
|
287 KB
|
| 260 |
MK 1084
|
|
246 KB
|
| 261 |
Datopotamab/Deruxtecan
|
|
253 KB
|
| 262 |
Amivantamab
|
|
254 KB
|
| 263 |
RO7790121/F05, 225 mg/1.5 ml (antibody) (RVT-3101, ANTI TL1A)r
|
|
265 KB
|
| 264 |
RO7790121/F05, 225 mg/1.5 ml (antibody) (RVT-3101, ANTI TL1A)
|
|
265 KB
|
| 265 |
NM5072 (Recombinant humanized monoclonal antibody)
|
|
705 KB
|
| 266 |
NM8074Recombinant humanized monoclonal antibody
|
|
774 KB
|
| 267 |
NM8074 (Recombinant humanized monoclonal antibody)
|
|
773 KB
|
| 268 |
Datopotamab Deruxtecan (DATO-DXD, DS-1062) and Osimertinib
|
|
256 KB
|
| 269 |
Mavacamten Capsules 2.5 mg, 5 mg, 10 mg and 15 mg
|
|
3683 KB
|
| 270 |
GIM-122
|
|
253 KB
|
| 271 |
Saruparib (AZD5305) 20mg
|
|
253 KB
|
| 272 |
PF-06823859 Solution for Injection, 60 mg per m
|
|
245 KB
|
| 273 |
Mavorixafor
|
|
283 KB
|
| 274 |
EluxadolineTablets 75 mg & 100 mg
|
|
2200 KB
|
| 275 |
Live Attenuated Varicella Vaccine
|
|
1053 KB
|
| 276 |
Nivolumab 10mg/mL
|
|
725 KB
|
| 277 |
Bevacizumab 25mg/mLM/s Reliance
|
|
733 KB
|
| 278 |
Recombinant Human Albumin 20% (r-DNA origin)
|
|
732 KB
|
| 279 |
KSHN001126
|
|
281 KB
|
| 280 |
Tocilizumab 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL
|
|
717 KB
|
| 281 |
Amorphous Hydrogel with Colloidal Silver
|
|
1772 KB
|
| 282 |
VAY736 (Ianalumab)
|
|
249 KB
|
| 283 |
Vilanterol Trifenatate eq. to Vilanterol + Umeclidinium + Fluticasone Furoate (12.5mcg + 31.25mcg + 50mcg & 12.5mcg + 31.25mcg + 100mcg) Inhalation
|
|
936 KB
|
| 284 |
WAL0921
|
|
245 KB
|
| 285 |
Leriglitazone
|
|
282 KB
|
| 286 |
AVT16 (INN Vedolizumab)
|
|
301 KB
|
| 287 |
Tocilizumab, Concentrate solution for infusion, 80mg/4mL
|
|
965 KB
|
| 288 |
NNC0519-0130 B 34 mg/ml / placebo
|
|
257 KB
|
| 289 |
Lumateperoned
|
|
246 KB
|
| 290 |
Dapagliflozin Prpanediol USP eq. to Dapagliflozin 10mg + Eplerenone IP 25mg film coated tablet
|
|
916 KB
|
| 291 |
OXFENDAZOLE
|
|
281 KB
|
| 292 |
Levetiracetam
|
|
284 KB
|
| 293 |
Sodium zirconium cyclosilicate (SZC)
|
|
281 KB
|
| 294 |
BAY94-8862
|
|
248 KB
|
| 295 |
SAR443765 solution for injection 165mg/1.1 mL (150mg/mL)
|
|
286 KB
|
| 296 |
Amivantamab
|
|
257 KB
|
| 297 |
Barzolvolimab (CDX-0159)
|
|
293 KB
|
| 298 |
Carbetocin RTS
|
|
243 KB
|
| 299 |
Pembrolizumab (BAT3306)
|
|
252 KB
|
| 300 |
"GME751 (pembrolizumab) concentrate for solution for infusion 25 mg/mL (100 mg/vial)"
|
|
263 KB
|
| 301 |
SAR445229 /amlitelimab
|
|
287 KB
|
| 302 |
BI 456906 solution for injection 0.5 ml
|
|
255 KB
|
| 303 |
AZD0901 Powder for solution for infusion (50 mg/vial)
|
|
247 KB
|
| 304 |
Astegolimab (RO7187807)
|
|
296 KB
|
| 305 |
AZD5462
|
|
254 KB
|
| 306 |
Budesonide++Glycopyrronium+ Formoterol fumarate (BGF)
|
|
255 KB
|
| 307 |
Miricorilant
|
|
|
| 308 |
BI 690517
|
|
|
| 309 |
Trospium chloride+Xanomeline tartrate
|
|
250 KB
|
| 310 |
BI 690517
|
|
252 KB
|
| 311 |
Golcadomide (BMS- 986369/CC -99282)
|
|
252 KB
|
| 312 |
LNP023 (Iptacopan)
|
|
244 KB
|
| 313 |
Recombinant Hepatitis E Vaccine (E. Coli)
|
|
996 KB
|
| 314 |
Lumateperone Capsules 42 mg
|
|
903 KB
|
| 315 |
Clascosterone cream 1% w/w
|
|
3661 KB
|
| 316 |
Dengue Monoclonal Antibody, 25mg
|
|
781 KB
|
| 317 |
Lumateperone
|
|
249 KB
|
| 318 |
Intas Ranibizumab Solution for Injection, 10mg/mL
|
|
719 KB
|
| 319 |
Ocrelizumab, 30mg/mL
|
|
1001 KB
|
| 320 |
GZ402671/venglustat
|
|
286 KB
|
| 321 |
Olezarsen (ISIS 678354)M/s. Medpace Clinical
|
|
286 KB
|
| 322 |
Insulin Glargine Injection I.P., 100 IU/ml (BGL-GLAR)
|
|
976 KB
|
| 323 |
Bevacizumab Injection, 1.25mg/50µL
|
|
757 KB
|
| 324 |
Liraglutide, 6.0 mg/ml
|
|
805 KB
|
| 325 |
Olezarsen (ISIS 678354)
|
|
286 KB
|
| 326 |
PF-07899801 or Rimegepant
|
|
245 KB
|
| 327 |
Etavopivat
|
|
251 KB
|
| 328 |
Vonoprazan Tablets 20mg
|
|
1068 KB
|
| 329 |
Inosine Pranobex 500mg/1000 mg Tablets
|
|
1049 KB
|
| 330 |
Esaxerenone Tablets 5.0mg
|
|
835 KB
|
| 331 |
Balcinrenone 15 mg+Dapagliflozin 10 mg
|
|
259 KB
|
| 332 |
SKB264 2870
|
|
246 KB
|
| 333 |
Etavopivat 200mg/ PlaceboM/s Novo Nordisk
|
|
251 KB
|
| 334 |
Sun Ranibizumab Solution for Injection, 10 mg/mL
|
|
645 KB
|
| 335 |
Avibactam 0.5 g + Aztreonam 1.5 g Powder for Concentrate for Solution for Infusion
|
|
247 KB
|
| 336 |
Abatacept Solution for Injection, 125mg/mL
|
|
561 KB
|
| 337 |
Toripalimab Injection, 240 mg/ 6ml
|
|
742 KB
|
| 338 |
Recombinant Human Follicle Stimulating Hormone Solution for Injection, 300 IU in pre-filled pen
|
|
729 KB
|
| 339 |
LY3537982
|
|
261 KB
|
| 340 |
PLN-74809
|
|
250 KB
|
| 341 |
Measles, Mumps and Rubella Vaccine (Live) I.P. (Freeze Dried)
|
|
412 KB
|
| 342 |
BI 690517
|
|
263 KB
|
| 343 |
Japanese Encephalitis Vaccine Inactivated (Adsorbed, Human) I.P.
|
|
339 KB
|
| 344 |
Meningococcal(A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze-Dried)
|
|
226 KB
|
| 345 |
EFRUXIFERMIN (EFX)
|
|
261 KB
|
| 346 |
Anifrolumab (MEDI-546) Solution for injection
|
|
249 KB
|
| 347 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (24 Valent)
|
|
222 KB
|
| 348 |
Dexpramipexole dihydrochloride monohydrate
|
|
261 KB
|
| 349 |
Measles and Rubella Vaccine (Live) LP. (Freeze Dried) in Multi dose vial (2.5 ml - 5 dose)
|
|
420 KB
|
| 350 |
Cenobamate
|
|
251 KB
|
| 351 |
Cagrilintide+Semaglutide
|
|
248 KB
|
| 352 |
Baxdrostat Tablets 1mg/ 2mg/Placebo,
|
|
249 KB
|
| 353 |
LY3437943
|
|
250 KB
|
| 354 |
TIN816
|
|
274 KB
|
| 355 |
Datopotamab deruxtecan (DS-1062a) 100mg/ vial; 2. Rilvegostomig (AZD2936) 750mg/vial (50mg/ml)
|
|
252 KB
|
| 356 |
BMS-986278 c
|
|
260 KB
|
| 357 |
Filgrastim injection IP 300 mcg/ 0.5 ml
|
|
854 KB
|
| 358 |
Liraglutide Injection, 6 mg/mL
|
|
721 KB
|
| 359 |
Pegylated Erythropoietin, 100 mcg/0.3 ml injection (PEG-EPO)
|
|
702 KB
|
| 360 |
Tedizolid phosphate Tablets and Injection
|
|
2124 KB
|
| 361 |
Olsalazine
|
|
1827 KB
|
| 362 |
BMS-986278
|
|
704 KB
|
| 363 |
Mezigdomide (CC-92480)
|
|
686 KB
|
| 364 |
OAV101Novartis Healthcare
|
|
668 KB
|
| 365 |
OAV101
|
|
668 KB
|
| 366 |
Luspatercept
|
|
667 KB
|
| 367 |
BAY 3283142
|
|
677 KB
|
| 368 |
AVIPTADIL INJECTIONI 150UG/10MLCT/SND/14/2024
|
|
1523 KB
|
| 369 |
Amoxicillin Trihydrate IP eq. to Amoxicillin USP 600mg + Potassium Clavulanate diluted IP eq. to Clavulanic Acid 42.9mg per 5ml powder for reconstitution into suspension
|
|
4710 KB
|
| 370 |
Dostarlimab, Belrestotug
|
|
697 KB
|
| 371 |
VAY736 (Ianalumab)
|
|
667 KB
|
| 372 |
Volrustomig (MEDI5752) Lyophilized product for concentrate for solution for infusion 250 mg/vial (50mg/mL)
|
|
679 KB
|
| 373 |
CagriSema
|
|
682 KB
|
| 374 |
Glycopyrrolate IP eq. to Glycopyrronium 25mcg + Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 20mcg + Budesonide IP 0.5mg inhalation suspension
|
|
6827 KB
|
| 375 |
SAR441344 /frexalimab1
|
|
691 KB
|
| 376 |
Etavopivat 200mg
|
|
659 KB
|
| 377 |
Retatrutide
|
|
720 KB
|
| 378 |
NNC0519-0130
|
|
642 KB
|
| 379 |
DeucravacitinibBristol-Myers Squibb
|
|
638 KB
|
| 380 |
SKB264 (MK-2870)
|
|
641 KB
|
| 381 |
lepodisiran sodium (LY3819469)
|
|
675 KB
|
| 382 |
Plazomicin injection 500 mg/10mL
|
|
2261 KB
|
| 383 |
Repotrectinib ( BMS-986472,TPX-0005)
|
|
681 KB
|
| 384 |
Deucravacitinib
|
|
683 KB
|
| 385 |
REGN7999
|
|
643 KB
|
| 386 |
SAR441344 /frexalimab
|
|
649 KB
|
| 387 |
Enzene Ranibizumab Injection, 10mg/ml
|
|
1054 KB
|
| 388 |
Faricimab, 6 mg/0.05 mL
|
|
824 KB
|
| 389 |
SEMAGLUTIDE INJECTION 2MG/1.5MLCT/SND/13/2024
|
|
1573 KB
|
| 390 |
Relugolix Tablets
|
|
874 KB
|
| 391 |
Asciminib tablets
|
|
572 KB
|
| 392 |
PY test Kit Carbon 14 Urea Capsule
|
|
898 KB
|
| 393 |
Cilnidipine IP 20mg + Telmisartan IP 40mg film coated tablet
|
|
6282 KB
|
| 394 |
Clascosterone and minoxidil Topical Solution Clascosterone and latanoprost Topical Solution
|
|
10385 kb
|
| 395 |
Relugolix 40mg + Estradiol USP (as hemihydrate) eq. to Estradiol 1mg + Norethindrone Acetate USP 0.5mg film coated tablets
|
|
5218 KB
|
| 396 |
Gefapixant tablets
|
|
1109 KB
|
| 397 |
Adalimumab, 40 mg/0.4ml
|
|
624 KB
|
| 398 |
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
|
|
218 KB
|
| 399 |
BI 1015550 9 mg & BI 1015550 18 mg
|
|
633 KB
|
| 400 |
Brolucizumab, 120 mg/mL
|
|
688 KB
|
| 401 |
56 film coated tablets of BI 1015550 9 mg OR 56 film coated tablets of BI 1015550 18 mg
|
|
633 KB
|
| 402 |
CuraTeq Vedolizumab 300mg/vial
|
|
850 KB
|
| 403 |
Remifentanil Hydrochloride 1mg/2mg for injection
|
|
1018 KB
|
| 404 |
Insulin Glargine Injection IP 100 IU/mL
|
|
697 KB
|
| 405 |
Indacaterol (as Indacaterol acetate) 150mcg + Glycopyrronium (As Glycopyrrolate IP) 50mcg + Mometasone Furoate IP 160mcg powder for inhalation in capsule
|
|
5820 KB
|
| 406 |
Tocilizumab, 20mg/mL
|
|
695 KB
|
| 407 |
CT-08-2024 GSK
|
|
1668 KB
|
| 408 |
Zibotentan
|
|
773 KB
|
| 409 |
Human cell line recombinant Factor VIII
|
|
553 KB
|
| 410 |
Insulin Glargine 100U/mL + Lixisenatide 33mcg/mL
|
|
261 KB
|
| 411 |
MORF-057
|
|
704 KB
|
| 412 |
MORF-057M/s PSI CRO
|
|
704 KB
|
| 413 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride (As ER) (10mg + 1mg + 1000mg & 10mg + 2mg + 1000mg) film coated tablets
|
|
6423 KB
|
| 414 |
CT-07-2024 Zydus
|
|
213 KB
|
| 415 |
Live-Attenuated Respiratory Syncytial Virus (RSV) ∆NS2/∆1313/I1314L vaccine (RSVt vaccine)
|
|
672 KB
|
| 416 |
LEE011M/s Novartis Healthcare
|
|
656 KB
|
| 417 |
LEE011
|
|
656 KB
|
| 418 |
ALT-P1 30 mg/ vial
|
|
711 KB
|
| 419 |
Zanidatamab (ZW25 and JZP598)
|
|
669 KB
|
| 420 |
LOU064 (Remibrutinib)
|
|
664 KB
|
| 421 |
CT-06 2024 Bio.E
|
|
414 KB
|
| 422 |
ELIGLUSTAT SUBLINGUAL FILCT/SND/12/2024
|
|
1564 KB
|
| 423 |
elmisartan IP + Amlodipine Besilate IP eq .to Amlodipine + Bisoprolol Fumarate IP (40mg + 5mg + 2.5mg & 40mg + 5mg + 5mg) film coated tablets
|
|
5831 KB
|
| 424 |
Dexamethasone (1.5% w/v)
|
|
574 KB
|
| 425 |
Dexamethasone (1.5% w/v)
|
|
574 KB
|
| 426 |
Tafenoquine 50mg and 150 mg Tablets
|
|
2205 KB
|
| 427 |
Pegfilgrastim Injection 6mgd
|
|
675 KB
|
| 428 |
Pegfilgrastim Injection 6mg
|
|
675 KB
|
| 429 |
LNP023
|
|
664 KB
|
| 430 |
LNP023
|
|
664 KB
|
| 431 |
.Trastuzumab Emtansine, 100 mg/Vial and 160 mg/Vial
|
|
725 KB
|
| 432 |
TEMOZOLOMIDE POWDER FOR ORAL SUSPENSION 20MG/ML (300MG/15ML)CT/SND/10/2024
|
|
1499 KB
|
| 433 |
CYCLOPHOSPHAMIDE POWDER FOR ORAL SOLUTION 30MG/MCT/SND/08/2024
|
|
1603 KB
|
| 434 |
Polmacoxib Capsules 2mg
|
|
2293 KB
|
| 435 |
CT-05 2024 TB
|
|
714 KB
|
| 436 |
Dexamethasone (1.5% w/v)
|
|
648 KB
|
| 437 |
Omalizumab
|
|
649 KB
|
| 438 |
Omalizumab
|
|
679 KB
|
| 439 |
Glycopyrronium Bromide (Eq. to 50mcg of Glycopyrronium) (63mcg) + Vilanterol Trifenatate (Eq. to 25mcg Vilanterol) (40mcg) powder for inhalation in capsules
|
|
5100 KB
|
| 440 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (10mg + 100mg & 25mg + 100mg) film coated tablet
|
|
5445 KB
|
| 441 |
PF-07220060 100mg Tablets
|
|
656 KB
|
| 442 |
VAY736 (Ianalumab)
|
|
639 KB
|
| 443 |
REGN3500 (Itepekimab) 300 mg (150 mg/mL) Solution
|
|
654 KB
|
| 444 |
ALT-803 (N-803)
|
|
680 KB
|
| 445 |
Leuprolide acetate for injectable suspension
|
|
782 KB
|
| 446 |
Osivelotor
|
|
671 KB
|
| 447 |
GSK4057190A/Dostarlimab
|
|
696 KB
|
| 448 |
PF 06463922 Lorlatinib 25mg Tablets
|
|
634 KB
|
| 449 |
Bedaquiline, Rifampicin, Clofazimine, Dapsone
|
|
674 KB
|
| 450 |
Baxdrostat Tablets, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg
|
|
697 KB
|
| 451 |
Cannabidiol 100mg/ml Oral Solution
|
|
1051 KB
|
| 452 |
Ziltivekimab C 30 mg/ml / placebo
|
|
831 KB
|
| 453 |
Entrectinib Capsules 100mg and 200mg
|
|
1063 KB
|
| 454 |
ZRC-NB-3224 (humanized monoclonal antibody (IgG4 k isotype)
|
|
991 KB
|
| 455 |
Trastuzumab deruxtecan, 100mg/vial
|
|
647 KB
|
| 456 |
Crisaborole Ointment 2%
|
|
1285 KB
|
| 457 |
Lobeglitazone Sulfate 0.5mg + Glimepiride 1mg Tablets
|
|
1083 KB
|
| 458 |
Volrustomig (MEDI5752)
|
|
758 KB
|
| 459 |
Luspatercept (ACE-536)
|
|
740 KB
|
| 460 |
SAR445229 / amlitelimab
|
|
746 KB
|
| 461 |
Ravulizumab 10mg/mL (300mg/ 30mL) or Placebo
|
|
692 KB
|
| 462 |
Insulin icodec 700 U/ml
|
|
746 KB
|
| 463 |
AP063
|
|
456 KB
|
| 464 |
DIPEROXOCHLORIC ACID TOPOCAL SOLUTION 1.16MGCT/SND/25/2023
|
|
1572 KB
|
| 465 |
Olokizumab 160mg/ml
|
|
593 KB
|
| 466 |
DRL Vedolizumab 300mg vial
|
|
698 KB
|
| 467 |
Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5%w/v + Nepafenac 0.1%w/v + Benzalkonium Chloride IP 0.01%v/v (as preservative) Ophthalmic Solution
|
|
5707 KB
|
| 468 |
Insulin Glargine Injection BP 100 IU/mL
|
|
715 KB
|
| 469 |
Bevacizumab 25mg/ml
|
|
724 KB
|
| 470 |
Relugolix,Estradiol and Norethindrone Acetate Tablets
|
|
1904 KB
|
| 471 |
Inclisiran solution for injection in Prefilled syringe 284mg/1.5ml
|
|
1334 KB
|
| 472 |
DRL_AB
|
|
547 KB
|
| 473 |
Recombinant L-Asparaginase-II. (Lyophilized Recombinant L-asparaginase -II for Injection 10,000 IU)
|
|
829 KB
|
| 474 |
Tildrakizumab Injection 100 mg/ ml
|
|
502 KB
|
| 475 |
Tildrakizumab
|
|
520 KB
|
| 476 |
RITLECITINIB
|
|
657 KB
|
| 477 |
Durvalumab versus Sunitinib
|
|
554 KB
|
| 478 |
Insulin Aspart Mix (30% Insulin Aspart and 70% Insulin Aspart Protamine suspension) Injection 100 units/ml
|
|
999 KB
|
| 479 |
Dydrogesterone IP 2.5mg + Estradiol EP 0.5mg tablets
|
|
5004 KB
|
| 480 |
ISB 2001
|
|
655 KB
|
| 481 |
Benralizumab
|
|
557 KB
|
| 482 |
AMISULPRIDE 5MG/2MCT/SND/04/2024
|
|
1485 KB
|
| 483 |
GIREDESTRANT
|
|
671 KB
|
| 484 |
AZD5305
|
|
689 KB
|
| 485 |
CABAZITAXEL TABLETS 50MGCT/SND/05/2024
|
|
322 KB
|
| 486 |
AKP02G2
|
|
657 KB
|
| 487 |
Typhoid Vi Conjugate Vaccine (Typhoid (Vi Capsular Polysaccharide) - Tetanus Toxoid Conjugate Vaccine)
|
|
284 KB
|
| 488 |
Romiplostim 250µg/0.5mL
|
|
568 KB
|
| 489 |
Fluticasone Furoate 100mcg + Glycopyrronium Bromide Ph. Eur eq. to Glycopyrronium 50mcg + Vilanterol Trifenatate
|
|
215 KB
|
| 490 |
Filgrastim 300mcg/0.5ml
|
|
698 KB
|
| 491 |
Ustekinumab 45mg/0.5mL
|
|
700 KB
|
| 492 |
Brexpiprazole 1mg/2mg/3mg/4mg Tablets
|
|
1310 KB
|
| 493 |
Belantamab Mafodotin
|
|
569 KB
|
| 494 |
Sisunatovir
|
|
666 KB
|
| 495 |
cagrilintide and semaglutide (CagriSema) 2.4mg/2.4mg s.c.
|
|
749 KB
|
| 496 |
Bevacizumab 25 mg/mL
|
|
706 KB
|
| 497 |
iptacopan (LNP023)
|
|
654 KB
|
| 498 |
BION-1301
|
|
685 KB
|
| 499 |
Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized)
|
|
350 KB
|
| 500 |
Datopotamab Deruxtecan (Dato-DXd)100mg/vial,Durvalumab (MEDI4736) 500mg/vial
|
|
766 KB
|
| 501 |
Datopotamab Deruxtecan (Dato-DXd)
|
|
688 KB
|
| 502 |
Rusfertide (PTG-300)
|
|
652 KB
|
| 503 |
ziltivekimab
|
|
805 KB
|
| 504 |
AZD4604
|
|
672 KB
|
| 505 |
ALXN1850
|
|
657 KB
|
| 506 |
Varicella Zoster Virus (VZV) Vaccine
|
|
283 KB
|
| 507 |
CEFEPIME-ZIDEBACTAM (FEP-ZID) WCK5222
|
|
660 KB
|
| 508 |
Bevacizumab Injection 1.25 mg
|
|
719 KB
|
| 509 |
KLU156 with Coartem®
|
|
655 KB
|
| 510 |
Test Formulation A: Dutasteride 0.05% w/w + Minoxidil 5% w/w & Test Formulation B: Dutasteride 0.05% w/w + Latanoprost 0.03% w/w
|
|
361 KB
|
| 511 |
Vilanterol Trifenatate eq. to Vilanterol 25mcg + Glycopyrrolate IP eq. to Glycopyrronium 50mcg + Fluticasone Furoate 200mcg powder for inhalation in capsule
|
|
358 KB
|
| 512 |
PANTOPRAZOLE
|
|
659 KB
|
| 513 |
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed)
|
|
311 KB
|
| 514 |
NIMESULIDE GRANULES FOR ORAL SUSPENSION 100MG CT/SND/02/2024
|
|
1943 KB
|
| 515 |
Pembrolizumab
|
|
684 KB
|
| 516 |
ISB 1442
|
|
713 KB
|
| 517 |
tocilizumab biosimilar (DRL_Tocilizumab)
|
|
662 KB
|
| 518 |
Curcumin (Biocurcumax capsule)
|
|
875 KB
|
| 519 |
Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF)
|
|
671 KB
|
| 520 |
Camizestrant (AZD9833
|
|
695 KB
|
| 521 |
Denosumab (Bmab 1000) 120mg/1.7mL
|
|
668 KB
|
| 522 |
Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5%w/v + Nepafenac 0.1%w/v + Benzalkonium Chloride Solution IP 0.01%v/v
|
|
285 KB
|
| 523 |
GABAPENTINE ER TABLETS 300MG/600MGCT/SND/03/2024
|
|
2261 KB
|
| 524 |
ARTEMIDE-Biliary01GCT/CT04/FF/2023/39848 CT/23/0001222
|
|
750 KB
|
| 525 |
Fexuprazan Tablets
|
|
1408 KB
|
| 526 |
GIREDESTRANT
|
|
671 KB
|
| 527 |
Dupilumab 150 mg/mL
|
|
995 KB
|
| 528 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg +10mg) film coated tablets
|
|
294 KB
|
| 529 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg + Sacubitril and Valsartan as Sodium salt complex 200mg (97mg and 103mg)
|
|
425 KB
|
| 530 |
Brentuximab Vedotin 50mg
|
|
562 KB
|
| 531 |
Lupin Denosumab 60mg/mL
|
|
883 KB
|
| 532 |
cetirizine ophthalmic solution 0.24% w/vct/snd/01/2024
|
|
1928 KB
|
| 533 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IPd
|
|
339 KB
|
| 534 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Linagliptin + Metformin Hydrochloride IP(10mg + 5mg + 500mg & 10mg + 5mg + 1000mg film coated tabletss
|
|
340 KB
|
| 535 |
Vonoprazan Fumarate 20 mg Tablets
|
|
1085 KB
|
| 536 |
IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IBERDD)
|
|
668 KB
|
| 537 |
Eluxadoline Tablets
|
|
1999 KB
|
| 538 |
Insulin Aspart Mix 30, 100IU/mL
|
|
735 KB
|
| 539 |
Efonidipine Hydrochloride Ethanolate 40mg + Telmisartan IP 40mg uncoated bilayered tablets
|
|
280 KB
|
| 540 |
Triafarotene 50 µg/g Cream
|
|
1812 KB
|
| 541 |
Niraparib Tablets 100 mg
|
|
1940 KB
|
| 542 |
Upadacitinib Extednded Release Tablets
|
|
1972 KB
|
| 543 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (10mg + 100mg & 25mg + 100mg) film coated tablets
|
|
295 KB
|
| 544 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP
|
|
278 KB
|
| 545 |
Gabapentin IP (as film coated tablets) + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) (300mg + 30mg & 200mg + 20mg)
|
|
282 KB
|
| 546 |
Gabapentin IP (as sustained release) + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptylinefilm coated bilayered tablets (Phase III)
|
|
311 KB
|
| 547 |
Silodosin JP 8mg (as film coated tablet) + Tadalafil IP 5mg (as film coated tablet) hard gelatin capsules (Phase III)
|
|
301 KB
|
| 548 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Telmisartan IP (10mg + 40mg & 10mg + 80mg tablets
|
|
280 KB
|
| 549 |
PHESGO
|
|
790 KB
|
| 550 |
Dostarlimab, 500mg/10mL
|
|
814 KB
|
| 551 |
Remibrutinib 25 mg b.i.d.
|
|
681 KB
|
| 552 |
DEGLUSTEROL ON FASTING GLUCOSE
|
|
652 KB
|
| 553 |
Mim8
|
|
672 KB
|
| 554 |
Ambrisentan
|
|
272 KB
|
| 555 |
Sibeprenlimab
|
|
684 KB
|
| 556 |
BI456906
|
|
675 KB
|
| 557 |
SB27 (proposed pembrolizumab biosimilar) and Keytruda
|
|
662 KB
|
| 558 |
abeLacimab
|
|
690 KB
|
| 559 |
Abatacept biosimilar (DRL_AB) with Orencia
|
|
671 KB
|
| 560 |
Capivasertib plus CDK4/6
|
|
693 KB
|
| 561 |
DEGLUSTEROL
|
|
657 KB
|
| 562 |
Linagliptin + Metformin Hydrochloride IP (as extended release) (2.5mg + 1000mg & 5mg + 1000mg) film coated bilayered tablet
|
|
331 KB
|
| 563 |
SARS-CoV-2 (Covid-19) Vaccine (Variant XBB.1.5)
|
|
324 KB
|
| 564 |
Mycobacterium Tuberculosis (Live, Attenuated) Vaccine
|
|
414 KB
|
| 565 |
Biphasic Isophane Insulin Injection IP 100IU/ml (30% soluble insulin/ 70% isophane insulin)
|
|
718 KB
|
| 566 |
Golimumab 50mg/0.5mL
|
|
1098 KB
|
| 567 |
101-PGC-005005CT/ND/45/2023
|
|
883 KB
|
| 568 |
CagriSema s.c. in doses 2.4/2.4 mg
|
|
346 KB
|
| 569 |
101-PGC-005
|
|
829 KB
|
| 570 |
Afimetoran
|
|
657 KB
|
| 571 |
AnifrolumabAs
|
|
687 KB
|
| 572 |
Vilanterol Trifenatate eq. to Vilanterol 12.5mcg + Glycopyrrolate IP eq. to Glycopyrronium 25mcg + Fluticasone Furoate 100mcg metered dose inhalation
|
|
275 KB
|
| 573 |
Cilnidipine IP 10mg + Bisoprolol Fumarate IP 5mg film coated tablet
|
|
206 KB
|
| 574 |
Zinc chloride Ph. Eur. 1050 mcg + Sodium fluoride Ph. Eur. 210.0 mcg + Potassium iodide Ph. Eur. 16.60 mcg
|
|
2187 KB
|
| 575 |
Yellow Fever Vaccine (Live) I.P.
|
|
284 KB
|
| 576 |
Iberdomidebri
|
|
674 KB
|
| 577 |
spesolimab i.v
|
|
657 KB
|
| 578 |
Volrustomig
|
|
687 KB
|
| 579 |
Rusfertide PTG-300
|
|
670 KB
|
| 580 |
Pretomanid BJ
|
|
652 KB
|
| 581 |
CBT-001
|
|
673 KB
|
| 582 |
JNJ-77242113
|
|
658 KB
|
| 583 |
iptacopan
|
|
657 KB
|
| 584 |
Durvalumab
|
|
652 KB
|
| 585 |
Tozorakimabdec
|
|
674 KB
|
| 586 |
FXIa inhibitor asundexianBAY 2433334
|
|
562 KB
|
| 587 |
Varicella Vaccine (Live, Attenuated)
|
|
427 KB
|
| 588 |
Dengue Tetravalent Vaccine (Live, Attenuated) Serum
|
|
319 KB
|
| 589 |
Acebrophylline 100mg + Erdosteine 300mg film coated tablets
|
|
305 KB
|
| 590 |
Gabapentin USP 6.0%w/w + Lidocaine HCl IP eq. to Lidocaine 5.0%w/w gel
|
|
289 KB
|
| 591 |
Zetomipzomib KZR-616 30 mg or 60
|
|
802 KB
|
| 592 |
CRN04894dec
|
|
660 KB
|
| 593 |
Pregabalin IP (as granules) + Duloxetine hydrochloride IP+ Methylcobalamin IP (as granules)hard gelatin capsule
|
|
305 KB
|
| 594 |
Pegozafermin
|
|
677 KB
|
| 595 |
Camizestrant AZD9833
|
|
695 KB
|
| 596 |
Denosumab 120mg/1.7mL
|
|
736 KB
|
| 597 |
Cefepime-Tazobactam WCK 4282 vs. Meropenem
|
|
658 KB
|
| 598 |
EYU688
|
|
654 KB
|
| 599 |
remibrutinib LOU064
|
|
700 KB
|
| 600 |
Baxdrostat
|
|
695 KB
|
| 601 |
RO7200220
|
|
812 KB
|
| 602 |
Metformin Hydrochloride IP (SR) + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Linagliptin
|
|
326 KB
|
| 603 |
Bempedoic Acid 180mg + Ezetimibe 10mg film coated tablets
|
|
337 KB
|
| 604 |
Tedizolid Phosphate 200mg Tablet
|
|
1090 KB
|
| 605 |
Dapagliflozin propanediol Monohydrate eq. to Dapagliflozin 10mg + Telmisartan 80mg film coated tablets
|
|
275 KB
|
| 606 |
Desidustat Tablets 25mg, 50mg, 100mgCT/SND/27/2023
|
|
1240 KB
|
| 607 |
Cetuximab 100 mg/20 ml
|
|
807 KB
|
| 608 |
ianalumabdec
|
|
658 KB
|
| 609 |
Efruxifermindec
|
|
703 KB
|
| 610 |
SAR443765
|
|
515 KB
|
| 611 |
Tislelizumab
|
|
653 KB
|
| 612 |
Ustekinumab Solution for Injection
|
|
1014 KB
|
| 613 |
Olezarsen (ISIS 678354)
|
|
682 KB
|
| 614 |
Sitagliptin Phosphate IP 100mg + Lobeglitazone Sulfate 0.5mg film coated tablet
|
|
306 KB
|
| 615 |
Glimepiride IP + Linagliptin + Metformin HCL (As ER) IP (1mg + 2.5mg + 1000mg & 2mg + 2.5mg + 1000mg) film coated bilayered tablet
|
|
325 KB
|
| 616 |
Zetomipzomib (KZR-616)
|
|
801 KB
|
| 617 |
Tenalisib 400mg Tablet
|
|
938 KB
|
| 618 |
Pregabalin IP 75mg + Duloxetine hydrochloride IP eq. to Duloxetine 30mg + Mecobalamin IP 1500mcg hard gelatin capsule
|
|
333 KB
|
| 619 |
Tropicamide 0.2mg + Phenylephrine Hydrochloride IP 3.1mg + Lidocaine Hydrochloride IP 10mg per ml Injection (Phase IV)
|
|
296 KB
|
| 620 |
Suplatast Tosilate 100mg Capsule
|
|
1290 KB
|
| 621 |
Tofacitinib Lotion 2%w/vCT/SND/26/2023
|
|
1528 KB
|
| 622 |
Povidone Iodine throat spray 0.45% w/vCT/SND/24/2023
|
|
14176 KB
|
| 623 |
Typhoid Vi Conjugate Vaccine I.P.
|
|
421 KB
|
| 624 |
POZELIMAB AND CEMDISIRAN23
|
|
665 KB
|
| 625 |
Tezepelumab
|
|
677 KB
|
| 626 |
Serpin PCInven
|
|
652 KB
|
| 627 |
TIN816
|
|
654 KB
|
| 628 |
LY3502970 Compared with Placebo
|
|
674 KB
|
| 629 |
CRN04894
|
|
660 KB
|
| 630 |
LY3502970l
|
|
670 KB
|
| 631 |
20-valent Pneumococcal Conjugate vaccine
|
|
669 KB
|
| 632 |
PEGylated Factor VIII(BAX 855)
|
|
673 KB
|
| 633 |
Efruxifermin
|
|
673 KB
|
| 634 |
LY3871801
|
|
659 KB
|
| 635 |
BLU-5937IQVIA
|
|
666 KB
|
| 636 |
ESK-001
|
|
680 KB
|
| 637 |
JDQ443
|
|
658 KB
|
| 638 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Lobeglitazone Sulfate 0.5mg film coated tablets (Phase III)
|
|
270 KB
|
| 639 |
Glimepiride IP + Metformin Hydrochloride IP (As sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1mg + 1000mg + 100mg & 2mg + 1000mg + 10mg) film coated bilayer tablets (Phase III)
|
|
312 KB
|
| 640 |
Parenteral TK-112690
|
|
659 KB
|
| 641 |
Pacritinib
|
|
615 KB
|
| 642 |
Combined tetanus toxoid, reduced diphtheria toxoid, reduced recombinant pertussis vaccine. (Tdapgen)
|
|
274 KB
|
| 643 |
Bilastine IP 3.3mg + Phenylephrine Hydrochloride IP 5mg + Dextromethorphan Hydrobromide IP 10mg syrup (Phase III)
|
|
353 KB
|
| 644 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg + 10mg) film coated tablets (Phase III)
|
|
345 KB
|
| 645 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg + 10mg) film coated tablets (Phase III)
|
|
345 KB
|
| 646 |
Montelukast Sodium IP 10mg + Fexofenadine hydrochloride IP 180mg Uncoated bilayered tablet (Phase III)
|
|
319 KB
|
| 647 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (25mg + 100mg & 10mg + 100mg) film coated tablet (Phase III)
|
|
336 KB
|
| 648 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Metoprolol Succinate IP eq. to Metoprolol TartrateExtended Release50mg film coated bilayered tablet
|
|
250 KB
|
| 649 |
Oral NRC-2694-A
|
|
654 KB
|
| 650 |
BEMNIFOSBUVIR (BEM) AND RUZASVIR (RZR)
|
|
654 KB
|
| 651 |
LY3437943eli
|
|
690 KB
|
| 652 |
LY3502970lily
|
|
678 KB
|
| 653 |
PF-06823859
|
|
657 KB
|
| 654 |
IcoSema and daily insulin glargine 100 units/mL
|
|
678 KB
|
| 655 |
MK-7684 with Pembrolizumab
|
|
661 KB
|
| 656 |
TP-102
|
|
656 KB
|
| 657 |
NAPTUMOMAB ESTAFENATOX
|
|
512 KB
|
| 658 |
POZELIMAB AND CEMDISIRAN
|
|
665 KB
|
| 659 |
RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD)
|
|
704 KB
|
| 660 |
Lumateperone
|
|
670 KB
|
| 661 |
ASTEGOLIMAB
|
|
697 KB
|
| 662 |
Povidone Iodine Nasal Solution 0.5% w/vCT/SND/21/2023
|
|
1279 KB
|
| 663 |
Mavacamten
|
|
663 KB
|
| 664 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Pioglitazone Hydrochloride IP 15mg film coated tablets (Phase III)
|
|
282 KB
|
| 665 |
Benralizumab 100mg
|
|
677 KB
|
| 666 |
Insulin Injection IP 100 IU/mL
|
|
578 KB
|
| 667 |
Vonoprazan Fumarate 20mg tablet
|
|
1994 KB
|
| 668 |
Dydrogesterone Modified Release Tablet 30mgCT-SND/22/2023
|
|
1487 KB
|
| 669 |
Glimepiride IP + Metformin Hydrochloride IP (as extended release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1mg + 1000mg + 100mg & 2mg + 1000mg + 100mg) tablets (Phase III)
|
|
308 KB
|
| 670 |
Polmacoxib 2mg + Paracetamol IP 325 mg (Phase III)
|
|
299 KB
|
| 671 |
Denosumabcura
|
|
697 KB
|
| 672 |
Divozilimab
|
|
558 KB
|
| 673 |
SerpinPC
|
|
641 KB
|
| 674 |
LY3437943
|
|
672 KB
|
| 675 |
Dengue Tetravalent Vaccine (Live, Attenuated)
|
|
298 KB
|
| 676 |
Pegfilgrastim
|
|
885 KB
|
| 677 |
Insulin Lispro Ultrarapid(UR) Injection
|
|
669 KB
|
| 678 |
Atacicept
|
|
683 KB
|
| 679 |
Lumateperone Tosylate 42mg capsule
|
|
1137 KB
|
| 680 |
Milvexian, an Oral Factor XIa Inhibitor
|
|
739 KB
|
| 681 |
Metformin Hydrochloride IP (as ER) + Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1000mg + 1mg + 100mg & 1000mg + 2mg + 100mg) film coated bilayered tablets (Phase III)
|
|
350 KB
|
| 682 |
Omalizumab
|
|
847 KB
|
| 683 |
Benralizumab
|
|
648 KB
|
| 684 |
Denosumab Injection
|
|
820 KB
|
| 685 |
Crovalimab
|
|
641 KB
|
| 686 |
Insulin Glargine Injection
|
|
578 KB
|
| 687 |
Denosumabrdna
|
|
733 KB
|
| 688 |
Fexofenadine Hydrochloride IP 180mg + Montelukast Sodium IP eq. to Montelukast 10mg tablets (Phase III)
|
|
316 KB
|
| 689 |
PB016 and Entyvio
|
|
723 KB
|
| 690 |
Tadalafil IP 5mg (as film coated tablet) + Tamsulosin Hydrochloride IP 0.4mg (Prolonged release tablet) hard gelatin capsules (Phase IV)
|
|
305 KB
|
| 691 |
Varespladib
|
|
648 KB
|
| 692 |
Tozorakimab (MEDI3506)
|
|
672 KB
|
| 693 |
FXIa inhibitor asundexian (BAY 2433334)
|
|
547 KB
|
| 694 |
Bilastine 40mg + Montelukast Sodium IP eq. to Montelukast 10mg tablets (Phase III)
|
|
291 KB
|
| 695 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Metoprolol Succinate IP eq. to Metoprolol Tartrate (as extended release) 50mg film coated bilayered tablet (Phase III)
|
|
583 KB
|
| 696 |
RSVPreF3
|
|
615 KB
|
| 697 |
nebulized PC945
|
|
654 KB
|
| 698 |
Trinbelimab Injection
|
|
734 KB
|
| 699 |
Denosumab
|
|
643 KB
|
| 700 |
Quadrivalent Human Papillomavirus (Serotypes 6, 11, 16 & 18) Vaccine
|
|
441 KB
|
| 701 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14 Valent)
|
|
341 KB
|
| 702 |
BI1015550
|
|
643 KB
|
| 703 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Bisoprolol Fumarate IP (10mg + 5mg & 10mg +10mg) tablet (Phase III)
|
|
508 KB
|
| 704 |
Bempedoic Acid + Rosuvastatin Calcium IP eq. to Rosuvastatin (180mg + 5mg, 180mg + 10mg & 180mg + 20mg) tablets (Phase III)
|
|
587 KB
|
| 705 |
Dapagliflozin propanediol Monohydrate eq. to Dapagliflozin + Linagliptin + Metformin Hydrochloride IP (as sustained release) tablets (Phase III)
|
|
406 KB
|
| 706 |
Indacaterol (as acetate) eq. to Indacaterol + Glycopyrrolate IP eq. to Glycopyrronium + Mometasone Furoate IP powder for inhalation (Phase IV)
|
|
348 KB
|
| 707 |
WD1905 Tablets with SINEMET
|
|
637 KB
|
| 708 |
HT-6184
|
|
636 KB
|
| 709 |
LY3502970
|
|
681 KB
|
| 710 |
Tenecteplase
|
|
732 KB
|
| 711 |
Bilastine + Dextromethorphan Hydrobromide + Phenylephrine Hydrochloride syrup (Phase III)
|
|
414 KB
|
| 712 |
Budesonide IP + Formoterol Fumarate IP + Glycopyrronium Ph. Eur inhalation powder (Phase IV
|
|
435 KB
|
| 713 |
RLS Protein Subunit Vaccine against SARS CoV 2 Virus
|
|
612 KB
|
| 714 |
Febuxostat Extended Release Tablet 40mg/80mgCT/SND/15/2023
|
|
1370 KB
|
| 715 |
Afliberceptz
|
|
624 KB
|
| 716 |
Pilocarpine Hydrochloride Solution USP 1.25% w/vCT/SND/18/2023
|
|
1220 KB
|
| 717 |
Tofacitinib film forming lotion 2% w/wCT/SND/19/2023
|
|
1334 KB
|
| 718 |
PZN-128 powder for solution
|
|
480 KB
|
| 719 |
Gedatolisib
|
|
657 KB
|
| 720 |
Ketamine Solution 50mg/mlCT/SND/16/2023
|
|
1461 KB
|
| 721 |
Pregabalin Gel 8% w/wCT/SND/17/2023
|
|
1358 KB
|
| 722 |
IPV vaccine
|
|
410 KB
|
| 723 |
Milvexian, an Oral Factor XIa
|
|
684 KB
|
| 724 |
NM8074
|
|
692 KB
|
| 725 |
CC-92480 (BMS-986348)
|
|
663 KB
|
| 726 |
ExPEC9V
|
|
668 KB
|
| 727 |
Mirabegron (as extended release form) + Silodosin tablets (Phase III)
|
|
313 KB
|
| 728 |
Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase IV
|
|
329 KB
|
| 729 |
Metformin Hydrochloride IP (As Extended release form) + Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin tablets (Phase IV)
|
|
314 KB
|
| 730 |
AZD2693
|
|
405 KB
|
| 731 |
Tegoprazan
|
|
535 KB
|
| 732 |
ianalumab (VAY736)g
|
|
636 KB
|
| 733 |
Levormeloxifene
|
|
2039 KB
|
| 734 |
Indacaterol Acetate eq. to Indacaterol IH+ Glycopyrronium Bromide eq. to Glycopyrronium Ph Eur + Mometasone Furoate eq. to Mometasone Furoate IP inhalation powder (Phase IV)
|
|
313 KB
|
| 735 |
LtdLNP3693
|
|
2170 KB
|
| 736 |
HRF-10071 and Lamivudine
|
|
1753 KB
|
| 737 |
GIREDESTRANT
|
|
663 KB
|
| 738 |
cagrilintide 2.4 mg s.c.
|
|
695 KB
|
| 739 |
BI 685509
|
|
645 KB
|
| 740 |
Varicella Vaccine
|
|
391 KB
|
| 741 |
Diltiazem Hydrochloride 2% Gel
|
|
385 KB
|
| 742 |
Dydrogesterone Sustained Release Tablet 20mgCT/SND/10/2023
|
|
1513 KB
|
| 743 |
Dydrogesterone Modified Release Tablet 20mg
|
|
1484 KB
|
| 744 |
Ozanimod
|
|
404 KB
|
| 745 |
Dydrogesterone Sustained Release Tablet 20mgCT/SND/13/2023
|
|
17478 KB
|
| 746 |
Dydrogesterone Extended Release Tablet 30mg
|
|
1106 KB
|
| 747 |
Pegfilgrastim Injection
|
|
660 KB
|
| 748 |
TeriparatideI
|
|
772 KB
|
| 749 |
Imeglimin 500mg and 1000mg tablets
|
|
2234 KB
|
| 750 |
Pertuzumab And Trastuzumab
|
|
653 KB
|
| 751 |
Diperoxochloric acid topical solution 0.29mg/mlCT/SND/12/2023
|
|
1751 KB
|
| 752 |
MK-7684A (Vibostolimab with Pembrolizumab)
|
|
640 KB
|
| 753 |
BI 1015550
|
|
393 KB
|
| 754 |
AUR107,
|
|
3145 KB
|
| 755 |
TAR-200
|
|
648 KB
|
| 756 |
Insulin Aspart Mix 70/30 Injection
|
|
749 KB
|
| 757 |
VTX958
|
|
642 KB
|
| 758 |
Mino-Lok Therapy (MLT)
|
|
668 KB
|
| 759 |
ADL-018 150 mg and 300 mg
|
|
454 KB
|
| 760 |
Anti-COVID-19 AKS-452
|
|
644 KB
|
| 761 |
ianalumab (VAY736)
|
|
640 KB
|
| 762 |
finerenone plus empagliflozin
|
|
655 KB
|
| 763 |
Montelukast Sodium IP + Bilastine orodispersible tablets (Phase IV)
|
|
322 KB
|
| 764 |
Gabapentin IP + Nortriptyline HCl IP eq. to Nortriptyline film coated tablets (Phase IV)
|
|
271 KB
|
| 765 |
Asciminib
|
|
641 KB
|
| 766 |
Vedolizumab injection
|
|
696 KB
|
| 767 |
BevacizumabRLS
|
|
651 KB
|
| 768 |
BLU-5937
|
|
405 KB
|
| 769 |
PertuzumabA
|
|
915 KB
|
| 770 |
Sovateltide injection 30μg
|
|
2837 KB
|
| 771 |
Dydrogesterone Sustained Release Tablet 30mgCT/SND/09/2023
|
|
1223 KB
|
| 772 |
CKJX839D12302inclisiran
|
|
689 KB
|
| 773 |
Darbepoetin alfa
|
|
763 KB
|
| 774 |
Idursulfase
|
|
672 KB
|
| 775 |
Japanese Encephalitis Vaccine
|
|
139 KB
|
| 776 |
(+)-Alpha- Dihydrotetrabenazine ({+})-α-DHTBZ) Powder
|
|
2205 KB
|
| 777 |
SAR408701 versus docetaxel
|
|
507 KB
|
| 778 |
Nor-Ursodeoxycholic Acid 1500mg
|
|
2575 KB
|
| 779 |
Tofacitinib Gel 2% w/w
|
|
438 KB
|
| 780 |
Glycopyrronium (As Glycopyrrolate IP) + Budesonide IP + Formoterol Fumarate (As Formoterol Fumarate Dihydrate IP) powder for inhalation (in capsule) (Phase IV)
|
|
325 KB
|
| 781 |
Auxora
|
|
639 KB
|
| 782 |
Ustekinumab
|
|
681 KB
|
| 783 |
Bemnifosbuvir
|
|
672 KB
|
| 784 |
Amoxycillin Trihydrate IP eq. to Amoxycillin + Potassium Clavulanate diluted IP eq. to Clavulanic Acid of the reconstituted suspension (Phase IV)
|
|
362 KB
|
| 785 |
ABX464 once daily
|
|
667 KB
|
| 786 |
ABX464
|
|
676 KB
|
| 787 |
ABX464 25 mg or 50 mg
|
|
727 KB
|
| 788 |
Fluconazole (MARIO)
|
|
651 KB
|
| 789 |
Guselkumab and Golimumab in Participants
|
|
644 KB
|
| 790 |
Guselkumab and Golimumab
|
|
649 KB
|
| 791 |
Aztreonam- Avibactam ± Metronidazole
|
|
638 KB
|
| 792 |
ARV-471 (PF-07850327)
|
|
661 KB
|
| 793 |
ziltivekimab
|
|
697 KB
|
| 794 |
Daratumumab SC and Lenalidomide (Tec-DR)
|
|
645 KB
|
| 795 |
Tildrakizumab
|
|
508 KB
|
| 796 |
Adalimumab Injection
|
|
731 KB
|
| 797 |
Oral Ozanimod
|
|
662 KB
|
| 798 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Pioglitazone Hydrochloride IP Eq. to Pioglitazone tablets (Phase III)
|
|
289 KB
|
| 799 |
Hexavalent DtwP-HepB-IPV-Heb Liq.Hexa vaccine
|
|
127 KB
|
| 800 |
Glycopyrrolate IP + Budesonide IP + Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate per actuation delivers (ex-actuator) inhalation aerosol (Phase IV)
|
|
311 KB
|
| 801 |
Linagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
345 KB
|
| 802 |
Bupropion Hydrochloride IP (as extended release) + Dextromethorphan Hydrobromide IP tablets (Phase III)
|
|
365 KB
|
| 803 |
FluticasonePropionate HFA Pressurized Metered Dose Inhaler 110mcg ex-actuator dose (125rncg ex-valve dose)
|
|
2510 KB
|
| 804 |
Guselkmab
|
|
650 KB
|
| 805 |
Fluticasone Propionate HFA ,Pressurized Metered Dose Inhaler 110mcg ex-actuator dose (125rncg ex-valve dose)
|
|
1256 KB
|
| 806 |
Guselkumab
|
|
650 KB
|
| 807 |
Faricimab (RO686746
|
|
656 KB
|
| 808 |
Vonoprazan 20 Mg Tablets/ Pantoprazole 40 Mg
|
|
2421 KB
|
| 809 |
Vonoprazan 20 Mg. Tablets/ Pantoprazole 40 Mg
|
|
125 KB
|
| 810 |
Datopotamab Deruxtecan (Dato-DXd)
|
|
657 KB
|
| 811 |
Ozanimod
|
|
662 KB
|
| 812 |
Trastuzumab
|
|
752 KB
|
| 813 |
AUR108
|
|
2378 KB
|
| 814 |
Lumateperone
|
|
677 KB
|
| 815 |
Ixekizumab
|
|
657 KB
|
| 816 |
filgotinib
|
|
655 KB
|
| 817 |
Topical 1% AKP-11
|
|
2339 KB
|
| 818 |
AUR107
|
|
2418 KB
|
| 819 |
Agalsidase alfa
|
|
567 KB
|
| 820 |
Basimglurant
|
|
667 KB
|
| 821 |
Imlunestrant
|
|
674 KB
|
| 822 |
Lumateperone as Adjunctive Therapy
|
|
677 KB
|
| 823 |
Ranibizumab r-dna
|
|
693 KB
|
| 824 |
Pertuzumabf
|
|
832 KB
|
| 825 |
Pegfilgrastimn
|
|
699 KB
|
| 826 |
Imeglimin Hydrochloride sustend release tablets 1000 mg
|
|
2277 KB
|
| 827 |
ianalumab (VAY736)
|
|
639 KB
|
| 828 |
fitusiran prophylaxis
|
|
498 KB
|
| 829 |
ARO-APOC3
|
|
771 KB
|
| 830 |
Coagulation Factor VIII (Recombinant) rFVIII
|
|
840 KB
|
| 831 |
Ocrelizumab
|
|
675 KB
|
| 832 |
xevinapant
|
|
645 KB
|
| 833 |
Aflibercept
|
|
1115 KB
|
| 834 |
Sodium Zirconium Cyclosilicatec
|
|
378 KB
|
| 835 |
cagrilintide s.c. 2.4 mg
|
|
675 KB
|
| 836 |
Teclistamab
|
|
653 KB
|
| 837 |
JNJ-63723283
|
|
657 KB
|
| 838 |
Dydrogesterone Extended Release Tablet 20 mgM
|
|
358 KB
|
| 839 |
Dydrogesterone Extended Release Tablet 20 mg/30mgCT/SND/01/2023
|
|
1084 KB
|
| 840 |
Tozorakimab
|
|
660 KB
|
| 841 |
Tofacitinib Gel 2% w/wCT/SND/07/2023
|
|
1268 KB
|
| 842 |
EPX-100
|
|
749 KB
|
| 843 |
Pioglitazone Hydrochloride IP Eq. to Pioglitazone Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
327 KB
|
| 844 |
HRF-10071 tablet 120 mg and Metformin 500mg IR Tablet
|
|
2048 KB
|
| 845 |
AUR106
|
|
2112 KB
|
| 846 |
Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin tablets (Phase III)
|
|
367 KB
|
| 847 |
Glimepiride IP + Linagliptin film coated tablets (Phase III)
|
|
354 KB
|
| 848 |
Rosuvastatin Calcium IP eq. to Rosuvastatin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
395 KB
|
| 849 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablets
|
|
329 KB
|
| 850 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Pioglitazone HCl IP eq. to Pioglitazone film coated tablets (Phase III)
|
|
308 KB
|
| 851 |
Vildagliptin + Dapagliflozin + Metformin Hydrochloride IP tablets (Phase III)
|
|
304 KB
|
| 852 |
Chlorthalidone IP + Cilnidipine IP + Bisoprolol Fumarate IP film coated tablets
|
|
298 KB
|
| 853 |
Dydrogesterone Extended Release Tablet 20 mg
|
|
411 KB
|
| 854 |
Dydrogesterone Extended Release Tablet 20 mg
|
|
1221 KB
|
| 855 |
Tirzepatide
|
|
664 KB
|
| 856 |
17β-Hydroxysteroid Dehydrogenase type 13
|
|
654 KB
|
| 857 |
HBI-8000 Combined with Nivolumab
|
|
661 KB
|
| 858 |
LY3209590
|
|
644 KB
|
| 859 |
FS118
|
|
699 KB
|
| 860 |
Ranibizumab
|
|
715 KB
|
| 861 |
JDQ443 versus docetaxel
|
|
651 KB
|
| 862 |
Faricimab (RO6867461)
|
|
640 KB
|
| 863 |
Pertuzumab
|
|
780 KB
|
| 864 |
ianalumab
|
|
657 KB
|
| 865 |
Dydrogesterone Sustained Release Tablet 30 mg
|
|
1665 KB
|
| 866 |
Vilanterol Trifenatate eq. to Vilanterol + Glycopyrrolate IP eq. to Glycopyrronium metered dose inhalation (Phase III)
|
|
380 KB
|
| 867 |
Ianalumab CT/22/000006
|
|
657 KB
|
| 868 |
MORF-057
|
|
667 KB
|
| 869 |
Elagolix Tablets 150 mg & 200mg
|
|
2413 KB
|
| 870 |
POZELIMAB AND CEMDISIRAN
|
|
677 KB
|
| 871 |
Elagolix Tablets ,150 mg & 200mg
|
|
2413 KB
|
| 872 |
Sodium Zirconium Cyclosilicate
|
|
671 KB
|
| 873 |
Bepirovirsen in HBeAg-negative
|
|
682 KB
|
| 874 |
Bepirovirsen
|
|
680 KB
|
| 875 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Metoprolol Succinate IP eq. to Metoprolol Tartrate (As sustained release) film coated bilayered tablets (Phase III)
|
|
349 KB
|
| 876 |
Liquid Nasal Spray (Nitric oxide) (100 ppm)
|
|
351 KB
|
| 877 |
Fosnetupitant 235 mg and Palonosetron 0.25mg
|
|
2476 KB
|
| 878 |
Imeglimi.n Hydrochloride sustend release tablets 1000 mg
|
|
2277 KB
|
| 879 |
Fosnetupitant, 235 mg and Palonosetron 0.25mg
|
|
2472 KB
|
| 880 |
Vildagliptin IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
351 KB
|
| 881 |
Recombinant Rabies G protein Vaccine
|
|
94 KB
|
| 882 |
VTX002
|
|
661 KB
|
| 883 |
Hydrochloride, 500 tablets
|
|
2545 KB
|
| 884 |
Prolectin-I Injection
|
|
1915 KB
|
| 885 |
NV-CoV-2 Oral Syrup Oral Gummy(Chewable gel)
|
|
2202 KB
|
| 886 |
Vonoprazan, Tablets 10mg/20mg
|
|
2768 KB
|
| 887 |
Vonoprazan Tablets 10mg/20mg
|
|
2786 KB
|
| 888 |
sImeglimin Hydrochloride 1000 tablets
|
|
2845 KB
|
| 889 |
sImeglimin Hydrochloride 500 tablets
|
|
2545 KB
|
| 890 |
Bisoprolol Fumarate IP 5mg + Cilnidipine IP film coated tablets (Phase III)
|
|
346 KB
|
| 891 |
Imeglimin. Hydrochloride 1000 tablets
|
|
2845 KB
|
| 892 |
(Research Park)LNP7457
|
|
2397 KB
|
| 893 |
Polmacoxib Capsules 2 mg
|
|
2399 KB
|
| 894 |
Tegoprazan .50 mg tablets
|
|
2016 KB
|
| 895 |
Polmacoxib. Capsules 2 mg
|
|
2399 KB
|
| 896 |
AZD9977 and Dapagliflozin
|
|
669 KB
|
| 897 |
Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tablets (Phase III)
|
|
440 KB
|
| 898 |
Lorlatinib
|
|
658 KB
|
| 899 |
Norditropin®
|
|
507 KB
|
| 900 |
20-valent Pneumococcal Conjugate (20vPnC) Vaccine
|
|
556 KB
|
| 901 |
Macitentan 75 mg
|
|
516 KB
|
| 902 |
Marstacimab Prophylaxi
|
|
654 KB
|
| 903 |
Trastuzumab Emtasine
|
|
698 KB
|
| 904 |
Linagliptin + Dapagliflozin tablets (Phase III)
|
|
275 KB
|
| 905 |
Cannabidol Oral. Solution 150 mg/ml
|
|
2629 KB
|
| 906 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III)
|
|
287 KB
|
| 907 |
Vilanterol trifenatate eq. to Vilanterol + Glycopyrrolate IP eq. to Glycopyrronium + Flucticasone Furoate Ph. Eur metered dose inhalation (Phase III)
|
|
318 KB
|
| 908 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP film coated tablets (Phase III)
|
|
324 KB
|
| 909 |
Tegoprazan 50 mg tablets
|
|
2016 KB
|
| 910 |
Cannabidol Oral Solution 150 mg/ml
|
|
2629 KB
|
| 911 |
ianalumab
|
|
657 KB
|
| 912 |
Tildrakizumab23jan
|
|
664 KB
|
| 913 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Sitagliptin Phosphate Monohydrochloride IP eq. to Sitagliptin tablet (Phase III)
|
|
307 KB
|
| 914 |
FB2001
|
|
528 KB
|
| 915 |
Ibrutinib
|
|
514 KB
|
| 916 |
Romosozumab
|
|
842 KB
|
| 917 |
Tildrakizumab
|
|
663 KB
|
| 918 |
NNC 0365-3769 (Mim8) prophylaxis
|
|
514 KB
|
| 919 |
S-217622
|
|
588 KB
|
| 920 |
LYT-100
|
|
681 KB
|
| 921 |
Prolectin M
|
|
2190 KB
|
| 922 |
TEV-45779
|
|
770 KB
|
| 923 |
Gliclazide IP (As sustained release) + Dapagliflozin film coated bilayered tablets (Phase III)
|
|
307 KB
|
| 924 |
Metformin Hydrochloride IP (As extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet
|
|
334 KB
|
| 925 |
Ursodiol Injection 625 mg/25ml (25mg/ml
|
|
404 KB
|
| 926 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Glimperide IP + Metformin Hydrochloride IP (as extended release) film coated tablets
|
|
376 KB
|
| 927 |
IVIEW-1201
|
|
405 KB
|
| 928 |
Tildrakizumab Injection
|
|
720 KB
|
| 929 |
Trelagliptin tablets 25mg/50mg/100mg
|
|
2552 KB
|
| 930 |
Glycopyrroinum Bromide Ph. Eur + Fluticasone Furoate + Vilanterol Trifenatate inhalation powder
|
|
293 KB
|
| 931 |
STN1010904
|
|
401 KB
|
| 932 |
Human Albumin (r-DNA origin)
|
|
705 KB
|
| 933 |
Recombinant human FSH
|
|
699 KB
|
| 934 |
decitabine-tetrahydrouridine
|
|
345 KB
|
| 935 |
Ranibizumab Solution for Injection, 10 mg/mL vial
|
|
696 KB
|
| 936 |
Pimavenserin Capsules 34 mg
|
|
2383 KB
|
| 937 |
Imeglimin Hydrochloride Sustained Relase Tablet 1000 mg
|
|
482 KB
|
| 938 |
Dapagliflozin Propanediol monohydrate + Linagliptin film coated tablets (Phase III)
|
|
4371 KB
|
| 939 |
Glycopyrroinum Bromide Ph. Eur + Vilanterol Trifenatate inhalation powder
|
|
328 KB
|
| 940 |
Lasmiditan tablets 50 mg / 100 mg
|
|
2304 KB
|
| 941 |
Mesenchymal Stem Cell
|
|
663 KB
|
| 942 |
Paracetamol Injection 1000 mg/4ml iv use
|
|
501 KB
|
| 943 |
Luspatercept powder for solution for injection: 25 mg and 75 mg
|
|
796 KB
|
| 944 |
Docetaxel
|
|
788 KB
|
| 945 |
101-PGC-005…20mg
|
|
2347 KB
|
| 946 |
Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet (Phase III)
|
|
320 KB
|
| 947 |
Asunercept
|
|
791 KB
|
| 948 |
101-PGC-005…20mg
|
|
2347 KB
|
| 949 |
LL-BMT1
|
|
701 KB
|
| 950 |
QIV Vaccine
|
|
438 KB
|
| 951 |
Recombinant Hepatits E
|
|
228 KB
|
| 952 |
BCD-201 (JSC BIOCAD) and Keytruda®
|
|
797 KB
|
| 953 |
HRF-10071 -120 mg
|
|
2200 KB
|
| 954 |
HRF-100071- 20 mg/40mg/ 100mg
|
|
2576 KB
|
| 955 |
NBTXR3
|
|
668 KB
|
| 956 |
SAR440340/REGN3500/itepekimabd
|
|
333 KB
|
| 957 |
Hexavalent Vaccine
|
|
561 KB
|
| 958 |
Pregabalin IP (as prolonged release) + Etoricoxib IP film coated bilayered tablets (Phase IV)
|
|
348 KB
|
| 959 |
Vildagliptin + Pioglitazone Hcl IP eq. Pioglitazone uncoated tablet (Phase III)
|
|
326 KB
|
| 960 |
Alcohol IP + Ketoprofen IP gel (Phase III)
|
|
271 KB
|
| 961 |
Metformin Hydrochloride IP + Glimepiride IP + Dapagliflozin Propanediol Monohydrate tablets (Phase III).
|
|
303 KB
|
| 962 |
Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin + Pioglitazone Hydrochloride IP equivalent to Pioglitazone film coated tablets (Phase III)
|
|
393 KB
|
| 963 |
BCD-217 (Nurulimab + Prolgolimab)
|
|
667 KB
|
| 964 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP (as sustained release) IP tablets (Phase III)
|
|
286 KB
|
| 965 |
Etifoxine HCl 50 mg
|
|
2623 KB
|
| 966 |
Liothyronine Sodium Tablets 5mcg & 20 mcg
|
|
2533 KB
|
| 967 |
Gliclazide IP (As sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III)
|
|
367 KB
|
| 968 |
Dulaglutide solution for injection 0.75mg and 1.5mg prefilled pen
|
|
712 KB
|
| 969 |
Linagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
307 KB
|
| 970 |
Ivermectin cutaneous solution 0.5%
|
|
665 KB
|
| 971 |
mepolizumab 100 mg SC
|
|
688 KB
|
| 972 |
Durvalumab plus Olaparib
|
|
679 KB
|
| 973 |
cagrilintide s.c. 2.4 mg
|
|
588 KB
|
| 974 |
Diphtheria and Tetanus vaccine for Adults and Adolescents I.P (Td Vaccine)
|
|
91 KB
|
| 975 |
Pneumococcal Conjugate Vaccine (2+1 schedule)
|
|
141 KB
|
| 976 |
Elagolix tablets 150 mg
|
|
2471 KB
|
| 977 |
Latanoprost IP + Netarsudil Mesylate eq. to Netarsudil + Benzalkonium Chloride IP (As preservative) per ml ophthalmic solution (Phase III)
|
|
287 KB
|
| 978 |
Montelukast IP + Fexofenadine Hydrochloride IP suspension (Phase III)
|
|
323 KB
|
| 979 |
Thymosin Alpha 1 for injection 1.6mg
|
|
420 KB
|
| 980 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
410 KB
|
| 981 |
Brilaroxazine (RP5063)
|
|
671 KB
|
| 982 |
C-TB, Tubercullin PPD RT23 SSI
|
|
1988 KB
|
| 983 |
AVT06 Compared with EU-Eylea
|
|
813 KB
|
| 984 |
Aflibercept with Eylea
|
|
789 KB
|
| 985 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP film coated tablet (Phase III).
|
|
325 KB
|
| 986 |
Lyophilized mRNA Vaccine for Injection (COVID-19
|
|
234 KB
|
| 987 |
Liraglutide injection 6mg/ml
|
|
724 KB
|
| 988 |
Itolizumab for Injection 100 mg/vial
|
|
574 KB
|
| 989 |
Solifenacin Succinate IP + Silodosin film coated bilayered tablets (Phase III)
|
|
279 KB
|
| 990 |
Desidustat 50 mg
|
|
2107 KB
|
| 991 |
Nivolumab
|
|
1158 KB
|
| 992 |
Proxalutamide (GT0918)
|
|
656 KB
|
| 993 |
Sitagliptin Phosphate Monohydrate eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Metformin Hydrochloride IP (As extended release) film coated bilayered tablet (Phase III),
|
|
334 KB
|
| 994 |
Vildagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablet (Phase III)
|
|
242 KB
|
| 995 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP (As extended release form) tablets (Phase III),
|
|
284 KB
|
| 996 |
[+]-α-dihydrotetrabenazine [ -α- DHTB -5mg/7.5mg/10mg/15mg/22.5mg
|
|
2181 KB
|
| 997 |
Pseudoephedrine Hydrochloride IP + Fexofenadine Hydrochloride IP extended release tablet (Phase IV
|
|
292 KB
|
| 998 |
Pantoprazole Sodium IP eq. to Pantoprazole (as gastro-resistant tablet) + Acotiamide Hydrochloride Hydrate (as 3 extended release tablets of each) hard gelatin capsules (Phase III)
|
|
308 KB
|
| 999 |
Bisoprolol Fumarate IP + Telmisartan IP film coated bilayered tablet (Phase III)
|
|
353 KB
|
| 1000 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Glimepiride IP + Metformin Hydrochloride IP (As sustained release form) film coated bilayered tablet (Phase III)
|
|
318 KB
|
| 1001 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP (as extended release form) tablet (Phase III)
|
|
312 KB
|
| 1002 |
Lifitegrast Opthalamic Solution 5%
|
|
2753 KB
|
| 1003 |
Sibeprenlimab
|
|
670 KB
|
| 1004 |
Pneumococcal Polysaccharide Conjugate Vaccine (adsorbed), I.P. (15 valent
|
|
429 KB
|
| 1005 |
Datopotamab Deruxtecan (Dato-DXd)
|
|
481 KB
|
| 1006 |
Carboplatin and Paclitaxel
|
|
673 KB
|
| 1007 |
SAR440340/REGN3500/itepekimab
|
|
511 KB
|
| 1008 |
Adenoviral-Vector Based Vaccine (VXA-CoV2-1.1-S) (Enteric Coated Tablet)
|
|
397 KB
|
| 1009 |
Ticagrelor 180 mg Tablet
|
|
3675 KB
|
| 1010 |
Live Attenuated Tetravalent Recombinant Dengue Vaccine
|
|
194 KB
|
| 1011 |
Silodosin + Mirabegron (SR) film coated bilayered tablets (Phase III)
|
|
296 KB
|
| 1012 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP film coated bilayered tablet (Phase IV)
|
|
306 KB
|
| 1013 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14
|
|
226 KB
|
| 1014 |
Insulin Injection,Biphasic Isophane Ph.Eur 100IU/ml
|
|
851 KB
|
| 1015 |
Metformin Hydrochloride IP eq. to Metformin (as extended release form) + Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated tablets (Phase III)
|
|
297 KB
|
| 1016 |
Metformin Hydrochloride IP (As extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet (Phase 3
|
|
300 KB
|
| 1017 |
Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
307 KB
|
| 1018 |
Tinofovir Pivafen Fumarate 50 mg
|
|
1982 KB
|
| 1019 |
Metformin Hydrochloride IP (Extended release) + Glimepiride IP 1mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated bilayered tablet (Phase III)
|
|
314 KB
|
| 1020 |
Metformin Hydrochloride IP (as extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablet (Phase III)
|
|
363 KB
|
| 1021 |
Triamcinolone Acetonide Cream 0.1% w/w
|
|
548 KB
|
| 1022 |
Dapagliflozin + Pioglitazone Hydrochloride IP eq. to Pioglitazone film coated tablets (Phase III)
|
|
309 KB
|
| 1023 |
Metformin Hydrochloride IP (as sustained release) + Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III)
|
|
360 KB
|
| 1024 |
HRF-10071tablets 120 mg and Pravastatin 40 mg
|
|
2028 KB
|
| 1025 |
HRF-10071tablets 120 mg and Rifampicin 600 mg capsules
|
|
2183 KB
|
| 1026 |
Selpercatinib
|
|
653 KB
|
| 1027 |
Finerenone 10 mg and 20 mg
|
|
2588 KB
|
| 1028 |
Mino-Lok Therapy (MLT
|
|
649 KB
|
| 1029 |
AZD1222 Vaccine
|
|
674 KB
|
| 1030 |
SRP-4045 and SRP-4053
|
|
659 KB
|
| 1031 |
ZY19489
|
|
2030 KB
|
| 1032 |
AB001 400mg Tablets
|
|
2052 KB
|
| 1033 |
Clotrimazole Vaginal Film 50 mg
|
|
437 KB
|
| 1034 |
PNB001
|
|
2240 KB
|
| 1035 |
Eteplirsen
|
|
667 KB
|
| 1036 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (ER) + Telmisartan IP + Amlodipine Besilate IP eq. to Amlodipine Film Coated Bilayered tablet (Phase III)
|
|
414 KB
|
| 1037 |
Thymosin Alpha 1 for injection 1.6 mg
|
|
411 KB
|
| 1038 |
LNP023gc
|
|
659 KB
|
| 1039 |
LNP023
|
|
659 KB
|
| 1040 |
Dupilumabr
|
|
792 KB
|
| 1041 |
Sovateltide
|
|
2118 KB
|
| 1042 |
Ramatroban tablets 75 mg
|
|
1855 KB
|
| 1043 |
Pantoprazole Dual Release Gastro-Resistant Tablet 80 mg
|
|
372 KB
|
| 1044 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride As sustained release formIP uncoated bilayered tablets (Phase III
|
|
182 KB
|
| 1045 |
Inhaled Itracoanzole Dry Powder for inhalation 10 mg capsule (PUR 1900)
|
|
471 KB
|
| 1046 |
Glycopyrrolate IP + Formoterol Fumarate dehydrate IP eq. to Formoterol Fumarate + Budesonide IP Per actuation deliver (Phase IV)
|
|
184 KB
|
| 1047 |
ES16001
|
|
645 KB
|
| 1048 |
inclisiran
|
|
645 KB
|
| 1049 |
Telmisartan IP + Bisoprolol Fumarate IP tablets (Phase III)
|
|
256 KB
|
| 1050 |
101-PGC-005
|
|
2107 KB
|
| 1051 |
Azelastine Hydrohloride 1 mg/ml Nasal Spray
|
|
423 KB
|
| 1052 |
Guselkumab
|
|
788 KB
|
| 1053 |
remibrutinib versus teriflunomide
|
|
661 KB
|
| 1054 |
Fosfomycin Trometamol Powder 3 gm
|
|
477 KB
|
| 1055 |
NRC-1111
|
|
2198 KB
|
| 1056 |
HRF-10071, Darunavir and Ritonavir
|
|
2004 KB
|
| 1057 |
Pneumococcal Polysaccharide Conjugate Vaccine I.P. (PCV13-TT
|
|
562 KB
|
| 1058 |
Mirabegron (ER) + Solifenacin Succinate IP film coated bilayered tablet (Phase IV
|
|
186 KB
|
| 1059 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablet (Phase III)
|
|
283 KB
|
| 1060 |
Teriparatide 20microgram/80 micro litre solution for injection in prefilled pen
|
|
828 KB
|
| 1061 |
Vildagliptin IP (as sustained release)Pioglitazone Hydrochloride IP eq. to Pioglitazone tablets (Phase III)
|
|
229 KB
|
| 1062 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tabletPhase III)
|
|
195 KB
|
| 1063 |
Vericiguat therapy
|
|
2443 KB
|
| 1064 |
Dapagliflozin IP +Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP bilayered tablet (Phase III)
|
|
192 KB
|
| 1065 |
Rabies Vaccine, Human I.P. [Purified Inactivated Vero Cell Rabies vaccine – Lyophilized
|
|
484 KB
|
| 1066 |
Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP + Sitagliptin Phosphate IP eq. to Sitagliptin film coated bilayered tablet (Phase III)
|
|
206 KB
|
| 1067 |
Paclitaxel-Carboplatin-Oregovomab)
|
|
673 KB
|
| 1068 |
Dupilumabn
|
|
691 KB
|
| 1069 |
Ondansetron Extended Relese Injectable Supension 100mg/ml
|
|
400 KB
|
| 1070 |
Typhoid Conjugate Vaccine (Bivalent)
|
|
235 KB
|
| 1071 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone uncoated tabletsPhase III)
|
|
211 KB
|
| 1072 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) + Amlodipine Besilate IP eq. to Amlodipine + Chlorthalidone IP film coated bilayered tablets (Phase III)
|
|
206 KB
|
| 1073 |
Trelagliptin
|
|
2481 KB
|
| 1074 |
remibrutinib versus teriflunomidegc
|
|
654 KB
|
| 1075 |
HRF-10071 and Dolutegravir
|
|
2256 KB
|
| 1076 |
Oral AUR105
|
|
2312 KB
|
| 1077 |
Durvalumabgct
|
|
668 KB
|
| 1078 |
Tirzepatide
|
|
664 KB
|
| 1079 |
Durvalumab plus Domvanalimab (AB154
|
|
684 KB
|
| 1080 |
Capivasertib + Docetaxel
|
|
657 KB
|
| 1081 |
Cefepime Zidebactam vs. Meropenem
|
|
661 KB
|
| 1082 |
Biphasic Insulin Aspart Injection IP 100 IU/mL
|
|
700 KB
|
| 1083 |
Novel Corona virus-2019-nCoV Vaccine
|
|
572 KB
|
| 1084 |
IcoSema and once weekly insulin icodec
|
|
687 KB
|
| 1085 |
Tremelimumab ± Lenvatinib
|
|
676 KB
|
| 1086 |
Bucillamine tablets 100mg
|
|
2592 KB
|
| 1087 |
Linagliptin + Dapagliflozin tablets (Phase III)
|
|
260 KB
|
| 1088 |
Omalizumab Injection
|
|
693 KB
|
| 1089 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated tablets (Phase III)
|
|
192 KB
|
| 1090 |
Triamcinolone Hexacetonide Injectable Suspension 20 mg/ml
|
|
2426 KB
|
| 1091 |
Vildagliptin (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase III)
|
|
206 KB
|
| 1092 |
Tofacitinib Ointment 2%
|
|
491 KB
|
| 1093 |
Virion Inactivated Corona Virus Vaccine
|
|
320 KB
|
| 1094 |
Teriperatide Injection solution for injection in a pre-filled pen 600mcg/2.4ml (Synthetic Origin)
|
|
538 KB
|
| 1095 |
Omalizumab 150 mg/ml
|
|
560 KB
|
| 1096 |
EMPAgliflozin
|
|
800 KB
|
| 1097 |
Dapagliflozin Propanedilol Monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film Coated Tablets (Phase III)
|
|
294 KB
|
| 1098 |
Pregabalin IP (As Prolonged Release) + Etoricoxib IP film coated bilayered tablets (Phase IV)
|
|
309 KB
|
| 1099 |
Lyka Labs
|
|
426 KB
|
| 1100 |
Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablets (Phase III)
|
|
291 KB
|
| 1101 |
HRF-10071, Tenofovir, Dolutegravir
|
|
2031 KB
|
| 1102 |
Glycopyrrolate IP eq. to Glycopyrronium _+ Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate + Budesonide inhalation powder (Phase IV)
|
|
319 KB
|
| 1103 |
Ajanta Pharma
|
|
365 KB
|
| 1104 |
f GSK S. aureus candidate vaccine
|
|
673 KB
|
| 1105 |
CSJ117
|
|
651 KB
|
| 1106 |
CSJ117
|
|
651 KB
|
| 1107 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (Phase II
|
|
275 KB
|
| 1108 |
Nor-ursodeoxycholic acid
|
|
2242 KB
|
| 1109 |
HRF-10071, Tenofovir alafenamide and Ripivirine
|
|
2175 KB
|
| 1110 |
HRF-10071, Ripivirine
|
|
2165 KB
|
| 1111 |
AUR103 Calciumin
|
|
2392 KB
|
| 1112 |
MS/ Veeda
|
|
2124 KB
|
| 1113 |
Chlorthalidone IP + Efonidipine Hydrochloride Ethanolate IP tablets (Phase III)
|
|
266 KB
|
| 1114 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
293 KB
|
| 1115 |
HRF-10071, Tenofovir alafenamide and Emtricitabin
|
|
2148 KB
|
| 1116 |
Varicella Vaccine Live, Attenuated IP(VARIVAX) 2000 PFU
|
|
146 KB
|
| 1117 |
Paltusotine
|
|
674 KB
|
| 1118 |
Human Insulin Short acting
|
|
706 KB
|
| 1119 |
Insulin Glargine (r-DNA origin) Injection 100 units/mL
|
|
702 KB
|
| 1120 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP Tablets (Phase III)
|
|
319 KB
|
| 1121 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Dapagliflozin (Phase III)
|
|
248 KB
|
| 1122 |
concizumab prophylaxis
|
|
653 KB
|
| 1123 |
Elobixibat
|
|
2497 KB
|
| 1124 |
LL-BMT1
|
|
652 KB
|
| 1125 |
SCO-120
|
|
487 KB
|
| 1126 |
Fosravuconazole capsules
|
|
2338 KB
|
| 1127 |
Silodosin + Tdalafil IP hard gelatin capsule (Phase III)
|
|
277 KB
|
| 1128 |
Linaclotide Capsules
|
|
2258 KB
|
| 1129 |
Umifenovir Tablet
|
|
2240 KB
|
| 1130 |
Brinzolamide IP + Timolol Maleate IP eq. to Timolol + Potassium Sorbate IP (as preservative) Ophthalmic suspension (Phase IV)
|
|
308 KB
|
| 1131 |
Montelukast Sodium IP eq. to Montelukast + Bilastine Orodispersible tablet (Phase IV)
|
|
301 KB
|
| 1132 |
Atrasentan
|
|
662 KB
|
| 1133 |
Inactivated Influenza Vaccine (Split Virion) I.P. (Tetravalent)
|
|
330 KB
|
| 1134 |
Savolitinib plus Durvalumab
|
|
806 KB
|
| 1135 |
Tislelizuma
|
|
673 KB
|
| 1136 |
IRINOTECAN AND TEMOZOLOMIDE
|
|
653 KB
|
| 1137 |
TOPOTECAN AND CYCLOPHOSPHAMIDE
|
|
653 KB
|
| 1138 |
MYL-1701P
|
|
655 KB
|
| 1139 |
Naftifine hydrochloride cream 2% b
|
|
2544 KB
|
| 1140 |
ASLAN004
|
|
672 KB
|
| 1141 |
LY3484356
|
|
669 KB
|
| 1142 |
Efonidipine Hydrochloride Ethanolate IP + Telmisartan IP film coated tablets (Phase III)
|
|
290 KB
|
| 1143 |
osimertinib
|
|
707 KB
|
| 1144 |
Polmacoxib Capsules
|
|
3066 KB
|
| 1145 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (13- valent)
|
|
588 KB
|
| 1146 |
Semaglutide on functional capacity
|
|
652 KB
|
| 1147 |
TK-90M/s. SiRO
|
|
627 KB
|
| 1148 |
Sitagliptin Phosphate monohydrate eq. to Sitagliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
366 KB
|
| 1149 |
GRC 54276
|
|
2658 KB
|
| 1150 |
Pegfilgrastim
|
|
674 KB
|
| 1151 |
AUR-101
|
|
2296 KB
|
| 1152 |
HGCO19 Lyophilized mRNA Vaccine for Injection
|
|
568 KB
|
| 1153 |
Hepatitis A (Live) Vaccine, Freeze-Dried
|
|
497 KB
|
| 1154 |
Inactivated Salk Polio Vaccine
|
|
333 KB
|
| 1155 |
Pneumococcal Polysaccharide Conjugate Vaccine
|
|
327 KB
|
| 1156 |
Denosumab
|
|
700 KB
|
| 1157 |
Metformin Hydrochloride IP (as sustained release) + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin tablets (Phase III
|
|
306 KB
|
| 1158 |
Belantamab Mafodotin (GSK2857916)
|
|
649 KB
|
| 1159 |
TK-90
|
|
626 KB
|
| 1160 |
SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine [COVOVAX]
|
|
300 KB
|
| 1161 |
A vector vaccine for the prevention of the coronavirus infection
|
|
302 KB
|
| 1162 |
Sodium Hyaluronate BP + Chontroitin Sulfate Sodium BP + Poloxamer IP per 10ml oral liquid (Phase IV)
|
|
311 KB
|
| 1163 |
SAR442168 to placebo
|
|
671 KB
|
| 1164 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III)
|
|
317 KB
|
| 1165 |
Vildagliptin (as sustained release) + Pioglitazone Hydrochloride eq. to Pioglitazone IP uncoated bilayered tablets (Phase III)
|
|
304 KB
|
| 1166 |
Dapagliflozin Propanediol eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to to Sitagliptin film coated tablet (Phase III)
|
|
320 KB
|
| 1167 |
NUCALA
|
|
2527 KB
|
| 1168 |
Sun Pharma
|
|
416 KB
|
| 1169 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III
|
|
326 KB
|
| 1170 |
CRIZOTINIB
|
|
422 KB
|
| 1171 |
Teriparatide
|
|
545 KB
|
| 1172 |
Revefenacin
|
|
2350 KB
|
| 1173 |
Sun Pharma
|
|
505 KB
|
| 1174 |
Vildagliptin (as sustained release) + Dapagliflozin (100mg+5mg & 100mg + 10mg) tablets (Phase III)M/s. Ravenbhel Healthcare Pvt. Ltd
|
|
281 KB
|
| 1175 |
Chlorpheniramine Maleate IP + Noscapine IP per 5ml oral liquid (Phase III)
|
|
392 KB
|
| 1176 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP uncoated bilayered tablets (Phase III)
|
|
290 KB
|
| 1177 |
Pegfilgrastim Solution for Injection
|
|
393 KB
|
| 1178 |
Remogliflozin Etabonate + Vildagliptin + Metformin Hydrochloride IP Film coated tablet (Phase IV)
|
|
329 KB
|
| 1179 |
TOFACITINIB
|
|
663 KB
|
| 1180 |
Whole Virion Inactivated Corona Virus Vaccine
|
|
337 KB
|
| 1181 |
Tamsulosin Hydrochloride IP (as prolonged release pellets) + Tadalafil IP (as film coated tablet) capsules (Phase IV)
|
|
352 KB
|
| 1182 |
Teneligliptin IP + Dapagliflozin tablets (Phase III)
|
|
271 KB
|
| 1183 |
AT-752
|
|
787 KB
|
| 1184 |
ELRANATAMAB
|
|
665 KB
|
| 1185 |
Lifeviro treat inhalation
|
|
2497 KB
|
| 1186 |
dupilumab
|
|
667 KB
|
| 1187 |
Nitazoxanide Tablets 500 mg
|
|
656 KB
|
| 1188 |
Atropine Sulphate Ophthalmic Solution 0.05% w/v0.05 % w/v Ophthalmic Solution
|
|
466 KB
|
| 1189 |
Acalabrutinib1
|
|
665 KB
|
| 1190 |
Metoprolol IP + Chlorthalidone IP + Cilnidipine IP tablets (Phase III)
|
|
276 KB
|
| 1191 |
Abrocitinib
|
|
30383KB
|
| 1192 |
Follicle Stimulating Hormone (Human Recombinant)
|
|
564 KB
|
| 1193 |
BI 690517
|
|
677 KB
|
| 1194 |
SAR442168
|
|
849 KB
|
| 1195 |
Imeglimin tabletsv
|
|
2952 KB
|
| 1196 |
tofacitinib
|
|
390 kB
|
| 1197 |
secukinumab (Cosentyx)
|
|
661 KB
|
| 1198 |
SATRALIZUMAB
|
|
653 KB
|
| 1199 |
SAR443122
|
|
674 KB
|
| 1200 |
alteplase
|
|
671 KB
|
| 1201 |
Aflibercept
|
|
712 KB
|
| 1202 |
Elranatamab (PF-06863135
|
|
670 KB
|
| 1203 |
fitusiran prophylaxis
|
|
657 KB
|
| 1204 |
Intraversial SN-38 Lipid Suspension
|
|
2587 KB
|
| 1205 |
Intravenous Allogeneic Mesenchymal
|
|
654 KB
|
| 1206 |
ligelizumab (QGE031)
|
|
664 KB
|
| 1207 |
Picrorhiza kurroa
|
|
2654 KB
|
| 1208 |
Amlodipine Besylate IP eq. to Amlodipine + Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets (Phase III)
|
|
316 KB
|
| 1209 |
fluticasone propionate
|
|
771 KB
|
| 1210 |
Tofacetinib Gel 2%
|
|
425 KB
|
| 1211 |
hydrogen peroxide
|
|
509 KB
|
| 1212 |
Mirikizumab
|
|
411 KB
|
| 1213 |
Dapagliflozin + Sitagliptin film coated tablet (Phase III)M/s. Glenmark Pharmaceuticals Ltd
|
|
286 KB
|
| 1214 |
Dapagliflozin + Sitagliptin film coated tablet (Phase IIIg
|
|
286 KB
|
| 1215 |
Tranexamic Acid Spray 10% w/v Acid Spray 10% w/v Acid Spray 10% w/v
|
|
394 KB
|
| 1216 |
SAR442168 to teriflunomide (Aubagio®)
|
|
663 KB
|
| 1217 |
Mepolizumab
|
|
325 KB
|
| 1218 |
Imeglimin tablets
|
|
2592 KB
|
| 1219 |
Naftifine hydrochloride cream 2%
|
|
2682 KB
|
| 1220 |
Dapagliflozin + Metformin Hydrochloride IP + Vildagliptin film coated tablets (Phase III)
|
|
297 KB
|
| 1221 |
Quadrivalent Meningococcal Conjugate Vaccine
|
|
667 KB
|
| 1222 |
Bioactive concentrate from small marine fish + water for injection (WFI) solution for injection (Phase III)
|
|
296 KB
|
| 1223 |
Pimavenserin Capsules
|
|
2375 KB
|
| 1224 |
Chimpanzee Adenovirus Vectored COVID-19 Vaccine (BBV154)
|
|
232 KB
|
| 1225 |
Chimpanzee Adenovirus Vectored COVID-19 Vaccine
|
|
424 KB
|
| 1226 |
Vildagliptin SR + Dapagliflozin + film coated bilayered tablets (Phase III)
|
|
286 KB
|
| 1227 |
Ferric Pyrophosphate citrate
|
|
2622 KB
|
| 1228 |
tocilizumab
|
|
653 KB
|
| 1229 |
Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5
|
|
659 KB
|
| 1230 |
Nano Carrier Entrapped Vitamin D3 Oral Dispersion 60000IU
|
|
490 KB
|
| 1231 |
Vildagliptin + Dapagliflozin + Metformin hydrochloride IP tablets (Phase III)
|
|
341 KB
|
| 1232 |
(r-hFSH) 900 IU (66.0 μg)/1.5 mL Solution
|
|
657 KB
|
| 1233 |
PROphylaxis
|
|
347 KB
|
| 1234 |
Dapagliflozin + Metformin XR versus Metformin XR
|
|
548 KB
|
| 1235 |
PCV-20 Valent
|
|
556 KB
|
| 1236 |
IMM-101
|
|
654 KB
|
| 1237 |
Wosulin R, Wosulin N and Wosulin 30/70
|
|
742 KB
|
| 1238 |
Anifrolumab
|
|
657 KB
|
| 1239 |
LXE408
|
|
652 KB
|
| 1240 |
Amantadine Extended Release Tablet 129/193 mg
|
|
446 KB
|
| 1241 |
INO-4800
|
|
685 KB
|
| 1242 |
IcoSema and Daily Insulin Glargine 100 units/mL
|
|
733 KB
|
| 1243 |
LTX-109 3% gel
|
|
323 KB
|
| 1244 |
BI 685509
|
|
655 KB
|
| 1245 |
Dapagliflozin + Metformin Hydrochloride IP (Extended Release) + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III)
|
|
331 KB
|
| 1246 |
Cholera Vaccine (Inactivated, Oral), I.P.
|
|
306 KB
|
| 1247 |
Pertuzumab 420 mg/14mL Injection
|
|
693 KB
|
| 1248 |
MEDI3506
|
|
667 KB
|
| 1249 |
Alpelisib plus Fulvestrant
|
|
2590 KB
|
| 1250 |
Anti-HIV microbicide gel
|
|
2139 KB
|
| 1251 |
SARS-CoV-2 (Covid-19) Vaccine (RBD antigen of SARS CoV-2(Covid-19
|
|
234 KB
|
| 1252 |
Measles (Edmonston Zagreb) and Rubella (RA27/3) Vaccine Live, Attenuated (Freeze Dried), IP
|
|
329 KB
|
| 1253 |
OMS721
|
|
675 KB
|
| 1254 |
Mupirocin 2% w/w Ointment
|
|
428 KB
|
| 1255 |
Dato-DXd
|
|
782 KB
|
| 1256 |
remibrutinib LOU064
|
|
675 KB
|
| 1257 |
Metformin Hydrochloride IP (as prolonged release) + Teneligliptin IP + Dapagliflozin tablets (Phase III)
|
|
190 KB
|
| 1258 |
COVID-19 (Adapt Out COVID)
|
|
748 KB
|
| 1259 |
Paclitaxel-Carboplatin-Oregovomab)
|
|
655 KB
|
| 1260 |
Trastuzumab Deruxtecanas
|
|
771 KB
|
| 1261 |
Mirabegron (As extended release) + Silodosin film coated bilayered tablets (Phase III)
|
|
184 KB
|
| 1262 |
Lemborexant
|
|
23275 KB
|
| 1263 |
Bempedoic acid
|
|
24271 KB
|
| 1264 |
Darolutamide
|
|
2994 KB
|
| 1265 |
Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
258 KB
|
| 1266 |
CKD-314
|
|
689 KB
|
| 1267 |
Ozenoxacin Lotion 2% w/v
|
|
1196 KB
|
| 1268 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP tablets (Phase III)
|
|
247 KB
|
| 1269 |
Esmprazole Dual release Gastro Resistant Tablets 80 mg
|
|
515 KB
|
| 1270 |
Adjuvant Giredestrant
|
|
739 KB
|
| 1271 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III)
|
|
234 KB
|
| 1272 |
brequinar combined dipyridamole
|
|
657 KB
|
| 1273 |
Metoprolol Succinate IP (ER) + Azelnidipine IP film coated bilayered tablets (Phase III)
|
|
184 KB
|
| 1274 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml oral suspension (Phase III)
|
|
168 KB
|
| 1275 |
Plecanatide
|
|
23335 KB
|
| 1276 |
remibrutinib (LOU064)
|
|
671 KB
|
| 1277 |
IMU-838 versus Placebo
|
|
656 KB
|
| 1278 |
Cariprazine
|
|
2129 KB
|
| 1279 |
IMU-838
|
|
657 KB
|
| 1280 |
Peptide Receptor Radionuclide Therapy (PRRT)
|
|
765 KB
|
| 1281 |
Typhoid Conjugate Vaccine (Monovalent) [Typhoid Vi ConjugateVaccine]
|
|
583 KB
|
| 1282 |
asciminib
|
|
656 KB
|
| 1283 |
dabrafenib plus trametinib
|
|
660 KB
|
| 1284 |
INTP24 Against Avastin®
|
|
661 KB
|
| 1285 |
Teneligliptin IP + Rosuvastatin Calcium IP tablets (Phase III)
|
|
253 KB
|
| 1286 |
Amivantamab and Lazertinib
|
|
668 KB
|
| 1287 |
cccc
|
|
2368 KB
|
| 1288 |
triptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Tablets (Phase III)
|
|
231 KB
|
| 1289 |
Dapagliflozin + Vildagliptin tablets (Phase III)
|
|
198 KB
|
| 1290 |
Trastuzumab Deruxtecan (T-DXd)
|
|
521 KB
|
| 1291 |
Tirzepatiden
|
|
680 KB
|
| 1292 |
LIB003 in Heterozygous
|
|
659 KB
|
| 1293 |
Alcaftadine Nasal Spray ALDP001
|
|
389 KB
|
| 1294 |
Lastacaft
|
|
389 KB
|
| 1295 |
Alcaftadine Nasal Spray
|
|
400 KB
|
| 1296 |
Alcaftadine Nasal Spray CT NOC
|
|
404 KB
|
| 1297 |
Rilematovir (JNJ-53718678)
|
|
505 KB
|
| 1298 |
CSJ117
|
|
653 KB
|
| 1299 |
MSP008-22c
|
|
2128 KB
|
| 1300 |
Zinc Citrate Trihydrate eq. to Zinc IP +Ascorbic Acid IP effervescent tablets (Phase IV)
|
|
187 KB
|
| 1301 |
Bisoprolol Fumarate IP + Telmisartan IP uncoated bilayered tablets (Phase III)
|
|
172 KB
|
| 1302 |
LIB003n
|
|
650 KB
|
| 1303 |
LIB003 (Low density lipoprotein)
|
|
650 KB
|
| 1304 |
Itolizumab
|
|
670 KB
|
| 1305 |
Marstacimab Prophylaxis
|
|
645 KB
|
| 1306 |
Capmatinib film coated tablet 150 mg/200 mg
|
|
2260 KB
|
| 1307 |
antiviral therapies
|
|
4141 KB
|
| 1308 |
INO-4800
|
|
673 KB
|
| 1309 |
Pharmacokinetics of Remdesivir
|
|
2831 KB
|
| 1310 |
ADG20
|
|
514 KB
|
| 1311 |
Brazikumabn
|
|
665 KB
|
| 1312 |
Proxalutamide (GT0918
|
|
518 KB
|
| 1313 |
Brazikumab
|
|
666 KB
|
| 1314 |
Deupirfenidone (LYT-100)
|
|
501 KB
|
| 1315 |
Finerenone
|
|
508 KB
|
| 1316 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP (as extended release) Film coated bilayered tablets (Phase III)
|
|
245 KB
|
| 1317 |
NNC0194-0499
|
|
529 KB
|
| 1318 |
OAV101
|
|
496 KB
|
| 1319 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (11-valent)
|
|
324 KB
|
| 1320 |
Letrozole Tablet 5 mg
|
|
2846 KB
|
| 1321 |
Inactivated Hepatitis A Vaccine (Adsorbed
|
|
315 KB
|
| 1322 |
Brinzolamide IP + Brimonidine Tartrate IP Ophthalmic suspension (Phase III)
|
|
184 KB
|
| 1323 |
Urosodiol Injection 625 mg/25ml 925mg/ml)
|
|
3072 KB
|
| 1324 |
Study (NEST)
|
|
652 KB
|
| 1325 |
MYL-1701P
|
|
510 KB
|
| 1326 |
Remdesivir for injection 100mg/vial
|
|
2819 KB
|
| 1327 |
Intravitreal OPT-302
|
|
338 KB
|
| 1328 |
Ad26.COV2.S
|
|
664 KB
|
| 1329 |
Loeglitazone sulphate 0.5 mg tablets
|
|
2617 KB
|
| 1330 |
Typhoid Vi Conjugate Vaccine I.
|
|
232 KB
|
| 1331 |
Quadrivalent Influenza vaccine (Split Virion, Inactivated)
|
|
306 KB
|
| 1332 |
PF-07321332/Ritonavir
|
|
410 KB
|
| 1333 |
OPT-302
|
|
672 KB
|
| 1334 |
Vilanterol Trifenatate eq. to Vilanterol + Fluticasone Furoate per actuation delivers metered dose inhalation (Phase III)
|
|
224 KB
|
| 1335 |
HRF-10071
|
|
2295 KB
|
| 1336 |
Peg-filgrastim Injection 6 mg/0.6ml
|
|
684 KB
|
| 1337 |
Insulin Aspart Injection (100 IU/mL)
|
|
695 KB
|
| 1338 |
PDP-1 17
|
|
2303 KB
|
| 1339 |
ISTH0036
|
|
476 KB
|
| 1340 |
ziltivekimab1
|
|
646 KB
|
| 1341 |
FP-025
|
|
483 KB
|
| 1342 |
Gadoteridol 279.3mg/ml Injection
|
|
2210 KB
|
| 1343 |
MRG-001,
|
|
646 KB
|
| 1344 |
Acalabrutinibz
|
|
967 KB
|
| 1345 |
Anti-COVID-19 AKS-452 vaccine
|
|
671 KB
|
| 1346 |
Nortriptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Film Coated Tablets (Phase III)
|
|
203 KB
|
| 1347 |
Naltrexone Hydrochloride + Zonisamide sustained release capsules (Phase II)
|
|
242 KB
|
| 1348 |
Teneligliptin Hydrobromide IP + Dapagliflozin tablets (Phase III)
|
|
131 KB
|
| 1349 |
Insulin Aspart Injection 100 U/mL
|
|
697 KB
|
| 1350 |
Novel Corona virus-2019-nCoV Vaccine (recombinant)
|
|
229 KB
|
| 1351 |
Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin
|
|
502 KB
|
| 1352 |
Varespladib-Methyl
|
|
650 KB
|
| 1353 |
Angiotensin Receptor Blocker (ARB)
|
|
651 KB
|
| 1354 |
Imetelstat (GRN163L)
|
|
514 KB
|
| 1355 |
Favipiravir Tablet 200/800 m
|
|
675 KB
|
| 1356 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP tablets (Phase III)
|
|
230 KB
|
| 1357 |
Apremilast Topcial Gel 2%
|
|
3225 KB
|
| 1358 |
BP01 (Bevacizumab)
|
|
656 KB
|
| 1359 |
Betamethasone dipropionate Ph. Eur + Calcipotriol anhydrous Ph. Eur. Cutaneous spray (Phase III)
|
|
220 KB
|
| 1360 |
Polatuzumab Vedotin
|
|
649 KB
|
| 1361 |
unadjuvanted RSV Maternal vaccine
|
|
657 KB
|
| 1362 |
Bisoprolol IP + Telmisartan IP tablets (Phase III)
|
|
208 KB
|
| 1363 |
Bempedoic acid 180 mg tabletct
|
|
239 KB
|
| 1364 |
Azelnidipine + Telmisartan IP tablets (Phase III)
|
|
215 KB
|
| 1365 |
Secukinumab
|
|
654 KB
|
| 1366 |
Inhaled Ampion
|
|
668 KB
|
| 1367 |
Saroglitazar Tablet 4 mg
|
|
2782 KB
|
| 1368 |
Bilastine + Montelukast Sodium IP eq. to Montelukast oral suspension (Phase III)
|
|
197 KB
|
| 1369 |
Silodosin + Tadalafil capsules (Phase III)
|
|
287 KB
|
| 1370 |
Bempedoic acid 180 mg tablet
|
|
2853 KB
|
| 1371 |
Tirzepatide
|
|
660 KB
|
| 1372 |
Herpes Zoster vaccine
|
|
219 KB
|
| 1373 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP(as sustained release) tablets (Phase III)
|
|
233 KB
|
| 1374 |
Hydroxyprogesterone Caproate Intramuscular Injection
|
|
651 KB
|
| 1375 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP Phase III)
|
|
192 KB
|
| 1376 |
Iptacopan (LNP023)
|
|
651 KB
|
| 1377 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP per actuation delivers metered dose inhaler (Phase III)
|
|
197 KB
|
| 1378 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP dry powder for inhalation (capsules) (Phase III)
|
|
207 KB
|
| 1379 |
Pioglitazone Hydrochloride IP + Teneligliptin Hydrobromide Hydrate IP tablets (Phase III)
|
|
185 KB
|
| 1380 |
Fesoteroduine Fumarate Extend release tabklet 4 mg/8 mg and Solifenacin sucinate tablets 5 mg/10 mg
|
|
2540 KB
|
| 1381 |
Typhoid Conjugate
|
|
567 KB
|
| 1382 |
Fimasartan Potassium + Chlorthalidone IP tablets (Phase III)
|
|
176 KB
|
| 1383 |
BP05 Versus EU-Approved Lucentis®
|
|
674 KB
|
| 1384 |
Cetrelimab
|
|
689 KB
|
| 1385 |
ziltivekimab
|
|
446 KB
|
| 1386 |
Nucleocapsid
|
|
326 KB
|
| 1387 |
Acalabrutinib
|
|
404 KB
|
| 1388 |
SARS-CoV-2Vaccine
|
|
323 KB
|
| 1389 |
Favipiravir Tablet 200/400/800 mg
|
|
2852 KB
|
| 1390 |
(KAE609)
|
|
653 KB
|
| 1391 |
Ozenoxacin Lotion 2% W/v
|
|
3467 KB
|
| 1392 |
Efonidipine hydrochloride Ethanolate + Telmisartan IP Film coated bilayered tablet (Phase III)
|
|
215 KB
|
| 1393 |
Amoxicillin Trihydrate 759.04 mg eq. to Amoxicillin free acid 652.78 mg* + Potassium Clavulanate 61.48 mg eq. to Clavulanic acid 50.41mg
|
|
176 KB
|
| 1394 |
Remdesivir 100 mgb
|
|
2180 KB
|
| 1395 |
Favipiravir tablet 200 mg/400 mg/800 mg
|
|
2836 KB
|
| 1396 |
Tapentadol Hydrochloride Nasal Spray 225 mg/ml
|
|
3553 KB
|
| 1397 |
Cipargamin
|
|
543 KB
|
| 1398 |
Atacicept
|
|
659 KB
|
| 1399 |
PTG-300
|
|
2593 KB
|
| 1400 |
Lenvatinib 4/10 mg Capsule
|
|
3239 KB
|
| 1401 |
HGCO19
|
|
313 KB
|
| 1402 |
SARS-CoV-2V
|
|
669 KB
|
| 1403 |
Favipiravir tablet 400 mg
|
|
2337 KB
|
| 1404 |
Favipiravir tablet 800 mg
|
|
2285 KB
|
| 1405 |
Recombinant Human Parathyroid Hormone (rhPTH1-34) injection (Teriparatide Injection) 750 mcg/3 mL
|
|
708 KB
|
| 1406 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
182 KB
|
| 1407 |
Vildagliptin SR + Metformin Hydrochloride (SR) uncoated bilayered tablets (Phase III)
|
|
199 KB
|
| 1408 |
Teneligliptin Hydrobromide hydrate eq. to Teneligliptin + Dapagliflozin tablets (Phase III)
|
|
170 KB
|
| 1409 |
Talazoparib With Enzalutamide
|
|
654 KB
|
| 1410 |
Remdesivir 100 mgh
|
|
2560 KB
|
| 1411 |
LNP023n
|
|
649 KB
|
| 1412 |
Remdesivir 100 mgc
|
|
2484 KB
|
| 1413 |
Mifepristone 10/25 mg Tablet
|
|
2861 KB
|
| 1414 |
Remdesivir 100 mgj
|
|
2305 KB
|
| 1415 |
Metformin hydrochloride IP (as an extended-release form) + Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
216 KB
|
| 1416 |
Cocculus hirsutus
|
|
3037 KB
|
| 1417 |
Sputnik Light
|
|
229 KB
|
| 1418 |
Rilematovir
|
|
409 KB
|
| 1419 |
C21
|
|
409 KB
|
| 1420 |
BBV154
|
|
423 KB
|
| 1421 |
Teneligliptin hydrobromide hydrate eq to Teneligliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
236 KB
|
| 1422 |
Remdesivir for Injection 100mg/ml
|
|
3135 KB
|
| 1423 |
Remdesivir for Injection 100mg/ml
|
|
2877 KB
|
| 1424 |
2-Deoxy-D-Glucose Oral Powder 2.34 gm & 3.0 gm
|
|
176 KB
|
| 1425 |
Semaglutide 2.4 mg
|
|
406 KB
|
| 1426 |
Favipiravir tablet 200 mgw
|
|
2590 KB
|
| 1427 |
Doxazosin Tablet 2 mg
|
|
2638 KB
|
| 1428 |
Chimpanzee Adenovirus Vectored
|
|
276 KB
|
| 1429 |
COVAXIN
|
|
308 KB
|
| 1430 |
Remdesivir 100 mg
|
|
2480 KB
|
| 1431 |
Atezolizumab
|
|
680 KB
|
| 1432 |
Encorafenib Plus Cetuximab
|
|
657 KB
|
| 1433 |
Remdesivir100 mg
|
|
248 KB
|
| 1434 |
Favipiravir tablet 200 mgdr
|
|
2181 KB
|
| 1435 |
Favipiravir tablet 200 mg
|
|
2181 KB
|
| 1436 |
Favipiravir tablet 200 mgf
|
|
2341 KB
|
| 1437 |
Lidocaine Spray 10% w/v
|
|
175 KB
|
| 1438 |
Favipiravirtablet 200 mg
|
|
2341 KB
|
| 1439 |
VIB7734
|
|
655 KB
|
| 1440 |
EQ001
|
|
639 KB
|
| 1441 |
Olaparib
|
|
501 KB
|
| 1442 |
Niclosamidee
|
|
496 KB
|
| 1443 |
Insulin Degludec 100 units/mL
|
|
410 KB
|
| 1444 |
ensovibep (MP0420)
|
|
530 KB
|
| 1445 |
Aspirin (EC) IP + Ticagrelor (SR) IP capsules (Phase III)
|
|
199 KB
|
| 1446 |
Duloxetine (as delayed release pellets) IP + Pregabalin IP hard gelatin capsules (Phase III)
|
|
217 KB
|
| 1447 |
Azilsartan Medoxomil + Amlodipine tablets (Phase III)
|
|
286 KB
|
| 1448 |
Levonadifloxacinw
|
|
2474 KB
|
| 1449 |
RP7214
|
|
2293 KB
|
| 1450 |
Endoxifen
|
|
2385 KB
|
| 1451 |
RP7214jss
|
|
2693 KB
|
| 1452 |
Levonadifloxacinn
|
|
2474 KB
|
| 1453 |
Vildagliptin SR + Metformin Hydrochloride SR IP Sustained release tablets (Phase III)
|
|
192 KB
|
| 1454 |
CA-170
|
|
2252 KB
|
| 1455 |
imatinib mesylate
|
|
458 KB
|
| 1456 |
Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP
|
|
405 KB
|
| 1457 |
PF-07321332
|
|
506 KB
|
| 1458 |
Amikacin Sulphate
|
|
386 KB
|
| 1459 |
LIB003
|
|
498 KB
|
| 1460 |
Endoxifen2
|
|
2358 KB
|
| 1461 |
Minocycline Hydrochloride Topical Gel 4%
|
|
2674 KB
|
| 1462 |
Atropine Sulfate Ophthalmic Solution USP 0.01% w/v
|
|
706 KB
|
| 1463 |
23-valent Pneumococcal Polysaccharide Vaccine I.P.
|
|
388 KB
|
| 1464 |
VPM1002 (rBCG) Vaccine
|
|
223 KB
|
| 1465 |
LY3471851
|
|
638 KB
|
| 1466 |
C-TB with QuantiFERON-TB Gold Plus and 2.T.U. Tuberculin PPD RT23
|
|
2167 KB
|
| 1467 |
Lifitegrast
|
|
2347 KB
|
| 1468 |
Dextromethorphan Polistirex eq. to Dextromethorphan Hydrobromide IP + Chlorpheniramine Polistirex eq. to Chlorpheniramine Maleate + Methylparaben IP + Propylparaben IP per 5ml sustained release oral suspension (Phase IV)
|
|
222 KB
|
| 1469 |
Nitric oxide
|
|
2443 KB
|
| 1470 |
ofatumumab and siponimod versus fingolimod
|
|
501 KB
|
| 1471 |
EMPAgliflozin
|
|
537 KB
|
| 1472 |
Coronavirus vaccine (rDNA) – BBV151
|
|
319 KB
|
| 1473 |
Dienogest 2mg Tablet
|
|
345 KB
|
| 1474 |
Aqueous chlorine S
|
|
2399 KB
|
| 1475 |
JNJ-42756493
|
|
492 KB
|
| 1476 |
Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III)
|
|
266 KB
|
| 1477 |
Urosdexycholic Acid Tablet 150/mg/300 mg
|
|
3327 KB
|
| 1478 |
Solidarity trial
|
|
3455 KB
|
| 1479 |
Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III)
|
|
233 KB
|
| 1480 |
Molnupiravir Mild2
|
|
3954 KB
|
| 1481 |
NNC0365-3769
|
|
404 KB
|
| 1482 |
Anti-Covid-19 mAbs cocktail drug product
|
|
561 KB
|
| 1483 |
OQL011
|
|
503 KB
|
| 1484 |
Hydrochloroquinee
|
|
187 KB
|
| 1485 |
Multitope Protein/ Peptide-Based SARS-CoV-2 Vaccine (Manufactured by M/s Aurobindo Pharma Limited, Hyderabad) 2. UB-612(Imported from M/s UBI Pharma (UBIP),Taiwan)
|
|
302 KB
|
| 1486 |
Metoprolol Succinate eq. to Metoprolol Tartrate IP + Azelnidipine IP tablets (Phase III)
|
|
198 KB
|
| 1487 |
Erdafitinib
|
|
497 KB
|
| 1488 |
Flupentixol + Melitracen tablets (Phase IV)
|
|
139 KB
|
| 1489 |
Montelukast Sodium IP eq. to Montelukast + Bilastine orodispersible tablet (Phase III)
|
|
190 KB
|
| 1490 |
Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate powder for inhalation (Phase IV)
|
|
201 KB
|
| 1491 |
ZYIL 1
|
|
2179 KB
|
| 1492 |
ODM-203
|
|
2225 KB
|
| 1493 |
AB1001
|
|
2037 KB
|
| 1494 |
GRC 17536
|
|
2255 KB
|
| 1495 |
PNB-001
|
|
2870 KB
|
| 1496 |
MKP-10241
|
|
2162 KB
|
| 1497 |
ZY-19489
|
|
2106 KB
|
| 1498 |
SARS-CoV-2 Adjuvanted Recombinant
|
|
505 KB
|
| 1499 |
Duloxetine Hydrochloride eq. to Duloxetine (as gastro resistant pellets) IP + Pregabalin IP Capsules (Phase III)
|
|
215 KB
|
| 1500 |
Quercetin Nutraceutical bar
|
|
2159 KB
|
| 1501 |
Gam-COVID-Vac combined vector vaccine Component Iand Component II
|
|
229 KB
|
| 1502 |
Anti-COVID19 Serum [Equine Anti Covid Antibody Fragments F(ab’)2]
|
|
292 KB
|
| 1503 |
Bilastine Tablets 40mg
|
|
3789 KB
|
| 1504 |
Palbociclib versus Anastrozole
|
|
326 KB
|
| 1505 |
Aviptadil2
|
|
2481 KB
|
| 1506 |
Molnupiravir Moderateapl
|
|
2472 KB
|
| 1507 |
Molnupiravir Mildapl
|
|
2404 KB
|
| 1508 |
Galcanezumab in Adolescent Patients
|
|
640 KB
|
| 1509 |
Larotrectinib
|
|
392 KB
|
| 1510 |
Niclosamide
|
|
2820 KB
|
| 1511 |
Chikungunya vaccine (Inactivated)
|
|
225 KB
|
| 1512 |
Chikungunya vaccine (Inactivated)
|
|
225 KB
|
| 1513 |
Quadrivalent Influenza Seasonal Vaccine (QIV) (Virus Like Particle)
|
|
294 KB
|
| 1514 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents IP
|
|
95 KB
|
| 1515 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents IP
|
|
86 KB
|
| 1516 |
Molnupiravir Moderatepure
|
|
3944 KB
|
| 1517 |
Galcanezumab
|
|
498 KB
|
| 1518 |
Oral Cholera Vaccine (Inactivated)
|
|
305 KB
|
| 1519 |
Vildagliptin +Dapagliflozin tablets (Phase III)
|
|
292 KB
|
| 1520 |
Molnupiravir Mildm1
|
|
1872 KB
|
| 1521 |
Molnupiravir Moderatem3
|
|
2003 KB
|
| 1522 |
Molnupiravir Milds1
|
|
2391 KB
|
| 1523 |
Adaptive Platform Treatment Trial
|
|
515 KB
|
| 1524 |
Recombinant Hepatitis E Vaccine
|
|
788 KB
|
| 1525 |
Molnupiravir MildB1
|
|
1709 KB
|
| 1526 |
Molnupiravir Moderateb2
|
|
1763 KB
|
| 1527 |
Molnupiravir Moderater1
|
|
1955 KB
|
| 1528 |
ATR-002
|
|
527 KB
|
| 1529 |
Molnupiravir Moderate2s
|
|
2451 KB
|
| 1530 |
Molnupiravir Mild1
|
|
2417 KB
|
| 1531 |
Molnupiravir Milda
|
|
2008 KB
|
| 1532 |
Molnupiravir Moderate
|
|
3074 KB
|
| 1533 |
Molnupiravir Moderate2
|
|
2469 KB
|
| 1534 |
Molnupiravir Mild
|
|
2203 KB
|
| 1535 |
Molnupiravir Mildh
|
|
2557 KB
|
| 1536 |
Molnupiravir Moderateh2
|
|
2634 KB
|
| 1537 |
LNP023 in primary IgA nephropathy
|
|
497 KB
|
| 1538 |
Molnupiravir Mildr
|
|
18881 KB
|
| 1539 |
Molnupiravir Moderaten
|
|
1999 KB
|
| 1540 |
Whole-Virion Inactivated SARS-CoV-2 Vaccine
|
|
566 KB
|
| 1541 |
Inactivated Japanese encephalitis vaccine
|
|
566 KB
|
| 1542 |
Aceclofenac IP + Linceed Oil (containing predominantly-Linolenic acid) + Methyl Salicylate IP + Capsaicin USP +Menthol IP + Benzyl Alcohol IP (as preservative) ointment (Phase III)
|
|
298 KB
|
| 1543 |
Carboplatin and Paclitaxel
|
|
619KB
|
| 1544 |
Equine Anti Covid Antibody Fragments F(ab)2
|
|
954 KB
|
| 1545 |
70% Human Insulin Isophane Suspension and 30% Human Insulin Injection (100 U/mL)
|
|
684 KB
|
| 1546 |
Trastuzumab and Pertuzumab
|
|
504 KB
|
| 1547 |
ruxolitinib and panobinostat (LBH589)
|
|
310 KB
|
| 1548 |
Pamrevlumab
|
|
496 KB
|
| 1549 |
Gam-COVID-Vac combined vector vaccine Component I and Component II)
|
|
442 KB
|
| 1550 |
Benralizumab
|
|
497 KB
|
| 1551 |
Sodium Hyaluronate + Polyethylene Glycol 400 + Propylene Glycol lubricant eye drops (Phase IV)
|
|
292 KB
|
| 1552 |
Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 (RBD antigen of SARS CoV-2 (Covid-19))
|
|
315 KB
|
| 1553 |
Tropicamide IP + Phenylephrine Hydrochloride IP + Lidocaine Hydrochloride IP injection (Phase IV)
|
|
300 KB
|
| 1554 |
Biapenam Injection 300 mg
|
|
2411 KB
|
| 1555 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin film coated tablets (Phase III)
|
|
286 KB
|
| 1556 |
Niclosamide Tablets
|
|
3263 KB
|
| 1557 |
Azelnidipine IP Metoprolol Succinate IP eq. to Metoprolol Tartrate (SR) film coated tablets (Phase III)
|
|
283 KB
|
| 1558 |
(TACTIC-E)
|
|
497 KB
|
| 1559 |
Liraglutide 3.0 mg
|
|
490 KB
|
| 1560 |
osilodrostat (LCI699)
|
|
491 KB
|
| 1561 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone film coated tablets (Phase III)
|
|
304 KB
|
| 1562 |
Randomized SARS
|
|
2197 KB
|
| 1563 |
Object Head wise Budget allocation for the year2021-22 under Revenue & Capital Expenditure in respect of CDSCO(HQ
|
|
14497 KB
|
| 1564 |
insulin glargine 100 units/m
|
|
503 KB
|
| 1565 |
AQCH
|
|
2605 KB
|
| 1566 |
SNG001
|
|
507 KB
|
| 1567 |
Desidustat
|
|
2242 KB
|
| 1568 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III)
|
|
329 KB
|
| 1569 |
Ozenoxacin2
|
|
2351 KB
|
| 1570 |
Sugammadex
|
|
2369 KB
|
| 1571 |
Aqueous chlorine
|
|
2210 KB
|
| 1572 |
Omalizumab150 mg/ml
|
|
697 KB
|
| 1573 |
MSP008-22
|
|
2172 KB
|
| 1574 |
SAR440340/REGN3500/itepekimab (anti-IL-33 mAb)
|
|
503 KB
|
| 1575 |
Pneumococcal (Polysaccharide Conjugate Vaccine (15-Valent)
|
|
339 KB
|
| 1576 |
Isophane Insulin Human suspension (100 IU/mL)
|
|
678 KB
|
| 1577 |
T4030
|
|
511 KB
|
| 1578 |
A vector vaccine for the prevention of the coronavirus infection induced by the SARSCoV-2 virus
|
|
337 KB
|
| 1579 |
Bilastine tab
|
|
2423 KB
|
| 1580 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml suspension (Phase III)
|
|
321 KB
|
| 1581 |
Vildagliptin + Metformin Hydrochloride IP Film coated bilayered tablets (Phase III)
|
|
322 KB
|
| 1582 |
SAR440340/REGN3500/itepekimab
|
|
498 KB
|
| 1583 |
selexipagn
|
|
360 KB
|
| 1584 |
Novel Corona Virus Vaccine -2019-nCov Vaccine (3mg dose- 28 days Schedule)
|
|
316 KB
|
| 1585 |
Budesonide, Glycopyrronium
|
|
326 KB
|
| 1586 |
fibrinogen concentrate (FIB Grifols)
|
|
316 KB
|
| 1587 |
Glycopyrrolate IP + Formoterol Fumarate Dihydrate IP eq to Formoterol Fumarate Inhalation Aerosol per actuation deliver (Phase IV)
|
|
215 KB
|
| 1588 |
Neoadjuvant Osimertinib
|
|
498 KB
|
| 1589 |
SAR443122
|
|
499 KB
|
| 1590 |
EdoxabaN foR IntraCranial Hemorrhage
|
|
524 KB
|
| 1591 |
CT-P42
|
|
519 KB
|
| 1592 |
RSV Maternal Vaccine
|
|
434 KB
|
| 1593 |
Pneumococcal (Polysaccharide Conjugate Vaccine (14-Valent)
|
|
327 KB
|
| 1594 |
Tropicamide IP + Phenylephrine Hydrochloride IP + Lidocaine Hydrochloride IP per ml solution for Injection (Phase IV)
|
|
5090 KB
|
| 1595 |
finerenone
|
|
394 KB
|
| 1596 |
Fenebrutinib
|
|
592 KB
|
| 1597 |
Tapentadol Hy
|
|
5845 KB
|
| 1598 |
Ozenoxacin
|
|
2072 KB
|
| 1599 |
Brazikumab2
|
|
622 KB
|
| 1600 |
Sucroferic oxyhydroxide
|
|
2340 KB
|
| 1601 |
Pregabalin IP (as prolonged release) + Etoricoxib IP uncoated bilayered tablets (Phase IV)
|
|
5808 KB
|
| 1602 |
Duloxetine Hydrochloride eq. to Duloxetine (as delayed release pellets) + Pregabalin IP Capsules
|
|
291 KB
|
| 1603 |
Inebilizumab2
|
|
495 KB
|
| 1604 |
30 mg bid of evenamide (NW-3509)
|
|
502 KB
|
| 1605 |
BG00012 and BIIB017
|
|
|
| 1606 |
Trastuzumab Deruxtecan (T-DXd, DS-8201a)
|
|
489 KB
|
| 1607 |
Trastuzumab Deruxtecan
|
|
498 KB
|
| 1608 |
Roxadustat (FG-4592)
|
|
495 KB
|
| 1609 |
Brazikumab
|
|
623 KB
|
| 1610 |
pasireotide
|
|
495 KB
|
| 1611 |
Efgartigimod PH20 SC1
|
|
494 KB
|
| 1612 |
Chimpanzee Adenovector Corona Virus Vaccine (BBV152)
|
|
222 KB
|
| 1613 |
SARS-Cov2-rs Protein recombinant spike protein nanoparticle vaccine
|
|
235 KB
|
| 1614 |
semaglutide 25 mg compared with 14 mg
|
|
423 KB
|
| 1615 |
Semaglutide with alcoholic steatohepatitis
|
|
509 KB
|
| 1616 |
Pregabalin IP (as sustained release tablet) + Duloxetine HCl IP eq to Duloxetine (as enteric coated tablet) hard gelatin capsule (Phase III)
|
|
307 KB
|
| 1617 |
Adapalene EP + Benzoyl Peroxide EP per gram topical Gel (Phase IV)
|
|
323 KB
|
| 1618 |
Linezolid in combination with Bedaquiline and Pretomanid
|
|
2517 KB
|
| 1619 |
Colchicine
|
|
2435 KB
|
| 1620 |
darolutamide
|
|
321 KB
|
| 1621 |
Vildagliptin + Metformin Hydrochloride IP Film coated bilayered sustained release tablets (Phase III)
|
|
321 KB
|
| 1622 |
Hyperimmune Intravenous Immunoglobulin
|
|
493 KB
|
| 1623 |
Leuprolide Acetatea
|
|
4345 KB
|
| 1624 |
Marzeptacog alfae
|
|
498 KB
|
| 1625 |
Durvalumab1
|
|
490 KB
|
| 1626 |
Aviptadiln
|
|
2393 KB
|
| 1627 |
M-RNA Vaccine for Injection (Covid-19)
|
|
405 KB
|
| 1628 |
Aviptadil
|
|
2363 KB
|
| 1629 |
Equine Covid-19 Antiserum
|
|
290 KB
|
| 1630 |
Levonadifloxacin
|
|
2507 KB
|
| 1631 |
Bempedoic acid
|
|
2475 KB
|
| 1632 |
S007-1500
|
|
2165 KB
|
| 1633 |
Chlorhexidine Gluconate solution + Metronidazole Benzoate BP eq to Metronidazole Gel (Phase III)
|
|
276 KB
|
| 1634 |
Inosine Pranobex
|
|
2553 KB
|
| 1635 |
Biapenam injection
|
|
2519 KB
|
| 1636 |
Tetracosactide
|
|
2087 KB
|
| 1637 |
Novel CoronaVirus2019-nCoV Vaccine
|
|
306 KB
|
| 1638 |
Oral Eflornithine NSRT2020
|
|
2898 KB
|
| 1639 |
Isophane Human Insulin suspension, (100 IU/mL)
|
|
625 KB
|
| 1640 |
Acalabrutinib
|
|
6492 KB
|
| 1641 |
Carvedilol _ Ivabradine Hydrochloride eq. to Ivabradine film coated tablets (Phase IV)
|
|
316 KB
|
| 1642 |
Efgartigimod PH20 SC
|
|
494 KB
|
| 1643 |
Selexipag
|
|
492 KB
|
| 1644 |
Taliglucerase Alfa
|
|
492 KB
|
| 1645 |
Bevacizumab
|
|
316 KB
|
| 1646 |
JS016
|
|
318 KB
|
| 1647 |
AMT-101
|
|
503 KB
|
| 1648 |
Mirabegron (ER) + Solifenacin Succinate IP tablets (Phase III
|
|
297 KB
|
| 1649 |
Levobupivacaine Hydrochloride eq. to Levobupivacaine + Dextrose liquid injection (Phase III)
|
|
321 KB
|
| 1650 |
Bepotastine Besilate + Montelukast Sodium IP eq. to Montelukast film coated tablets (Phase III)
|
|
285 KB
|
| 1651 |
Pregabalin (as sustained release) IP + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptyline IP tablets (Phase III)
|
|
300 KB
|
| 1652 |
Bilastine + Montelukast sodium IP eq. to Montelukast Oral Suspension (Phase III
|
|
318 KB
|
| 1653 |
Budesonide + Glycopyrronium + Formoterol Fumarate inhalation Powder (Phase IV)
|
|
304 KB
|
| 1654 |
noxaparin) in COVID-19
|
|
501 KB
|
| 1655 |
Metformin HCl (SR) + Myo-Inositol film coated bilayered tablets (Phase III)
|
|
330 KB
|
| 1656 |
RIVACA
|
|
3602 KB
|
| 1657 |
Potassium Chloride (K-Lyte)
|
|
419 KB
|
| 1658 |
Baricitinib
|
|
500 KB
|
| 1659 |
Pegylated interferon alfa-2b Cadila
|
|
430 KB
|
| 1660 |
Randomized
|
|
2969 KB
|
| 1661 |
Brimonidine IP + Brinzolamide IP + Timolol eq. to Timolol Maleate IP + Benzalkonium chloride solution IP (as preservative) + Water for injection IP q.s. per ml Ophthalmic Suspension (Phase III)
|
|
322 KB
|
| 1662 |
Alogliptin Benzoate eq. to Alogliptin + Metformin Hydrochloride IP Film Coated Tablet (Phase IV)
|
|
281 KB
|
| 1663 |
Marzeptacog Alfa
|
|
185 KB
|
| 1664 |
Lidocaine Hydrochloride IP + Diltiazem Hydrochloride IP Gel (Phase III)
|
|
286 KB
|
| 1665 |
2-Deoxy-D-glucose
|
|
2313 KB
|
| 1666 |
Daclatasvir dihydrochloride IP eq. to Daclatasvir + Sofosbuvir film coated tablet with or without Nitazoxanide in combination with standard of care in adult patients with moderate Covid-19 (Phase IIB)
|
|
3097 KB
|
| 1667 |
AS012
|
|
506 KB
|
| 1668 |
Pregabalin IP (as prolonged release form) + Mecobalamin IP + Nortriptyline HCl film coated bilayered tablet (Phase III)
|
|
3209 KB
|
| 1669 |
Pioglitazone IP + Vildagliptin (as sustained release form) Film coated bilayered tablet (Phase III)
|
|
3024 KB
|
| 1670 |
Amino Acid + Glucose 7.5% with Electrolytes and Vitamin B1 Injection (BFLUID) (1000 ml Bag each) (Phase III)
|
|
4216 KB
|
| 1671 |
Chikungunya vaccine (Inactivated)
|
|
533 KB
|
| 1672 |
inebilizumab
|
|
506 KB
|
| 1673 |
LY3471851
|
|
503 KB
|
| 1674 |
SARS-CoV-2 (Covid-19) Vaccine
|
|
1184 KB
|
| 1675 |
Mycobacterium w (Heat KilledInjection
|
|
394 KB
|
| 1676 |
Saxagliptin + Dapagliflozin Film coated tablets (Phase IV)
|
|
2849 KB
|
| 1677 |
Durvalumab
|
|
1426 KB
|
| 1678 |
Ketorolac Tromethamine 30mg
|
|
3039 KB
|
| 1679 |
Whole Virion, Inactivated Corona Virus Vaccine,BBV152
|
|
1793 KB
|
| 1680 |
Gam COVID Vac Combined vector vaccine component one and component two
|
|
1928 KB
|
| 1681 |
Chlorthalidone IP + Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium film coated tablets (Phase III)
|
|
2804 KB
|
| 1682 |
Insulin Glargine
|
|
518 KB
|
| 1683 |
Intramuscular Injection of Paracetamol 500 mg/2ml
|
|
2812 KB
|
| 1684 |
SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment)
|
|
561 KB
|
| 1685 |
Betamethasone Dipropionate USP + Clotrimazole USP + Gentamicin Sulfate USP Cream (Phase III)
|
|
2397 KB
|
| 1686 |
Bemcentinib
|
|
440 KB
|
| 1687 |
oral Etrasimod
|
|
2964 KB
|
| 1688 |
Sodium Copper Chlorophyllin
|
|
2955 KB
|
| 1689 |
M/s Synokem Pharmaceuticals Ltd
|
|
1087 KB
|
| 1690 |
LIB003 with Evolocumab
|
|
302 KB
|
| 1691 |
Pantoprazole Sodium IP Aspirin IP Capsules
|
|
664 KB
|
| 1692 |
Nertrasudil + Latanoprost
|
|
2686 KB
|
| 1693 |
Acotiamide Hydrochloride hydrate SR Tablet 300mg
|
|
3185 KB
|
| 1694 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrochloride Hydrate IP eq. to Teneligliptin tablets (Phase III)
|
|
2943 KB
|
| 1695 |
Follicle-Stimulating Hormone and Human Chorionic Gonadotropin
|
|
1997 KB
|
| 1696 |
Teriparatide solution for injection prefilled pen20 micrograms/ 80microliters, subcutaneous injection
|
|
478 KB
|
| 1697 |
Iguratimod tablets 25 mg
|
|
12792 KB
|
| 1698 |
Abemaciclib
|
|
1306 KB
|
| 1699 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP uncoated bilayered tablets (Phase III)
|
|
2608 KB
|
| 1700 |
SAR442168(Multiple Sclerosis)
|
|
498 KB
|
| 1701 |
Osimertinib Vs Savolitinib
|
|
494 KB
|
| 1702 |
Amivantamab & Carboplatin
|
|
494 KB
|
| 1703 |
Lasmiditan
|
|
502 KB
|
| 1704 |
lasmiditan (Migraine)
|
|
502 KB
|
| 1705 |
oral Etrasimod
|
|
392 KB
|
| 1706 |
Ticagrelor SR Tablets 120mg/180mg
|
|
3334 KB
|
| 1707 |
Pegfilgrastim 6mg/0.6ml subcutaneous injection
|
|
634 KB
|
| 1708 |
Lumasiran
|
|
1801 KB
|
| 1709 |
Ipilimumab (r-DNAorigin) Injection, 50mg/10mL(5mg/mL)
|
|
652 KB
|
| 1710 |
Metformin Hydrochloride + Doxycycline Hyclate gel (Phase II)
|
|
3020 KB
|
| 1711 |
Reversible Inhibition of Sperm under Guidance (RISUG)
|
|
227 KB
|
| 1712 |
Desidustat
|
|
285 KB
|
| 1713 |
Ruxolitinib
|
|
1483 KB
|
| 1714 |
PNB-001
|
|
10107 KB
|
| 1715 |
Gepotidacinrevised
|
|
502 KB
|
| 1716 |
Osimertinib Versus lazertinib
|
|
1456 KB
|
| 1717 |
Bosutinib tab
|
|
292 KB
|
| 1718 |
HRF-10071 tab
|
|
226 KB
|
| 1719 |
Semaglutide (T2diabetes)
|
|
508 KB
|
| 1720 |
GSK3196165
|
|
535 KB
|
| 1721 |
Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin + Pioglitazone Hydrochloride eq. to Pioglitazone film coated tablets (Phase III)
|
|
3333 KB
|
| 1722 |
SAR442168 to Placebo
|
|
500 KB
|
| 1723 |
Teriflunomide
|
|
414 KB
|
| 1724 |
Epinephrine Sublingual tab
|
|
202 KB
|
| 1725 |
M/s Biocon Biologics India LimitedItolizumab Injection
|
|
525 KB
|
| 1726 |
2'0 Methyl Antisense Oligonucleotide
|
|
290 KB
|
| 1727 |
Evenamide
|
|
272 KB
|
| 1728 |
Capmatinib
|
|
261 KB
|
| 1729 |
Ranibizumab Solution for Injection10 mg/ml, 0.23ml vial
|
|
195 KB
|
| 1730 |
dimethyl Fumarate
|
|
500 KB
|
| 1731 |
nWhole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152D)
|
|
264 KB
|
| 1732 |
PF-06826647n
|
|
509 KB
|
| 1733 |
Ligelizumab
|
|
509 KB
|
| 1734 |
SAR442168
|
|
481 KB
|
| 1735 |
Alpelisib
|
|
264 KB
|
| 1736 |
Thymosin a-1 for Injection 1.6mg
|
|
2970 KB
|
| 1737 |
Coagulation Factor VIII (Recombinant) rFVIII, Plasma/Albumin Free Method; OctocogAlfa
|
|
182 KB
|
| 1738 |
oral Semaglutide
|
|
505 KB
|
| 1739 |
Evobrutinib
|
|
403 KB
|
| 1740 |
Bilastine tablet 40mg
|
|
4275 KB
|
| 1741 |
Bilastine Tablet 40 mg
|
|
4257 KB
|
| 1742 |
Fluticasone Furoate + Oxymetazoline hydrochloride IP nasal spray (Phase III)
|
|
3016 KB
|
| 1743 |
Adjuvant Durvalumab
|
|
378 KB
|
| 1744 |
Typhoid Vi Conjugate Vaccine I.P.n
|
|
295 KB
|
| 1745 |
C21n
|
|
613 KB
|
| 1746 |
Niclosamide IM depot Injection
|
|
2410 KB
|
| 1747 |
Gemcitabine revised
|
|
775 KB
|
| 1748 |
Azelnidipine 8 mg plus Metoprolol Succinate ER 50 mg tab and Azelnidipine 16 mg plus Metoprolol Succinate ER 50 mg tab
|
|
13899 KB
|
| 1749 |
DFV890
|
|
487 KB
|
| 1750 |
Dapagliflozin
|
|
372 KB
|
| 1751 |
Otilimab
|
|
325 KB
|
| 1752 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as gastro resistant pellets) hard gelatin capsules (Phase III)
|
|
3280 KB
|
| 1753 |
Azelnidipine IP + Olmesartan Medomoxil IP film coated tablet (Phase III)
|
|
2918 KB
|
| 1754 |
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
|
|
2002 KB
|
| 1755 |
Trastuzumab Deruxtecan
|
|
491 KB
|
| 1756 |
Capaivasertib+Abiraterone
|
|
331 KB
|
| 1757 |
PF-06865571
|
|
377 KB
|
| 1758 |
TRC041266
|
|
10239 KB
|
| 1759 |
Inosine Pranobex 500 mg
|
|
11600 KB
|
| 1760 |
Adalimumab(40mg/0.8 mL) Pre-filledsyringe
|
|
175 KB
|
| 1761 |
Mirikizumab
|
|
259 KB
|
| 1762 |
Bepotastine Besilate + Ketorolac Tromethamine IP + Benzalkonium Chloride IP (as preservative) per ml Ophthalmic Solution (Phase III)
|
|
3761 KB
|
| 1763 |
Desidustat tab
|
|
11490 KB
|
| 1764 |
PF-06826647
|
|
260 KB
|
| 1765 |
Secukinumabd
|
|
257 KB
|
| 1766 |
Erenumab
|
|
497 KB
|
| 1767 |
Netarsudil Ophthalmic sol 0.02%`w/v
|
|
13846 KB
|
| 1768 |
Perampanel
|
|
305 KB
|
| 1769 |
Pregabalin ER
|
|
194 KB
|
| 1770 |
Trenexamic Acid
|
|
257 KB
|
| 1771 |
S (-) Metoprolol Succinate IH + Efonidipine Hydrochloride Ethanolate IH modified release uncoated bilayered tablets (Phase III)
|
|
1595 KB
|
| 1772 |
Druvalumab
|
|
515 KB
|
| 1773 |
Typhoid Vi Conjugate Vaccine I.P.
|
|
566 KB
|
| 1774 |
InsulinaspartMix30
|
|
633 KB
|
| 1775 |
Typhoid Vi Conjugate Vaccine I.P.1
|
|
566 KB
|
| 1776 |
dlnsulin Glargine 100U/mL
|
|
177 KB
|
| 1777 |
dInsulinGlargineInjection 100IU/ml
|
|
734 KB
|
| 1778 |
lnsulin Glargine 100U/mL
|
|
526 KB
|
| 1779 |
Efonidipine Hydrochloride Ethanolate + Chlorthalidone IP uncoated bilayered tablets (Phase III)
|
|
4512 KB
|
| 1780 |
InsulinGlargineInjection 100IU/ml
|
|
168 KB
|
| 1781 |
Tocilizumab Injection[180mg/mL PrefilledSyringes(162mg/0.9mL)
|
|
755 KB
|
| 1782 |
Dacomitinib tab 15 rm
|
|
234 KB
|
| 1783 |
SCD411 And Eylea
|
|
502 KB
|
| 1784 |
ct Umifenovir Hcl cap
|
|
1833 KB
|
| 1785 |
Novel Corona Virus 2019-nCoV Vaccine
|
|
1665 KB
|
| 1786 |
Brolucizumab
|
|
312 KB
|
| 1787 |
Lorlatinib tab 25 rmg
|
|
241 KB
|
| 1788 |
Gemcitabine
|
|
367 KB
|
| 1789 |
Fitusiran
|
|
475 KB
|
| 1790 |
Gepotidacin
|
|
483 KB
|
| 1791 |
VIB4920
|
|
318 KB
|
| 1792 |
Somapacitan
|
|
493 KB
|
| 1793 |
Whole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152)
|
|
330 KB
|
| 1794 |
Pirfenidone 267 mg tab
|
|
1675 KB
|
| 1795 |
Insulin Human 4units, 8units and 12units single-use cartridge Inhalation Powder (Recombinant human insulin)
|
|
404 KB
|
| 1796 |
Naftifine Hydrochloride Gel 2%
|
|
232 KB
|
| 1797 |
Dienogest (Ph IV)
|
|
254 KB
|
| 1798 |
Topiroxostat tablets 20 mg/40mg/60 mg
|
|
248 KB
|
| 1799 |
Hydrocorticosone Acetate
|
|
379 KB
|
| 1800 |
PF-06480605
|
|
377 KB
|
| 1801 |
Acodiamide Hydrochloride 300 mg
|
|
1873 KB
|
| 1802 |
Lipoprotein
|
|
674 KB
|
| 1803 |
C21
|
|
509 KB
|
| 1804 |
Acalabrutinib
|
|
399 KB
|
| 1805 |
Umifenovir
|
|
2588 KB
|
| 1806 |
Sphaeranthus Indicus Extract
|
|
2203 KB
|
| 1807 |
Tocilizumabconcentrate for solution for IV infusion
|
|
380 KB
|
| 1808 |
Measles and Rubella vaccine (Live)
|
|
288 KB
|
| 1809 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.
|
|
275 KB
|
| 1810 |
Benidipine Hydrochloride + Chlorthalidone IP Film coated tablets (Phase III)
|
|
273 KB
|
| 1811 |
Yellow Fever Vaccine (live) I.P.
|
|
220 KB
|
| 1812 |
Hepcidin Mimetic PTG-300
|
|
496 KB
|
| 1813 |
BDB001
|
|
236 KB
|
| 1814 |
Colloidal silver BP 50 ppm
|
|
12437 KB
|
| 1815 |
IIIM-290
|
|
942 KB
|
| 1816 |
Azacitidine
|
|
250 KB
|
| 1817 |
Ulinastatin for Injection
|
|
1431 KB
|
| 1818 |
Nafamostat Mesilate for inj
|
|
11361 KB
|
| 1819 |
ZYBK2
|
|
9991 KB
|
| 1820 |
Favipiravir & Umifenovir
|
|
12027 KB
|
| 1821 |
2-Deoxy-D-Glucose (2-DG)
|
|
240 KB
|
| 1822 |
NitazoxanideTablet 500 mgHydroxychloroquine Tablet 200 mg
|
|
1361 KB
|
| 1823 |
Pegylated interferon alfa-2b
|
|
511 KB
|
| 1824 |
Tocilizumab
|
|
222 KB
|
| 1825 |
Cocculus hirsutus
|
|
1154 KB
|
| 1826 |
Favipiravir
|
|
12309 KB
|
| 1827 |
NitazoxanideTabet 500 mg and Hydroxychloroquine Tablet 200 mg
|
|
1456 KB
|
| 1828 |
Dutasteride topical
|
|
371 KB
|
| 1829 |
Dustasteride Topical solution 0.01% w/v, 0.02% w/v and 0.005% w/v
|
|
679 KB
|
| 1830 |
BCG vaccine
|
|
219 KB
|
| 1831 |
Sotagliflozin
|
|
534 KB
|
| 1832 |
PIK3CA
|
|
296 KB
|
| 1833 |
Favipiravir
|
|
2366 KB
|
| 1834 |
Mycobacterium w (Heat Killed) Injection1
|
|
235 KB
|
| 1835 |
Mycobacterium w (Heat Killed) Injection2
|
|
235 KB
|
| 1836 |
Remdesevir (GS-5734) for inj 100 mg
|
|
1914 KB
|
| 1837 |
Mycobacterium w (Heat Killed) Injection
|
|
209 KB
|
| 1838 |
VPM1002(recombinant BCG) vaccine
|
|
207 KB
|
| 1839 |
Itolizumab Injection
|
|
511 KB
|
| 1840 |
Osimertinib
|
|
399 KB
|
| 1841 |
S.C. Secukinumab
|
|
360 KB
|
| 1842 |
VIS649
|
|
375 KB
|
| 1843 |
lumasiran
|
|
493 KB
|
| 1844 |
CPI-613
|
|
498 KB
|
| 1845 |
Concizumab
|
|
497 KB
|
| 1846 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium +Cilnidipine IP Film coated tablets (Phase III)
|
|
309 KB
|
| 1847 |
CA-170
|
|
234 KB
|
| 1848 |
Apremilast 60 mg Tablet 60 mg Tablet
|
|
1831 KB
|
| 1849 |
Zika Virus Vaccine (Adsorbed), Zika Virus Vaccine (Adsorbed)
|
|
221 KB
|
| 1850 |
vaporized cannabinoids
|
|
225 KB
|
| 1851 |
5-aminolevulinic Acid
|
|
384 KB
|
| 1852 |
Acotiamide Sustained 300 mg Tablet 300 mg t
|
|
1819 KB
|
| 1853 |
Acotiamide Sustained 300 mg Tablet 300 mg Tablet
|
|
2037 KB
|
| 1854 |
Glycopyrrolate IP eq. to Glycopyrronium + Arformoterol Tartrate eq. to Arformoterol Inhalation solution (Phase III)
|
|
303 KB
|
| 1855 |
Canagliflozin + Metformin HCl Film coated tablets (Phase IV)
|
|
216 KB
|
| 1856 |
Oral Pharmacokinetics and Safety of TRC041266 Powder with TRC4186 Tablet
|
|
195 KB
|
| 1857 |
Intravenous Secukinimab
|
|
497 KB
|
| 1858 |
Medroxyprogesterone Acetate SR tablet30 mg 30 mg Tablet
|
|
1570 KB
|
| 1859 |
Secukinumab
|
|
497 KB
|
| 1860 |
DE-109
|
|
258 KB
|
| 1861 |
Bilastine + Montelukast Sodium IP eq. to Montelukast Film coated tablets
|
|
288 KB
|
| 1862 |
M/s Biological E Limited
|
|
572 KB
|
| 1863 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III)
|
|
336 KB
|
| 1864 |
Cefpodoxime Proxetil 200/400 mgTablet
|
|
2025 KB
|
| 1865 |
Bevacizumab (r-DNAorigin) drug product100mg/4ml& 400mg/16m
|
|
648 KB
|
| 1866 |
Inactivated Hepatitis A vaccine
|
|
281 KB
|
| 1867 |
Selpercatinib
|
|
491 KB
|
| 1868 |
zelnidipine 8 mg plus Telmisartan 40 mg and Azelnidipine 16 mg plus Telmisartan 40mg tab versus Azelnidipine tab 16 mg and Telmisartan tab 40 mg
|
|
376 KB
|
| 1869 |
ZYBK2
|
|
206 KB
|
| 1870 |
Cabozantinib or Vandetanib
|
|
419 KB
|
| 1871 |
Adalimumab injection
|
|
177 KB
|
| 1872 |
Estradiol Valerate 4mg SR Table
|
|
1773 KB
|
| 1873 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) hard gelatin capsules (Phase III)
|
|
248 KB
|
| 1874 |
Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) Vaccine (Adsorbed)
|
|
308 KB
|
| 1875 |
Recombinant GrowthHormone(ALT-P1)
|
|
385 KB
|
| 1876 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III)
|
|
318 KB
|
| 1877 |
Evenamide (NW-3509)2
|
|
269 KB
|
| 1878 |
AR-301
|
|
251 KB
|
| 1879 |
Evenamide2
|
|
379 KB
|
| 1880 |
Tirzepatide
|
|
256 KB
|
| 1881 |
Bedaquiline, Delamanid
|
|
360 KB
|
| 1882 |
Bedaquiline Tablets 100mg
|
|
255 KB
|
| 1883 |
Dienogest (Visanne®)
|
|
196 KB
|
| 1884 |
Tropifexor (LJN452) & licogliflozin
|
|
429 KB
|
| 1885 |
Typhoid Conjugate Vaccine (Monovalent)
|
|
289 KB
|
| 1886 |
Insulin Injection, Biphasic Isophane IP /Ph. Eur. 100 IU/ml in 3 ml cartridge (containing 30 % human insulin soluble injection and 70 % human insulin isophane suspension)
|
|
517 KB
|
| 1887 |
Insulin Injection, Biphasic Isophane IP /Ph. Eur. 100 IU/ml in 3 ml cartridge (containing 30 % human insulin soluble injection and 70 % human insulin isophane suspension)
|
|
517 KB
|
| 1888 |
Recombinant Human Thrombopoietin Injection
|
|
175 KB
|
| 1889 |
Ramucirumab Injection
|
|
185 KB
|
| 1890 |
Hydroxychloroquine Sulfate Tablet 200mg/300 mg
|
|
788 KB
|
| 1891 |
Goserelin 10.8mg Injection1
|
|
1460 KB
|
| 1892 |
Hydrocortisone Acetate Suppositories, 25 Mg
|
|
303 KB
|
| 1893 |
INTP1- Granulocyte Colony Stimulating Factor (Filgrastim)
|
|
525 KB
|
| 1894 |
Ipatasertib
|
|
505 KB
|
| 1895 |
Inactivated Therapeutic Tuberculosis Vaccine.RUTI Vaccine
|
|
185 KB
|
| 1896 |
Inactivated Therapeutic Tuberculosis Vaccine
|
|
185 KB
|
| 1897 |
Fingolimod capsule
|
|
2608 KB
|
| 1898 |
Mepolizumab Powder for Solution for Injection
|
|
378 KB
|
| 1899 |
Glimepiride IP + Voglibose IP + Metformin HCl IP (as ER) uncoated bilayered tablet (Phase IV)
|
|
242 KB
|
| 1900 |
Remogliflozin Etabonate + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film coated tablets (Phase III)
|
|
302 KB
|
| 1901 |
Silodosin + Solifenacin Succinate Ph. Eur. Capsule (Phase III)
|
|
337 KB
|
| 1902 |
Mirabegron + Solifenacin Succinate tablets (Phase III)
|
|
232 KB
|
| 1903 |
Ivabradin Tablet
|
|
2543 KB
|
| 1904 |
sacubitril/valsartan
|
|
251 KB
|
| 1905 |
Liraglutide injection(r-DNA)
|
|
247 KB
|
| 1906 |
Bilastine + Montelukast Sodium IP eq. to Montelukast uncoated tablet (Phase III)
|
|
297 KB
|
| 1907 |
Goserelin 10.8mg Injection
|
|
381 KB
|
| 1908 |
BevacizumabInjection 100 mg/4mL
|
|
250 KB
|
| 1909 |
Brimonidine Tartrate 0.1% Ophthalmic Solution
|
|
325 KB
|
| 1910 |
Selonsertib
|
|
1460 KB
|
| 1911 |
Evenamide(NW-3509/008/II/2019)
|
|
375 KB
|
| 1912 |
PF-06741086
|
|
493 KB
|
| 1913 |
Capmatinib
|
|
249 KB
|
| 1914 |
Remogliflozin Etabonate Vildagliptin film coated tablet
|
|
1222 KB
|
| 1915 |
Hydrocortisone Acetate
|
|
358 KB
|
| 1916 |
Vedolizumab
|
|
349 KB
|
| 1917 |
Cephalexin extended release Clavulanate Potassium tablet
|
|
1016 KB
|
| 1918 |
Ripasudil HCl Hydrate eq. To Ripasudil Timolol Maleate IP Eq. To to Timolol eye drops
|
|
1008 KB
|
| 1919 |
Trastuzumabbio
|
|
3401 KB
|
| 1920 |
Ceftazidime
|
|
321 KB
|
| 1921 |
Goserelin 3.6 mg Injection
|
|
495 KB
|
| 1922 |
Triamcinolone acetonide IP Lignocaine HCl IP Gel
|
|
712 KB
|
| 1923 |
Ceftazidime-Avibactam
|
|
489 KB
|
| 1924 |
GSK2831781
|
|
502 KB
|
| 1925 |
Gepotidacin
|
|
256 KB
|
| 1926 |
Lipidol
|
|
3028 KB
|
| 1927 |
Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze Dried)
|
|
193 KB
|
| 1928 |
Evenamide(NW-3509/006/III/2019)
|
|
509 KB
|
| 1929 |
Evenamide(nw-3509)
|
|
509 KB
|
| 1930 |
Prohance® (Gadoteridol 279.3 mg/mllnjection
|
|
2667 KB
|
| 1931 |
Dalbavancin
|
|
2754 KB
|
| 1932 |
opivacaine Hydrochloride USP eq. to anhydrous Ropivacaine hydrochloride Dextrose IP per ml injection
|
|
959 KB
|
| 1933 |
Azelnidipine Olmesartan Medoxomil IP tablets
|
|
1260 KB
|
| 1934 |
Rosuvastatin IP Teneligliptin Film coated tablet
|
|
1099 KB
|
| 1935 |
Benidipine HCl Chlorthalidone IPTelmisartan IP Film coated bilayered tablets
|
|
876 KB
|
| 1936 |
Recombinant Insulin Aspart
|
|
1342 KB
|
| 1937 |
International Centre for Genetic Engineering and Biotechnology CampusBivalent (JAIVAC-2: PfMSPFu24 +PfF2/ Alhydrogel) P. falciparum malaria vaccine
|
|
167 KB
|
| 1938 |
Bevacizumab
|
|
549 KB
|
| 1939 |
SB3
|
|
249 KB
|
| 1940 |
Baricitinib eli lily
|
|
509 KB
|
| 1941 |
TRUNCATE – TB (tuberculosis)
|
|
3884 KB
|
| 1942 |
Lenvatinib Capsules 4 mg and 10 mg
|
|
330 KB
|
| 1943 |
Trastuzumab aur
|
|
213 KB
|
| 1944 |
Moroctocogalfa
|
|
177 KB
|
| 1945 |
Azilsartan KamedoxomilChlorthalidone IP tablet
|
|
654 KB
|
| 1946 |
Etanercept Lupin
|
|
140 KB
|
| 1947 |
Ticagrelor 120/180 mg SR Tablet
|
|
2652 KB
|
| 1948 |
Desidustat Tablet versus Epoetin alfa Injection
|
|
2558 KB
|
| 1949 |
AUR101
|
|
3310 KB
|
| 1950 |
AUR101
|
|
3310 KB
|
| 1951 |
Diptheria,Tetanus, Pertussis (Whole cell),Hepatitis B, Poliomyelitis (inactivated) and Haemophilus Influenzae Type b conjugate Vaccine (Adsorbed) [DTwPHepB-IPV-Hib vaccine (Adsorbed
|
|
207 KB
|
| 1952 |
PNB-001
|
|
267 KB
|
| 1953 |
Recombinant Hepatitis E Vaccine, Single Human Dose
|
|
266 KB
|
| 1954 |
Zileuton Ointment 1.25% and 5.0%
|
|
702 KB
|
| 1955 |
InsulinGlargine
|
|
275 KB
|
| 1956 |
Etrasimod
|
|
485 KB
|
| 1957 |
Avanafil tablets 100 mg & 200 mg
|
|
1223 KB
|
| 1958 |
Oral Baricitinib
|
|
503 KB
|
| 1959 |
LNP023(Rituximab)
|
|
260 KB
|
| 1960 |
Concizumab
|
|
327 KB
|
| 1961 |
Concizumab Prophylaxis
|
|
508 KB
|
| 1962 |
LNP023
|
|
366 KB
|
| 1963 |
Iodixanol
|
|
2023 KB
|
| 1964 |
Inotuzumab
|
|
370 KB
|
| 1965 |
Inactivated Hepatitis A Vaccine (Adsorbed) I.P.6nov
|
|
262 KB
|
| 1966 |
CT-P13
|
|
471 KB
|
| 1967 |
FEIBA
|
|
403 KB
|
| 1968 |
Etrasimod( IQVIA)
|
|
502 KB
|
| 1969 |
Etrasimod( IQVIA RDS)
|
|
513 KB
|
| 1970 |
Brazikumab
|
|
491 KB
|
| 1971 |
Ruxolitinib
|
|
310 KB
|
| 1972 |
GSK3196165
|
|
284 KB
|
| 1973 |
Ruxolitinib
|
|
310 KB
|
| 1974 |
Trastuzumabnn
|
|
176 KB
|
| 1975 |
Spironolactone Topical Cream 5%
|
|
1495 KB
|
| 1976 |
Apremilast Film Coated 10/10/30mg Tablets
|
|
2755 KB
|
| 1977 |
Tenofovir Alafenamide, Emtricitabine and Bictegravir
|
|
2682 KB
|
| 1978 |
Sofosbuvir 400 mg Tablet
|
|
2627 KB
|
| 1979 |
Peginterferonbeta-1a
|
|
144 KB
|
| 1980 |
Typhoid Vi conjugate VaccineRa
|
|
276 KB
|
| 1981 |
Cilnidipine IP Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets
|
|
609 KB
|
| 1982 |
Benidipine HCl IPTelmisartan IP Film coated tablets
|
|
641 KB
|
| 1983 |
Azelnidipine Telmisartan tablets
|
|
624 KB
|
| 1984 |
Typhoid Vi conjugate Vaccine30sep
|
|
185 KB
|
| 1985 |
Methylcobalamin Nasal spray 500 mcg
|
|
284 KB
|
| 1986 |
Certican / Zortress(everolimus EVR)
|
|
312 KB
|
| 1987 |
Tirzepatide
|
|
313 KB
|
| 1988 |
Tirzepatide1
|
|
313 KB
|
| 1989 |
QL1205 Versus Lucentis
|
|
304 KB
|
| 1990 |
Bupivacaine Hydrochloride IP eq. to anhydrous Bupivacaine Hydrochloride Fentanyl Citrate IP Eq. to Fentanyl injection
|
|
672 KB
|
| 1991 |
HP-hMG and Menopur®
|
|
2143 KB
|
| 1992 |
AT-10 (2-oxoclopidogrel bisulfate
|
|
2845 KB
|
| 1993 |
Brazikumab
|
|
393 KB
|
| 1994 |
Inactivated Hepatitis A vaccine (Adsorbed) I.P.
|
|
187 KB
|
| 1995 |
Rabies Vaccine, Human, I.P.
|
|
187 KB
|
| 1996 |
evenamide or placebo
|
|
273 KB
|
| 1997 |
Meningococcal Conjugate Vaccine
|
|
510 KB
|
| 1998 |
semaglutide versus placebo
|
|
477 KB
|
| 1999 |
Ribociclib plus goserelin acetate
|
|
434 KB
|
| 2000 |
Leuprolide acetate
|
|
2291 KB
|
| 2001 |
ligelizumab (QGE031)
|
|
328 KB
|
| 2002 |
MYL-1701P and Eylea
|
|
299 KB
|
| 2003 |
Netarsudil Ophthalmic solution 0.02%
|
|
3055 KB
|
| 2004 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB
|
| 2005 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB
|
| 2006 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB
|
| 2007 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP + Chlorthalidone IP Tablets (Phase III Clinical Trial
|
|
705 KB
|
| 2008 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Cilnidipine IP film coated tablet (Phase III Clinical Trial)
|
|
697 KB
|
| 2009 |
Mirikizumab
|
|
625 KB
|
| 2010 |
Tranexamic acid
|
|
1667 KB
|
| 2011 |
Menopausal Gonadotropin
|
|
2618 KB
|
| 2012 |
Azelnidipine IP + Chlorthalidone IP Uncoated Tablet (Phase III Clinical Trial)
|
|
617 KB
|
| 2013 |
k0706
|
|
592 KB
|
| 2014 |
baloxavir marboxil
|
|
492 KB
|
| 2015 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (10-Valent)
|
|
259 KB
|
| 2016 |
traconazole
|
|
1373 KB
|
| 2017 |
Mirikizumab (UC)
|
|
625 KB
|
| 2018 |
Semaglutide
|
|
2366 KB
|
| 2019 |
Semaglutide (SOUL)
|
|
2366 KB
|
| 2020 |
Filgotinib
|
|
591 KB
|
| 2021 |
Filgotinib (rheumatoid Arthritis)
|
|
519 KB
|
| 2022 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial)
|
|
531 KB
|
| 2023 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial)
|
|
531 KB
|
| 2024 |
Capivasertib + Paclitaxel versus placebo
|
|
228 KB
|
| 2025 |
Tigilanol Tiglate
|
|
368 KB
|
| 2026 |
Baricitinib
|
|
500 KB
|
| 2027 |
Baricitinib
|
|
500 KB
|
| 2028 |
Oral Baricitinib
|
|
316 KB
|
| 2029 |
Evenamide
|
|
608 KB
|
| 2030 |
HD204 to Avastin®
|
|
513 KB
|
| 2031 |
Aceclofenac Topical ointment 1.5% w/wIII
|
|
2285 KB
|
| 2032 |
Beclomethasone
|
|
1765 KB
|
| 2033 |
Evenamide
|
|
608 KB
|
| 2034 |
Ulipristal acetate tablet 30mgIII
|
|
2555 KB
|
| 2035 |
IVIEW-1201
|
|
264 KB
|
| 2036 |
Sertaconazole Nitrate + Terbinafine HCl cream (Phase III Clinical Trial)
|
|
643 KB
|
| 2037 |
Ribiciclib
|
|
289 KB
|
| 2038 |
INTP24 against Avastin® in
|
|
468 KB
|
| 2039 |
PMZ-1620
|
|
320 KB
|
| 2040 |
Nonacog Alfa(recombinant coagulation factor IX
|
|
115 KB
|
| 2041 |
PMZ-1620
|
|
320 KB
|
| 2042 |
Tenecteplase
|
|
123 KB
|
| 2043 |
Adenosine IP + Minoxidil IP Topical solution (Phase II Clinical Trial)
|
|
626 KB
|
| 2044 |
Benidipine Hydrochloride JP + Chlorthalidone IP Film coated tablets (Phase III Clinical Trial
|
|
580 KB
|
| 2045 |
Benidipine Hydrochloride + Metoprolol Succinate eq. to Metoprolol tartrate IP Film coated tablet (Phase III Clinical Trial)
|
|
357 KB
|
| 2046 |
AS012
|
|
230 KB
|
| 2047 |
Lenalidomide
|
|
267 KB
|
| 2048 |
Osimertinib in Combination with Savolitinib
|
|
492 KB
|
| 2049 |
Crizanlizumab
|
|
303 KB
|
| 2050 |
Golimumab
|
|
114 KB
|
| 2051 |
Biphasic Isophane Insulinm
|
|
187 KB
|
| 2052 |
RabiesHumanMonoclonalAntibody
|
|
142 KB
|
| 2053 |
Isophane Insulin
|
|
337 KB
|
| 2054 |
Saroglitazar tablet 4mg II
|
|
2058 KB
|
| 2055 |
Biapenem 300 mg inj
|
|
368 KB
|
| 2056 |
Sulbactam-ETX2514
|
|
427 KB
|
| 2057 |
Rifapentine plus Isoniazid
|
|
259 KB
|
| 2058 |
Toujeo 300 Units/ml
|
|
486 KB
|
| 2059 |
Ropivacaine Readyfusor 2mg/mlIII
|
|
2629 KB
|
| 2060 |
IQVIA
|
|
213 KB
|
| 2061 |
Acotiamide ER tablet 300 tabletIII
|
|
2090 KB
|
| 2062 |
Recombinant Hepatitis E Vaccine
|
|
155 KB
|
| 2063 |
Oral Galactose
|
|
252 KB
|
| 2064 |
Vi-capsular Polysaccharide-CRM197 Conjugate Typhoid Vaccine
|
|
284 KB
|
| 2065 |
Semaglutide (NN9535-4352)
|
|
429 KB
|
| 2066 |
Semaglutide
|
|
429 KB
|
| 2067 |
Pneumococcal polysaccharide conjugate vaccine (14-valent)
|
|
283 KB
|
| 2068 |
2Ó-Methyl-Phosphorothioate Anti Sense Oligoribonucleotide for treating patients with Duchenne Muscular Dystrophy
|
|
231 KB
|
| 2069 |
Curcumin (Biocurcumax cap) as an adjunct drug to standard therapy [(Artesunate) + (Sulfadoxine-Pyrimethamine) tablet]
|
|
238 KB
|
| 2070 |
Typhoid Vi Conjugate Vaccine
|
|
280 KB
|
| 2071 |
Cetuximab
|
|
182 KB
|
| 2072 |
Xlucane versus Lucentis®
|
|
443 KB
|
| 2073 |
Neoadjuvant/adjuvantDurvalumab
|
|
427 KB
|
| 2074 |
Durvalumab
|
|
427 KB
|
| 2075 |
Rituximab Biosimilar (DRL_RI) with MabThera®
|
|
434 KB
|
| 2076 |
Tirzepatide
|
|
432 KB
|
| 2077 |
Baricitinib
|
|
194 KB
|
| 2078 |
Phenobarbital Sodium Injection
|
|
191 KB
|
| 2079 |
METREXASSIST™
|
|
194 KB
|
| 2080 |
FDC of Daclatasvir Dihydrochloride Eq. to Daclatasvir 60mg Sofosbuvir 400mg film coated tablets (Phase IV)
|
|
1031 KB
|
| 2081 |
Trastuzumab
|
|
124 KB
|
| 2082 |
C.O.M.B.A.T
|
|
222 KB
|
| 2083 |
esidustat vs Darbepoetin
|
|
295 KB
|
| 2084 |
Sodium Fusidate eq. To Fusidic acid 2% w/w (Sofinox gel)
|
|
3105 KB
|
| 2085 |
Saroglitazar 2mg & 4mg Tablet
|
|
2767 KB
|
| 2086 |
Oral Nafithromycin vs oral Moxifloxacin
|
|
417 KB
|
| 2087 |
Tacrolimus lipid tablet 3mg
|
|
2677 KB
|
| 2088 |
Olaparib
|
|
250 KB
|
| 2089 |
TRC160334
|
|
295 KB
|
| 2090 |
Rivaroxaban tablets 2.5mg (Xarelto®)
|
|
2579 KB
|
| 2091 |
Typhoid Conjugate vaccineApril11
|
|
301 KB
|
| 2092 |
Biphasic Isophane insulin
|
|
109 KB
|
| 2093 |
Fitusira
|
|
419 KB
|
| 2094 |
SB12 and Soliris
|
|
202 KB
|
| 2095 |
Durvalumab
|
|
208 KB
|
| 2096 |
SAR341402 Mix 70/30 to NovoMix®3
|
|
337 KB
|
| 2097 |
Galcanezumab
|
|
327 KB
|
| 2098 |
Norditropin®
|
|
427 KB
|
| 2099 |
Lasmiditan
|
|
334 KB
|
| 2100 |
Typhoid Conjugate vaccine
|
|
301 KB
|
| 2101 |
Typhoid Conjugate vaccineTCV
|
|
299 KB
|
| 2102 |
Pharmacokinetic and Pharmacodynamic
|
|
476 KB
|
| 2103 |
Pharmacokinetics of Murepavadin
|
|
248 KB
|
| 2104 |
IMU-131 HER2/neu
|
|
427 KB
|
| 2105 |
Ipatasertib in Combination with Paclitaxel
|
|
194 KB
|
| 2106 |
Inactivated Japanese Encephalitis Vaccine
|
|
451 KB
|
| 2107 |
Trastuzumab powder for concentrate for solution for intravenous infusion
|
|
120 KB
|
| 2108 |
Inactivated poliomyelitis vaccine 12March
|
|
149 KB
|
| 2109 |
10-valent Pneumococcal Conjugate Vaccine
|
|
322 KB
|
| 2110 |
Etanercept
|
|
103 KB
|
| 2111 |
Octenidine Dihydrochloride
|
|
318 KB
|
| 2112 |
Bedaquiline, Delamanid, Linezolid and Clofazimine
|
|
267 KB
|
| 2113 |
Cetilistat
|
|
394 KB
|
| 2114 |
Bibrocathol 2% Eye ointment
|
|
303 KB
|
| 2115 |
Probiotic Supplementation lactic acid bacteria and Bifidobacteria, namely, L. Plantarum DSM24730, L. paracasei DSM 24733, L. delbrueckii subsp. Bulgaricus DSM 24734, L. acidophilus DSM24735, B. longam, DSM24736, B. Infantis DSM 24737, B. breve DSM 24732, and S. thermophilus DSM 24731 which is to be reconstituted with MCT oil drop with Medium Chain Triglyceride (MCT) oil
|
|
2042 KB
|
| 2116 |
Norethisterone CR tablet 15mg
|
|
2068 KB
|
| 2117 |
Teneligliptin and Sitagliptin
|
|
247 KB
|
| 2118 |
secukinumab SUNSHINE
|
|
570 KB
|
| 2119 |
iGlarLixi versus premixed
|
|
321 KB
|
| 2120 |
Secukinumab SUNRISE
|
|
570 KB
|
| 2121 |
Edoxaban tosylate
|
|
220 KB
|
| 2122 |
Durvalumab in combination
|
|
423 KB
|
| 2123 |
Inactivated poliomyelitis vaccine
|
|
488 KB
|
| 2124 |
Liquid ROTAVAC 5CM (Live Attenuated Rotavirus Vaccine)
|
|
277 KB
|
| 2125 |
Alfuzosin Hydrochloride IP (extended release form) Tadalafil IP film coated tablets (Phase III)
|
|
1141 KB
|
| 2126 |
Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil Cilnidipine film coated bilayaered tablet (Phase III)
|
|
1652 KB
|
| 2127 |
Evaluation of Vitamin D Supplementation in affecting the outcome of newly Diagnosed patients with Lymphoma
|
|
217 KB
|
| 2128 |
Tacrolimus lipid suspension 4mg/vial
|
|
1294 KB
|
| 2129 |
Oxaceprol tablet 600mg
|
|
1358 KB
|
| 2130 |
Baricitinib SLE
|
|
581 KB
|
| 2131 |
Ofatumumab toterability
|
|
195 KB
|
| 2132 |
Bepotastine besilate JP Montelukast Sodium IP tablets (Phase III)
|
|
1067 KB
|
| 2133 |
Beclomethasone Dipropionate
|
|
581 KB
|
| 2134 |
Ivermectin Lotion,0.5%
|
|
223 KB
|
| 2135 |
Durvalumab Monotherapy
|
|
355 KB
|
| 2136 |
Natalizumab
|
|
105 KB
|
| 2137 |
Follitropin delta
|
|
330 KB
|
| 2138 |
15-Valent Pneumococcal Conjugate Vaccine (PCV15)
|
|
322 KB
|
| 2139 |
Phase 3 Relamorelin
|
|
413 KB
|
| 2140 |
Benidipine Hydrochloride IP Telmisartan IP Film coated tablets (Phase III)
|
|
1695 KB
|
| 2141 |
Measles and Rubella Vaccine (Live)
|
|
320 KB
|
| 2142 |
JHL1101
|
|
498 KB
|
| 2143 |
Rotavirus Vaccine
|
|
321 KB
|
| 2144 |
efficacy ART-123
|
|
439 KB
|
| 2145 |
Relamorelin gastroparesis
|
|
238 KB
|
| 2146 |
Mirabegron (in extended release) Solifenacin Succinate Film coated bilayered tablets (Phase III)
|
|
1117 KB
|
| 2147 |
SHP640
|
|
196 KB
|
| 2148 |
Teriflunomide tab 14 mg
|
|
428 KB
|
| 2149 |
PNB028
|
|
266 KB
|
| 2150 |
HRF-4467
|
|
228 KB
|
| 2151 |
Durvalumab plus Olaparib
|
|
1481 KB
|
| 2152 |
M/s Reliance Life Sciences Pvt Ltd.
|
|
1313 KB
|
| 2153 |
Prednisone delayed Release Tablet 5 mg
|
|
2670 KB
|
| 2154 |
Itraconazole
|
|
1378 KB
|
| 2155 |
Dexamethasone Sodium Phosphate
|
|
1600 KB
|
| 2156 |
Relamorelin
|
|
1680 KB
|
| 2157 |
Durvalumab as Consolidation therapy
|
|
1497 KB
|
| 2158 |
Enbrel®’ (Etanercept
|
|
1379 KB
|
| 2159 |
Single dose Del Nido vs multi dose StThomas II Cardioplegia
|
|
235 KB
|
| 2160 |
PMZ-2010
|
|
283 KB
|
| 2161 |
CPL-2009-0031 tablet 140 mg
|
|
277 KB
|
| 2162 |
Azacitidine
|
|
239 KB
|
| 2163 |
CPL-2009-0031 tablet 140 mg of Cadila Pharmaceutical Ltd
|
|
222 KB
|
| 2164 |
Denosumab (120 mg/1.7 mL)
|
|
352 KB
|
| 2165 |
Durvalumab
|
|
1405 KB
|
| 2166 |
LNP3794 in apatients
|
|
1411 KB
|
| 2167 |
Pembrolizumab
|
|
1412 KB
|
| 2168 |
Crizanlizumab
|
|
1410 KB
|
| 2169 |
Dupilumab
|
|
1781 KB
|
| 2170 |
Ifetroban
|
|
1415 KB
|
| 2171 |
Ivabradine Tablets
|
|
2291 KB
|
| 2172 |
CT-P16
|
|
1586 KB
|
| 2173 |
TX05
|
|
1595 KB
|
| 2174 |
Herceptin® or TX05
|
|
1438 KB
|
| 2175 |
Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5%
|
|
1449 KB
|
| 2176 |
NexoBrid
|
|
1513 KB
|
| 2177 |
PXL01
|
|
1568 KB
|
| 2178 |
Semaglutide
|
|
1601KB
|
| 2179 |
ligelizumab (QGE031)
|
|
1696 KB
|
| 2180 |
tropifexor (LJN452) and cenicriviroc (CVC)
|
|
1460 KB
|
| 2181 |
Selinexor (KPT-330
|
|
1592 KB
|
| 2182 |
Ligelizumab (QGE031)
|
|
1614 KB
|
| 2183 |
Cefepime-Tazobactam vs. Meropenem
|
|
1484 KB
|
| 2184 |
ZS (sodium zirconium cyclosilicate
|
|
1636 KB
|
| 2185 |
Aztreonam-Avibactam (Atm-Avi)
|
|
1491 KB
|
| 2186 |
Coversin
|
|
1489 KB
|
| 2187 |
Azelnidipine tab 8 mg / 16 mg
|
|
287 KB
|
| 2188 |
Pembrolizumab (KEYTRUDA®)
|
|
1343 KB
|
| 2189 |
Epinephrine plus Vasopressin
|
|
226KB
|
| 2190 |
Azacitidine 100 mg
|
|
280 KB
|
| 2191 |
ENZ110 (similar biologic of Romiplostim)
|
|
1326 KB
|
| 2192 |
Saroglitazar Magnesium
|
|
17176 KN
|
| 2193 |
Bevacizumabbio
|
|
1366 KB
|
| 2194 |
BevacizumabM/s. Intas
|
|
1366 KB
|
| 2195 |
VELPANAT
|
|
197 KB
|
| 2196 |
Azelnidipine
|
|
371 KB
|
| 2197 |
FDC of Efonidipine Hydrochloride Ethanolate + Metoprolol Succinate IP (as extended release) (20 mg+25mg & 20mg+50mg) Film coated tablets.
|
|
17177 KB
|
| 2198 |
Pegfilgrastim (ZRC-3128)
|
|
1409 KB
|
| 2199 |
Doxycycline
|
|
225 KB
|
| 2200 |
Pregabalin
|
|
212 KB
|
| 2201 |
Bedaquiline, Delamanid, Linezolid and Clofazimine
|
|
218 KB
|
| 2202 |
fecombinant human follicle stimulating hormone (r-h-FSH)
|
|
1407 KB
|
| 2203 |
recombinant human follicle stimulating hormone (r-h-FSH)
|
|
1407 KB
|
| 2204 |
PMZ-1620
|
|
259 KB
|
| 2205 |
Enterogermina
|
|
179 KB
|
| 2206 |
Desidustat ZYAN1
|
|
236 KB
|
| 2207 |
Tulobuterol Transdermal
|
|
239 KB
|
| 2208 |
Nexagon® (NEXAGON)
|
|
1530 KB
|
| 2209 |
Tapentadol nasal spray 225mg/ml
|
|
966 KB
|
| 2210 |
Semaglutide
|
|
1637 KB
|
| 2211 |
Nitazoxanide 500 mg Tablets
|
|
1696 KB
|
| 2212 |
Granexin Gel
|
|
545 KB
|
| 2213 |
Edoxaban
|
|
1794 KB
|
| 2214 |
Aztreonam-Avibactam (ATM-AVI Pfizer
|
|
2029 KB
|
| 2215 |
Mirikizumab
|
|
1850 KB
|
| 2216 |
Ticagrelor
|
|
1672 KB
|
| 2217 |
LCZ696
|
|
1762 KB
|
| 2218 |
5-aminolevulinic acid hydrochloride
|
|
1845 KB
|
| 2219 |
Efpeglenatide
|
|
444 KB
|
| 2220 |
EG12014
|
|
1782 KB
|
| 2221 |
Brolucizumab
|
|
1822 KB
|
| 2222 |
Osilodrostat (LCI699
|
|
1794 KB
|
| 2223 |
Mirikizumab
|
|
1786 KB
|
| 2224 |
KAF156
|
|
1902 KB
|
| 2225 |
Esmolol Hydrochloride 14.00% w/w topical gel
|
|
1298 KB
|
| 2226 |
FDC of Daclatasvir dihydrochloride eq to Daclatasvir 60mg + Sofosbuvir 400mg film coated tablets
|
|
1246 KB
|
| 2227 |
Clostridium Botulinum Type-A Toxin Haemagglutinin complex injection 300 units
|
|
1737 KB
|
| 2228 |
Dalfampridine
|
|
124 KB
|
| 2229 |
Osimertinib
|
|
1773 KB
|
| 2230 |
Apremilast Tablets 10/20/30mg Phase IV .
|
|
1708 KB
|
| 2231 |
FDC of Metoprolol Tartrate IP + Ivabradine HCL eq to Ivabradine (25mg+5mg & 50mg+5mg) Film coated tablets
|
|
1316 KB
|
| 2232 |
FDC of Metoprolol Succinate ER + Cilnidipine +Telmisartan (25mg + 10mg + 40mg & 50mg + 10mg + 40mg) Tablets
|
|
1300 KB
|
| 2233 |
Mirikizumab
|
|
1786 KB
|
| 2234 |
EG12014
|
|
1782 KB
|
| 2235 |
Mirikizumab
|
|
1850 KB
|
| 2236 |
Edoxaban
|
|
1794 KB
|
| 2237 |
Osilodrostat (LCI699
|
|
1794 KB
|
| 2238 |
LCZ696
|
|
1762 KB
|
| 2239 |
Pilot study on Paracetamol Injection for IM route Pilot study
|
|
1593 KB
|
| 2240 |
Paracetamol Injection 500mg/2ml for IM route Phase III
|
|
1960 KB
|
| 2241 |
Bilastine 20 mg
|
|
312 KB
|
| 2242 |
Magnesium sulfate
|
|
116 KB
|
| 2243 |
Dolutegravir (Phase IV)
|
|
78.6 KB
|
| 2244 |
TRC041266
|
|
195 KB
|
| 2245 |
Nitazoxanide 500 mg Tablets
|
|
1696 KB
|
| 2246 |
5-aminolevulinic acid hydrochloride
|
|
1854 KB
|
| 2247 |
Scrub Typhus INTREST
|
|
1820 KB
|
| 2248 |
Granexin Gel
|
|
545 KB
|
| 2249 |
Aztreonam-Avibactam (ATM-AVI
|
|
2029 KB
|
| 2250 |
Brolucizumab
|
|
1822 KB
|
| 2251 |
KAF156
|
|
1902 KB
|
| 2252 |
Ticagrelor
|
|
1672 KB
|
| 2253 |
Tagrisso (Osimertinib)
|
|
137 KB
|
| 2254 |
Kyprolis (Carfilzomib)
|
|
184 KB
|
| 2255 |
Sodium Copper Chlorophyllin
|
|
155 KB
|
| 2256 |
Efonidipine Hydrochloride Ethanolate 20mg + Telmisartan IP 40mg film coated Tablets (Phase-III)
|
|
1,008 KB
|
| 2257 |
Pregabalin IP (As Prolonged Release) 75mg + Etoricoxib IP 60mg uncoated bilayered tablets (Phase-III).
|
|
1,195 KB
|
| 2258 |
Azilsartan Medoxomil + Chlorthalidone (40mg+25mg,40mg+12.5mg 40mg+6.25mg) Tablets (Phase-III).
|
|
1,118 KB
|
| 2259 |
Alcaftadine 0.25% w/v + Ketoroloc Tromethamine 0.4% w/v Eye drops (Phase-III).
|
|
1,163 KB
|
| 2260 |
Tadalafil + Dapoxetine (20mg +60mg, 20mg+30mg, 10mg+30mg) film coated tablets (Phase-III).
|
|
949 KB
|
| 2261 |
Metoprolol Succinate ER + Chlorthalidone + Telmisartan (50mg+12.5mg+40mg, 25mg+12.5mg+40mg)film coated tablets (Phase-III)
|
|
1,027 KB
|
| 2262 |
Semaglutide 2.4 mg
|
|
1,722 KB
|
| 2263 |
Efpeglenatide
|
|
444 KB
|
| 2264 |
Sotagliflozin
|
|
1,910 KB
|
| 2265 |
Filgotinib
|
|
1,786 KB
|
| 2266 |
Durvalumab
|
|
260 KB
|
| 2267 |
Cinacalcet Hydrochloride
|
|
1,710 KB
|
| 2268 |
Semaglutide 2.4 mg
|
|
1,708 KB
|
| 2269 |
emaglutide 2.4 mg CT/18/000019
|
|
1,708 KB
|
| 2270 |
Azelnidipine tab 16 mg
|
|
130 KB
|
| 2271 |
Delamanid
|
|
82 KB
|
| 2272 |
Enzalutamide
|
|
98.6 KB
|
| 2273 |
Desidustat
|
|
106 KB
|
| 2274 |
Calcipotriol/AKVANO 50 µg/g cutaneous solution
|
|
1,737,836 KB
|
| 2275 |
Efpeglenatide
|
|
444 KB
|
| 2276 |
Permission for conducting a Phase rB/IlA 'clinical study entitled , "A Phase IS /IrA, multi-center , open-label clinical trial to evaluate the safety, to lerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis "
|
|
97KB
|
| 2277 |
Permission for conducting A Phase 3 clinical trial titled "ATLAS- INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, With Inhibitory Antibodies to Factor VIII or IX
|
|
143KB
|
| 2278 |
Permission for conducting a clinical study entitle d, "A multicentric , Randomized , double blind , parallel group, comparative, Phase 3 clinical study to evaluate the efficacy, Safety and Tolerability of Azelnidipine Tablets 16 mg verus Amlodipine Tablets 10 mg in subjects with essential hypertension "
|
|
128KB
|
| 2279 |
Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB"
|
|
76KB
|
| 2280 |
Ivermectin topical lotion 0.5% w/w
|
|
1,858,593 KB
|
| 2281 |
Darunavir Tablet 800mg
|
|
143KB
|
| 2282 |
qHPV Vaccine
|
|
1862 KB
|
| 2283 |
Erdafitinib
|
|
1803 KB
|
| 2284 |
Permission for conducting a clinical study entitled , "A multicenter Phase-4 , Open-label, Single-arm, Safety and Efficacy Study of Enzalutarnide in Indian Patients with Progressive Metastatic Castration -Resistant Prostate Cancer (mCRPC) Previously Treated with Docetaxel-Based Chemotherapy"
|
|
105KB
|
| 2285 |
Canakinumab
|
|
1877 KB
|
| 2286 |
Paliperidone Palmitate
|
|
1757 KB
|
| 2287 |
Rigosertib
|
|
1688 KB
|
| 2288 |
Fitusiran
|
|
1875 KB
|
| 2289 |
Atezolizumab
|
|
1769 KB
|
| 2290 |
Baricitinib
|
|
300KB
|
| 2291 |
AMG 334
|
|
392KB
|
| 2292 |
Baricitinib
|
|
300KB
|
| 2293 |
Torsemide Extended Release
|
|
568KB
|
| 2294 |
QAW039
|
|
570KB
|
| 2295 |
NexoBrid
|
|
302KB
|
| 2296 |
Emicizumab
|
|
371KB
|
| 2297 |
MB02 (Bevacizumab Biosimilar Drug)
|
|
573KB
|
| 2298 |
Rilpivirine
|
|
577KB
|
| 2299 |
YLB113
|
|
299KB
|
| 2300 |
Exenatide
|
|
373KB
|
| 2301 |
SCY 078
|
|
242KB
|
| 2302 |
Pimodivir
|
|
1718 KB
|
| 2303 |
CLS-TA
|
|
1814 KB
|
| 2304 |
Pimodivir15
|
|
1640 KB
|
| 2305 |
Fitusiran
|
|
1758 KB
|
| 2306 |
ASN100
|
|
1753 KB
|
| 2307 |
MEDI-551
|
|
1763 KB
|
| 2308 |
Regorafenib
|
|
140KB
|
| 2309 |
Fluticasone Propionate 100 mcg and Salmeterol 50 mcg
|
|
1750 KB
|
| 2310 |
QVM149
|
|
1804 KB
|
| 2311 |
Lenvatinib
|
|
143KB
|
| 2312 |
Sofosbuvir / Velpatasvir FDC
|
|
100KB
|
| 2313 |
Februric (Febuxostat)
|
|
103KB
|
| 2314 |
Pirfenidone
|
|
100KB
|
| 2315 |
Anagliptin
|
|
162KB
|
| 2316 |
Verapamil ER
|
|
193KB
|
| 2317 |
Heptral
|
|
105KB
|
| 2318 |
Spironolactone cream 5%
|
|
926KB
|
| 2319 |
Heptral
|
|
105kb
|
| 2320 |
BIO-11006
|
|
565 KB
|
| 2321 |
LUBT010
|
|
371 KB
|
| 2322 |
Ataluren
|
|
269 KB
|
| 2323 |
ABP 798
|
|
340 KB
|
| 2324 |
ribociclib with endocrine
|
|
423 KB
|
| 2325 |
Nintedanib Systemic Sclerosis
|
|
404 KB
|
| 2326 |
Selinexor (KPT-330)
|
|
445 KB
|
| 2327 |
Povidone-Iodine Nail Solution
|
|
103 KB
|
| 2328 |
Dinutuximab and Irinotecan
|
|
456 KB
|
| 2329 |
SB11
|
|
282 KB
|
| 2330 |
Atezolizumab compared with chemotherapy
|
|
109 KB
|
| 2331 |
Lorlatinib (PF-06463922)
|
|
470 KB
|
| 2332 |
Dapagliflozin 5 and 10 mg
|
|
447 KB
|
| 2333 |
Canagliflozin in Children
|
|
439 KB
|
| 2334 |
Denosumab
|
|
320 KB
|
| 2335 |
CLS-TA Sapphire
|
|
100 KB
|
| 2336 |
Selinexor
|
|
448 KB
|
| 2337 |
Bempedoic Acid (ETC-1002)
|
|
582 KB
|
| 2338 |
LJN452
|
|
367 KB
|
| 2339 |
Atezolizumab(ANTI-PD-L1Antibody)
|
|
907 KB
|
| 2340 |
Ticagrlor
|
|
1115 KB
|
| 2341 |
Deferasirox Formulation(Granules)
|
|
842 KB
|
| 2342 |
Ruxolitinib
|
|
849 KB
|
| 2343 |
LCZ696 on NT Pro BNP
|
|
1117 KB
|
| 2344 |
QAW039 sept
|
|
1132 KB
|
| 2345 |
Ixekizumab
|
|
1165 KB
|
| 2346 |
Alpelisib
|
|
861 KB
|
| 2347 |
PEGylated factor
|
|
1154 KB
|
| 2348 |
Abemaciclib
|
|
1210 KB
|
| 2349 |
Apixaban
|
|
1104 KB
|
| 2350 |
RSV
|
|
868 KB
|
| 2351 |
Empagliflozin 10mg
|
|
1138 KB
|
| 2352 |
Empagliflozin
|
|
1228 KB
|
| 2353 |
LY900014 (Insulin Lispro)
|
|
1115 KB
|
| 2354 |
Dapagliflozin PC D1699C00001
|
|
1064 KB
|
| 2355 |
SAIT101 vs Rituximab
|
|
1353 KB
|
| 2356 |
ANF-Rho
|
|
1125 KB
|
| 2357 |
QMF149 150-80 microgram
|
|
1039 KB
|
| 2358 |
MOD-4023
|
|
1274 KB
|
| 2359 |
Canagliflozin
|
|
1121 KB
|
| 2360 |
Ribociclib
|
|
846 KB
|
| 2361 |
LNP1892
|
|
1018 KB
|
| 2362 |
Eltrombopag
|
|
867 KB
|
| 2363 |
Dulaglutide
|
|
985 KB
|
| 2364 |
SPI-2012
|
|
876 KB
|
| 2365 |
Safety Study of Atezolizumab
|
|
814 KB
|
| 2366 |
ovidone -Iodine
|
|
1133 KB
|
| 2367 |
sFilgotinib
|
|
1171 KB
|
| 2368 |
Secukinumab
|
|
888 KB
|
| 2369 |
Filgotinib Rheumatoid
|
|
842 KB
|
| 2370 |
Filgotinib Crohn
|
|
1203 KB
|
| 2371 |
Filgotinib combined phase
|
|
1008 KB
|
| 2372 |
LNP3794
|
|
819 KB
|
| 2373 |
Filgotinib Administered
|
|
196 KB
|
| 2374 |
Tenofovir Alafenamide
|
|
1111 KB
|
| 2375 |
LY900014
|
|
1048 KB
|
| 2376 |
Filgotinib
|
|
198 KB
|
| 2377 |
Dapagliflozin
|
|
1168 KB
|
| 2378 |
CLS-TA
|
|
59 KB
|
| 2379 |
Selonsertib NASH
|
|
1326 KB
|
| 2380 |
Filgotinib safety
|
|
1238 KB
|
| 2381 |
Ribociclib LEE011
|
|
831 KB
|
| 2382 |
Selonsertib
|
|
1320 KB
|
| 2383 |
Masitinib vs Placebo
|
|
807 KB
|
| 2384 |
Pemafibrate
|
|
1356 KB
|
| 2385 |
Bedaquiline
|
|
152 KB
|
| 2386 |
Daprodustat
|
|
183 KB
|
| 2387 |
aprodustat
|
|
227 KB
|
| 2388 |
Oral Semaglutide versus
|
|
192 KB
|
| 2389 |
LCZ696
|
|
145 KB
|
| 2390 |
SAIT101
|
|
148 KB
|
| 2391 |
Alphanate®
|
|
139 KB
|
| 2392 |
TK-112690
|
|
172 KB
|
| 2393 |
Ofatumumab safety
|
|
186 KB
|
| 2394 |
Etrolizumab PhaseII/III
|
|
204 KB
|
| 2395 |
Clindamycin phosphate
|
|
178 KB
|
| 2396 |
Ofatumumab
|
|
188 KB
|
| 2397 |
Pradaxa Capsules
|
|
155 KB
|
| 2398 |
Etrolizumab
|
|
207 KB
|
| 2399 |
DE-117
|
|
200 KB
|
| 2400 |
Lixisenatide
|
|
204 KB
|
| 2401 |
QVA149
|
|
294 KB
|
| 2402 |
Aclidinium
|
|
229 KB
|
| 2403 |
Nintedanib oral
|
|
197 KB
|
| 2404 |
Sarizotan
|
|
142 KB
|
| 2405 |
LY2835219
|
|
295 KB
|
| 2406 |
Palbociclib
|
|
178 KB
|
| 2407 |
FIASP
|
|
143 KB
|
| 2408 |
CBT124
|
|
222 KB
|
| 2409 |
Avelumab
|
|
150 KB
|
| 2410 |
Insulin Degludec
|
|
156 KB
|
| 2411 |
Guidance document for Functions and Responsibilities of Zonal, Sub-zonal & port offices of CDSCO
|
|
4,818kb
|
| 2412 |
Guidance Document for Export NOC
|
|
137kb
|
| 2413 |
Manual of OCTAMS
|
|
4,561kb
|
| 2414 |
Guidance for global access of OCTAMS
|
|
1,138kb
|
| 2415 |
Report Book
|
|
5,165kb
|
| 2416 |
Sofosbuvir Velpatasvir
|
|
158 KB
|
| 2417 |
Cardiovascular safety of Oral Semaglutide
|
|
216 KB
|
| 2418 |
Budesonide
|
|
150 KB
|
| 2419 |
Vedolizumab IV
|
|
152 KB
|
| 2420 |
MYL-14020
|
|
280 KB
|
| 2421 |
Dexamethasone sodium
|
|
141 KB
|
| 2422 |
Pegylated Interferon @-2a
|
|
143 KB
|
| 2423 |
BCD-055
|
|
148 KB
|
| 2424 |
Liraglutide
|
|
136 KB
|
| 2425 |
NC0195-0092
|
|
130 KB
|
| 2426 |
QAW039
|
|
128 KB
|
| 2427 |
Oral Semaglutide
|
|
133 KB
|
| 2428 |
GS-5745
|
|
138 KB
|
| 2429 |
RFB002
|
|
135 KB
|
| 2430 |
Trimcinolone Acetonide
|
|
173 KB
|
| 2431 |
Semaglutide IGlar SGT2i
|
|
160 KB
|
| 2432 |
Rivaroxaban
|
|
148 KB
|
| 2433 |
MEDI4736 aug
|
|
211 KB
|
| 2434 |
Ceritinib
|
|
144 KB
|
| 2435 |
MEDI4736
|
|
189 KB
|
| 2436 |
INC280
|
|
2112 KB
|
| 2437 |
Ticagrelor
|
|
158 KB
|
| 2438 |
Indacaterol
|
|
277 KB
|
| 2439 |
QMF149
|
|
225 KB
|
| 2440 |
BIASP-30
|
|
198 KB
|
| 2441 |
Insulin Aspart
|
|
195 KB
|
| 2442 |
NW-3509A
|
|
153 KB
|
| 2443 |
Insulin degludec may
|
|
216 KB
|
| 2444 |
Lopinavir/Ritonavir
|
|
144 KB
|
| 2445 |
MDR-TB Drugs
|
|
151 KB
|
| 2446 |
Sofosbuvir
|
|
143 KB
|
| 2447 |
B1695502
|
|
225 KB
|
| 2448 |
RLX030
|
|
190 KB
|
| 2449 |
Clindamycin
|
|
189 KB
|
| 2450 |
Semaglutide 2016
|
|
256 KB
|
| 2451 |
Masitinib
|
|
178 KB
|
| 2452 |
Carbetocin RTS
|
|
1542 KB
|
| 2453 |
YLB113
|
|
184 KB
|
| 2454 |
Insulin degludec
|
|
245 KB
|
| 2455 |
BYL719
|
|
189 KB
|
| 2456 |
LEE011
|
|
183 KB
|
| 2457 |
Nintedanib
|
|
204 KB
|
| 2458 |
Pregabali
|
|
182 KB
|
| 2459 |
Bevacizumab
|
|
181 KB
|
| 2460 |
Pregabalin
|
|
182 KB
|
| 2461 |
Recruitment Rule of Drugs Inspector in CDSCO
|
|
2,512kb
|
| 2462 |
Alirocumab
|
|
191 KB
|
| 2463 |
CT P10
|
|
186 KB
|
| 2464 |
QGE031 CQGE031B2201
|
|
166 KB
|
| 2465 |
QGE031 S.c
|
|
191 KB
|
| 2466 |
FG-3019s
|
|
190 KB
|
| 2467 |
Roxadustat
|
|
187 KB
|
| 2468 |
Roxadustat Anemia
|
|
190 KB
|
| 2469 |
GENA-05
|
|
160 KB
|
| 2470 |
Subcutaneous Secukinumab
|
|
221 KB
|
| 2471 |
Dydrogesterone
|
|
178 KB
|
| 2472 |
Pregabalin as adjunctive
|
|
171 KB
|
| 2473 |
Linaclotide
|
|
225 KB
|
| 2474 |
LCZ696 NYHA
|
|
204 KB
|
| 2475 |
LCZ696 Paradigm
|
|
235 KB
|
| 2476 |
Moroctocog alfa
|
|
166 KB
|
| 2477 |
RanibizumAB
|
|
173 KB
|
| 2478 |
Canagloflozin
|
|
209 KB
|
| 2479 |
Steroids in Iga
|
|
181 KB
|
| 2480 |
Insulin Aspart BIAsp
|
|
201 KB
|
| 2481 |
Salmeterol
|
|
193 KB
|
| 2482 |
Masitinib Lymphoma
|
|
189 KB
|
| 2483 |
LEE011 NSAI
|
|
182 KB
|
| 2484 |
Amended Checklist for test License Applications Effective From 15 June2011
|
|
69kb
|
| 2485 |
Checklist for Test License Appli8cations Effective From 15 June 2011
|
|
143kb
|
| 2486 |
Guidance Document on Grant of Licenses in Form 11(Test License)
|
|
618kb
|
| 2487 |
DE-109
|
|
180 KB
|
| 2488 |
Octafibrin
|
|
170 KB
|
| 2489 |
ACTG 5288
|
|
170 KB
|
| 2490 |
Dabigatran etexilate dual
|
|
239 KB
|
| 2491 |
Clindamycin 1%
|
|
215 KB
|
| 2492 |
Bococizumab PF-04950615)
|
|
368 KB
|
| 2493 |
Bococizumab
|
|
369 KB
|
| 2494 |
LEE011 with Lerozole
|
|
184 KB
|
| 2495 |
Masitinib Folfiri
|
|
209 KB
|
| 2496 |
Masitinib
|
|
210 KB
|
| 2497 |
Fibrinogen
|
|
182 KB
|
| 2498 |
Dabigatran Etexilate
|
|
255 KB
|
| 2499 |
Dabigatran
|
|
197 KB
|
| 2500 |
Chemotherapy
|
|
178 KB
|
| 2501 |
Rituximab
|
|
190 KB
|
| 2502 |
2 PARALLEL Masitinib
|
|
213 KB
|
| 2503 |
Chemoradiation
|
|
162 KB
|
| 2504 |
Ticagelor
|
|
189 KB
|
| 2505 |
QGE031
|
|
183 KB
|
| 2506 |
Isoniazid
|
|
172 KB
|
| 2507 |
Tiotropium
|
|
265 KB
|
| 2508 |
DS-5565
|
|
178 KB
|
| 2509 |
Nifedipine Daga
|
|
165 KB
|
| 2510 |
Nifedipine Daga
|
|
165 KB
|
| 2511 |
Labetalol
|
|
162 KB
|
| 2512 |
Insulin Detemir
|
|
181 KB
|
| 2513 |
LY2963019
|
|
200 KB
|
| 2514 |
NNC0195-0092
|
|
188 KB
|
| 2515 |
Mifepristone
|
|
160 KB
|
| 2516 |
LCI699
|
|
173 KB
|
| 2517 |
Pasireotide
|
|
173 KB
|
| 2518 |
Pasireotidestudy
|
|
171 KB
|
| 2519 |
Mifepristone and Misoprotol
|
|
163 KB
|
| 2520 |
Policy Initiatives Planned for 2015
|
|
85kb
|
| 2521 |
Antidepressant
|
|
149 KB
|
| 2522 |
Octafibrin GCT/64/14
|
|
197 KB
|
| 2523 |
LY2605541
|
|
200 KB
|
| 2524 |
Semaglutide 2014
|
|
198 KB
|
| 2525 |
Alglucosidase Alfa
|
|
164 KB
|
| 2526 |
Dabigatran BI 655075
|
|
223 KB
|
| 2527 |
Ranibizumab VEGF
|
|
180 KB
|
| 2528 |
Ranibizumab CRVO
|
|
180 KB
|
| 2529 |
Ranibizumab Brilliance
|
|
191 KB
|
| 2530 |
Trastuzumab
|
|
216 KB
|
| 2531 |
Afatinib for Patients
|
|
172 KB
|
| 2532 |
Rituximab RTXM83
|
|
185 KB
|
| 2533 |
Afatinib BiBW 2992
|
|
189 KB
|
| 2534 |
Alglucosidase
|
|
171 KB
|
| 2535 |
Herpes Zoster
|
|
169 KB
|
| 2536 |
Pregabalin Adjunctive
|
|
188 KB
|
| 2537 |
Paclitaxel
|
|
178 KB
|
| 2538 |
Eravacycline
|
|
197 KB
|
| 2539 |
UT-15C
|
|
176 KB
|
| 2540 |
Dapagliflozin 10mg
|
|
201 KB
|
| 2541 |
UT-15C Phase III
|
|
189 KB
|
| 2542 |
Bevacizumab AVASTIN
|
|
178 KB
|
| 2543 |
LDK378
|
|
219 KB
|
| 2544 |
Pasireotide LAR
|
|
163 KB
|
| 2545 |
Ifetroban Injection
|
|
192 KB
|
| 2546 |
FactorVIII
|
|
122 KB
|
| 2547 |
Baricitinib in Patients
|
|
222 KB
|
| 2548 |
Adalimumab
|
|
179 KB
|
| 2549 |
Cyclosporine
|
|
190 KB
|
| 2550 |
Fluocinolone acetonide intravitreal
|
|
174 KB
|
| 2551 |
Ranibizumab 0.5 mg
|
|
188 KB
|
| 2552 |
Everolimus with reduced calcineurin
|
|
256 KB
|
| 2553 |
Fosaprepitant
|
|
191 KB
|
| 2554 |
Liraglutide Sitagliptin
|
|
181 KB
|
| 2555 |
Sitagliptin
|
|
213 KB
|
| 2556 |
Masitinib
|
|
198 KB
|
| 2557 |
NOVA22007
|
|
191 KB
|
| 2558 |
QAW039 on FEV1
|
|
184 KB
|
| 2559 |
Clindamycin benzoyal peroxide
|
|
265 KB
|
| 2560 |
Pasireotide S.C
|
|
173 KB
|
| 2561 |
BCD-020
|
|
223 KB
|
| 2562 |
Ciprodex
|
|
212 KB
|
| 2563 |
Remicade
|
|
215 KB
|
| 2564 |
Ceftazidime CAZ AVI
|
|
200 KB
|
| 2565 |
Exenatide
|
|
174 KB
|
| 2566 |
Daclizumab
|
|
186 KB
|
| 2567 |
Enbrel
|
|
194 KB
|
| 2568 |
BCD-021
|
|
214 KB
|
| 2569 |
Buparlisib
|
|
182 KB
|
| 2570 |
Insulin Degludec versus insulin glargine
|
|
277 KB
|
| 2571 |
Liraglutide versus sulphonylurea
|
|
211 KB
|
| 2572 |
BCD-022
|
|
217 KB
|
| 2573 |
tolerability of Secukinumab
|
|
176 KB
|
| 2574 |
Everolimus alone
|
|
183 KB
|
| 2575 |
Everolimus RADOO1
|
|
192 KB
|
| 2576 |
Transfer Policy
|
|
421kb
|
| 2577 |
SAR236553
|
|
681 KB
|
| 2578 |
subcutaneous Secukinumab
|
|
166 KB
|
| 2579 |
Afatinib
|
|
225 KB
|
| 2580 |
Sofosbuvir plus ribavirin
|
|
291 KB
|
| 2581 |
Fluocinolone
|
|
292 KB
|
| 2582 |
Everolimus
|
|
243 KB
|
| 2583 |
Ceftazidime
|
|
283 KB
|
| 2584 |
FLU D-QIV
|
|
278 KB
|
| 2585 |
FIAsP Insulin
|
|
280 KB
|
| 2586 |
FIAsP 2014
|
|
279 KB
|
| 2587 |
Tenofovir Disoproxil
|
|
303 KB
|
| 2588 |
Tenofovir Alafenamide TAF
|
|
314 KB
|
| 2589 |
olasertib
|
|
289 KB
|
| 2590 |
Diclofenac Gel
|
|
370 KB
|
| 2591 |
Baricitinib LY3009104
|
|
348 KB
|
| 2592 |
Baricitinib
|
|
357 KB
|
| 2593 |
BEZ235
|
|
846 KB
|
| 2594 |
TechnologyMG145
|
|
1410 KB
|
| 2595 |
Producttrastuzumab
|
|
926 KB
|
| 2596 |
LAF237
|
|
293 KB
|
| 2597 |
Liraglutide sc Injection
|
|
306 KB
|
| 2598 |
Fesoterodine
|
|
305 KB
|
| 2599 |
Human rh FV III
|
|
301 KB
|
| 2600 |
CP-690,550
|
|
296 KB
|
| 2601 |
Lixisenatid Subcutaneous
|
|
382 KB
|
| 2602 |
Tenofovir
|
|
342 KB
|
| 2603 |
Octefibrin
|
|
290 KB
|
| 2604 |
ART-123
|
|
303 KB
|
| 2605 |
Quotation of rate contract for supply of Photostat Paper (JK Brand) Last date (27 Jul 2012 )
|
|
129kb
|
| 2606 |
Re-tendering for Housekeeping and General cleanliness in the CDSCO(HQ), FDA Bhawan, Kotla Road, New Delhi Last Date ( 27 Jul 2012 )
|
|
903kb
|
| 2607 |
Extension of Date of Notice Inviting Tender (NIT) Last Date( 27 Jul 2012 )
|
|
370kb
|
| 2608 |
Annual Rate Contract for Hiring taxies 1 Last Date( 27 Jul 2012 )
|
|
132kb
|
| 2609 |
Annual Rate Contract for Hiring taxies 2 Last Date ( 27 Jul 2012 )
|
|
1,775kb
|
| 2610 |
Annual Rate Contract for Hiring taxies 3 Last Date( 27 Jul 2012 )
|
|
162kb
|
| 2611 |
Paliperidone Palmitate Prolonged Release Suspension for Injection 25mg/50mg/75mg/100mg and 150mg (Pre-filled Syringes)
|
|
193 KB
|
